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Abbreviations 
AVP arginine  vasopressin 
BSA  bovine serum albumin 
CAPS Ca
2+-dependent activator proteins 
CNS  central nervous system 
csps  cysteine string proteins 
DAB diaminobenzidine 
DMEM  Dulbecco´s Modified Eagle Medium 
EAA  excitatory amino acid 
EDTA ethylenediaminetetraacetic  acid 
EGTA  ethylene glycol bis (β-aminoethyl ether)-N,N,N´,N´-tetraacetate 
ER endoplasmic  reticulum 
FCS  fetal calf serum 
FIFC fluorescein  isothiocyanate 
GABA  γ-aminobutyric acid 
GDI  GDP dissociation inhibitor 
GFAP  glial fibrillary acidic protein 
GFP  green fluorescent protein 
HA hemagglutinin 
HRP horseradish  peroxidase 
LDCV  large dense-core vesicle 
MV microvesicle 
NGF  nerve growth factor  
NMDA N-methyl-D-aspartate 
NSF N-ethylmaleimide-sensitive  factor 
NSG neurosecretory  granule 
OD optical  density 
OT oxytocin 
PB phosphate  buffer 
PBS  phosphate buffered saline 
PVP polyvinyl  pyrrolidon 
RFP  red fluorescent protein 
SDS  sodium dodecyl sulfate 
SNAP-25 synaptosomal  associated protein of 25 kDa 
SNAPs  soluble NSF attachment proteins 
SNARE  soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
t-SNARE  target membrane SNARE 
v-SNARE  vesicle membrane SNARE 
SV2  synaptic vesicle protein 2 
SV synaptic  vesicle 
TBS tris-buffered  saline 
TGN trans-Golgi  network 
VAMP  vesicle-associated membrane protein 
VOCC voltage-operated  Ca
2+ channel 
VSVG  vesicular stomatitis virus glycoprotein 
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1. Introduction 
1.1. Release of messenger substances from synaptic nerve 
terminals and neurosecretory endings 
The messenger substances in nerve endings are packaged in two types of secretory 
vesicles. Upon stimulation, they are released via calcium-dependent regulated exocytosis. The 
synaptic nerve terminals are equipped with morphologically specialized release sites, the 
active zones. In contrast, neurosecretory endings lack active zones. A number of synaptic 
proteins have been identified to be involved in the regulated exocytosis. 
1.1.1. Two primary classes of secretory vesicles  
The release of messenger substances is the fundamental form of intercellular 
communication in the nervous system. Two primary classes of secretory vesicles, synaptic 
vesicles (SVs) and neurosecretory granules (NSGs), have been known to be involved in the 
transmission of messengers in neuronal and neuroendocrine cells (De Camilli and Jahn, 1990; 
Zimmermann, 1990). Synaptic vesicles in fast synapses are responsible for the fast 
information transfer. They are highly homogeneous in size, with an average diameter of ~50 
nm. Synaptic vesicles are electron-lucent and contain some classical low-molecular weight 
messengers, such as glutamate, acetylcholine, glycine, and GABA. They are continuously 
regenerated by local exo-endocytotic recycling in nerve terminals (Regnier-Vigouroux and 
Huttner, 1993). By contrast, neuropeptide transmitters and hormones are packaged in larger, 
more heterogeneous granules. The granules possess an electron dense core and are also called 
large dense-core vesicles (LDCVs). They have a widespread distribution in the nervous tissue 
but are highly enriched in neuroendocrine cells (Thureson-Klein et al., 1986). The 
neurosecretory granules originate from the trans-Golgi network (TGN, Burgess and Kelly, 
1987; Bauerfeind and Huttner, 1993). After exocytosis, they cannot be reloaded in the cell 
periphery. Their membrane constituents must ultimately return to the TGN for regeneration.  
Both synaptic vesicles and neurosecretory granules release their messenger molecules via 
depolarization-induced, Ca
2+-dependent regulated exocytosis, but two distinct release modes 
occur in the nervous system. Docked synaptic vesicles release their contents extremely 
rapidly, within one millisecond  of the influx of calcium (Sabatini and Regehr, 1996). 
However, the latency for exocytosis of peptides is much higher (Leenders et al., 2002; Martin, Introduction  2
1994; Thomas et al., 1993). High frequency of stimulation favors peptide secretion (Jahn et 
al., 1990). The ratio of LDCVs/SVs increases with the enhancement of stimulation frequency. 
Remarkably, the types and the regulation of Ca
2+ channels and the Ca
2+ dependence of 
synaptic vesicle secretion differ clearly from those of the neurosecretory granules. A localized 
submembranous Ca
2+ increase is much more effective in evoking release of synaptic vesicles. 
The local increase in the Ca
2+ concentration at the active zone from the basal level of 100-200 
mM results in the release of docked synaptic vesicles (Mochida, 2000). In contrast, uniform 
elevation of Ca
2+ favors predominantly granule release (Burgoyne, 1991; Verhage et al., 
1991). Moreover, the neurotransmitter release is directly regulated by the different Ca
2+ 
channel types, whereas the cooperativity of multiple Ca
2+ channels in raising the intracellular 
Ca
2+ concentration above release threshold appears to be required for the release regulation of 
secretory granules (Leenders et al., 1999).  Correspondingly, the release site for synaptic 
vesicles and granules is obviously different. The exocytosis of the synaptic vesicles occurs 
only at the active zones, the specialized release site of the presynaptic plasma membrane. By 
contrast, the exocytosis of peptide-containing secretory granules appears to take place 
laterally to the active zone (Thureson-Klein and Klein, 1990), more widely at nerve terminals 
and dendrites (Zhu et al., 1986; Morris and Pow, 1988). Evidently, the exocytosis process of 
these two types of secretory vesicles is differentially controlled (Mochida et al., 1998; 
Leenders et al., 1999; De Camilli and Jahn, 1990; Zimmermann, 1997). 
1.1.2. Synaptic proteins in the regulated exocytosis of synaptic vesicles  
In the central nervous system, the presynaptic terminals of the fast synapses are filled 
predominantly with numerous small electron-lucent synaptic vesicles and a few larger 
electron dense granules. Synaptic vesicles are organized into two distinct functional pools, a 
large reserve pool and a quantitatively smaller releasable pool (Pieribone et al., 1995; Kuromi 
and Kidokoro, 1998). The releasable vesicles approach the active zone, where they are 
eventually released through fusion with the membrane upon stimulation. The less abundant 
granules have a more diffuse distribution in the neuronal cytoplasm. They release their 
contents preferentially lateral to the active zones (Zhu et al., 1986). The release of the fast-
acting low-molecular weight neurotransmitter from small synaptic vesicles is the main 
characteristics of fast synapse. It depends on the coordinated action of many relative 
proteins(Jahn et al., 2003). A number of the synaptic proteins have been found to play a 
crucial role in the regulated exocytosis of the synaptic vesicles. Introduction  3
SNARE hypothesis and the relative proteins  
The synaptic vesicle cycle at the nerve terminals consists of a number of distinct steps, 
including the vesicle release from reserve pool, targeting to the active zone, docking, priming, 
exocytosis and endocytotic retrieval of synaptic vesicles (Sudhof, 1995; Benfenati et al., 
1999). Among them, the exocytosis via membrane fusion is the key event. It has been known 
that the molecular mechanism for vesicular exocytosis is conserved in all eukaryotic 
organisms ranging from yeast to human (Morgan, 1995; Ferro-Novick and Jahn, 1994; 
Bennett and Scheller, 1993). A number of proteins that are involved in vesicle docking and 
fusion have been identified. The attractive SNARE (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor) hypothesis has been proposed to derive a generalized 
model for the regulation of vesicle exocytosis (Sollner et al., 1993a; Rothman, 1994a). The 
family of SNARE proteins whose members are found either on the target membranes, the t-
SNARES, or on vesicles, the v-SNAREs, is considered to provide the primary apparatus 
necessary for vesicle exocytosis. They are distinguished by the SNARE motif, heptad repeats 
of 60-70 amino acids (Jahn and Sudhof, 1999; Jahn et al., 2003; Rizo and Sudhof, 2002). In 
mammalian brain the 18 kDa vesicle-associated membrane protein (VAMP II, also known as 
synaptobrevin II), the major v-SNARE, combines specifically at the synaptic active zone with 
the plasma membrane proteins syntaxin I (35 kDa) and synaptosomal associated protein (25 
kDa, SNAP-25), the major t-SNAREs, to form a 7S core complex between the opposing 
vesicle membrane and the plasma membrane (Sollner et al., 1993b). VAMP II and syntaxin I 
are C-terminally anchored integral membrane proteins. To the contrary, the plasma membrane 
protein SNAP-25 does not contain transmembrane domains, but associates with the plasma 
membrane via palmitoylation on cysteine residues at the center of the protein (Zheng and 
Bobich, 1998). Structural analyses showed that the α-helical regions corresponding to the 
SNARE motifs of the v- and t-SNAREs assemble into four-stranded helical bundles that span 
opposing membranes, to which VAMP II and syntaxin I contribute one α-helix, respectively, 
but SNAP-25 provides two helices (Sutton et al., 1998; Fasshauer et al., 1998). Three SNARE 
proteins bind in parallel within the core complex that brings the membranes into very close 
contact (Hanson et al., 1997; Lin and Scheller, 1997; Poirier et al., 1998). The intermolecular 
interactions via coiled-coil structures were thought to be involved in complex formation 
(Chapman et al., 1994; Fasshauer et al., 1997a). This complex is very stable. It is resistant to 
heat (Fasshauer et al., 1997b) and sodium dodecyl sulfate (SDS), the denaturing detergent 
(Hayashi et al., 1994a; Pellegrini et al., 1995). Formation of this extremely stable  trans Introduction  4
(opposing membranes) SNARE complex brings the synaptic vesicles and cell membrane into 
close opposition and presumably provides the essential driving force for membrane fusion 
(Jahn and Sudhof, 1999; Robinson and Martin, 1998; Fasshauer et al., 2002).  
The functional involvement of the SNARE proteins VAMP II, SNAP-25 and syntaxin I in 
regulated exocytosis is evidenced strongly by the observation that they are substrates of some 
neurotoxin proteases (Rossetto et al., 2001; Montecucco and Schiavo, 1995; Link et al., 
1994). These neurotoxins are produced by anaerobic bacteria of genus Clostridium, including 
tetanus toxin (TeTx, with one single type) and the bolulinum neurotoxins (with seven distinct 
types, designated BoNT/A to BoNT/G). VAMP II is known to be cleaved by tetanus toxin 
and the botulinum toxins B, D, F and G. SNAP-25 is the target of botulinum toxins A and E. 
Syntaxin I is cleaved by botulinum toxin C (Ahnert-Hilger and Bigalke, 1995; Montecucco et 
al., 1996; Schiavo et al., 2000). All of these toxins are the severe inhibitors of neural 
transmission. Although the poisoned presynaptic nerve terminals reveal no morphological 
injury and the synaptic vesicles still appear docked to the presynaptic membrane (Pallanck et 
al., 1995; Sudhof, 1995), the selective proteolysis of these toxins prevents the assembly of the 
core complex and results in a blockade of vesicle exocytosis. This implies that the assembly 
of the core complex is essential for membrane fusion (Jahn and Sudhof, 1999; Rizo and 
Sudhof, 2002).  
Although the core complex resists dissociation by SDS denaturation and clostridial 
neurotoxin cleavage (Hayashi et al., 1994a; Pellegrini et al., 1994), it can be disassembled by 
the ATPase NSF (N-ethylmaleimide-sensitive factor) together with its adaptor proteins 
SNAPs (Hayashi et al., 1995; soluble NSF attachment proteins, Sollner et al., 1993a). The 
NSF and SNAPs are two structurally and functionally conserved proteins in the evolution of 
eukaryotic cells (Jahn and Sudhof, 1999). The formation of the SNARE complex provides a 
high affinity binding site for α-SNAP (McMahon and Sudhof, 1995), which in turn forms a 
NSF binding site. The 7S SNARE complex recruits NSF and SNAPs from the cytoplasm to 
form so-called 20S particles (Hanson et al., 1997). The ATPase activity of NSF is stimulated 
upon binding to α-SNAP (Barnard et al., 1997). NSF dissociates the SNARE complex under 
ATP hydrolysis. Then the components of the complex can participate in another round of 
membrane fusion. However, although the SNARE proteins VAMP II, SNAP-25 and syntaxin 
I have been demonstrated to be essential components of the neurotransmitter release process 
and the assembly and disassembly of the core complex tightly associated with membrane 
fusion, the precise mechanism remains to be further elucidated.  Introduction  5
Except for participating in the formation of the core complex, SNARE proteins are also 
found to interact with the other proteins in the nerve terminals that may play a regulatory role 
in SNARE function. The bindings of synaptophysin, a 38 kDa synaptic vesicle protein, to 
VAMP II (Edelmann et al., 1995), the ATPase Hrs-2 to SNAP-25 (Bean et al., 1997; Bean et 
al., 1997; Tsujimoto and Bean, 2000) as well as the mammalian neuronal proteins munc-18 
and munc-13 to syntaxin I (Hata et al., 1993; Betz et al., 1997; Margittai et al., 2003; Yang et 
al., 2000) have been proposed to prevent inappropriate formation of docking and fusion 
complex before docking. Munc-18 has recently been found to be essential factors for 
membrane fusion (Gallwitz and Jahn, 2003; Jahn et al., 2003; Toonen and Verhage, 2003). In 
addition, the SNARE complex can also interact with the 65-kDa vesicle-associated protein 
synaptotagmin I that is displaced by α-SNAP during the disassembly of the core complex 
(Sollner et al., 1993a). Synaptotagmin I is thought to function as a calcium sensor and a 
fusion clamp, preventing the release of neurotransmitter from docked vesicles in the absence 
of a signal (Sollner et al., 1993a; Volknandt, 1995). The hydrophilic complexins compete 
with α-SNAP, but not with synaptotagmin I, for binding to the core complex (McMahon et al., 
1995; Pabst et al., 2000). Complexins stabilize the fully assembled SNARE complex and 
modulate neuroexocytosis (Chen et al., 2002; Rizo and Sudhof, 2002; Pabst et al., 2002). 
Thus, by regulating assembly or disassembly of the SNARE complex these proteins play 
essential roles in synaptic vesicle exocytosis.  
SV2 - an abundant vesicle-associated protein 
Synaptic vesicle protein 2 (SV2), a widespread membrane glycoprotein in neurons and 
endocrine cells, is specifically integral to the synaptic vesicle membrane but does not 
participate in the SNARE complex. SV2 is expressed in two major isoforms, SV2A and 
SV2B, and one minor isoform SV2C with a restricted cellular distribution (Janz and Sudhof, 
1999; Bajjalieh et al., 1994). As a ubiquitous vesicle protein, SV2 is used extensively as a 
general marker for the synaptic vesicles (Volknandt, 1995). SV2 contains 12 transmembrane 
domains: Its six N-terminal and six C-terminal transmembrane domains are highly 
homologous to glucose and neurotransmitter transporters in the plasma membrane (Feany et 
al., 1992; Bajjalieh et al., 1992). However, despite its homology to transporter proteins, the 
function of SV2 remains to be established. A Ca
2+-regulated direct interaction between SV2A 
and synaptotagmin has been reported (Schivell et al., 1996). Recently, it has been revealed by 
electrophysiological studies that SV2s are probably Ca
2+ dependent inhibitors of 
neurotransmitter release. They function as redundant Ca
2+ regulators  in neurotransmitter Introduction  6
release (Janz et al., 1999). However, by direct measuring the exocytosis in adrenal chromaffin 
cells, it has also been proposed recently that SV2 is required to modulate the readily 
releasable pool of secretory vesicles. Loss of SV2A has been found to be associated with 
fewer SDS-resistant SNARE complexes. SV2 may modulate directly the formation of fusion 
complexes (Xu and Bajjalieh, 2001). 
The role of Rab3A in the regulation of neurotransmitter release 
Rab3A belongs to the family of the small GTP-binding Rab proteins (20-25kDa). Members 
of the Rab family have a distinct subcellular localization among various cellular 
compartments (Jahn and Sudhof, 1999; Simons and Zerial, 1993; Olkkonen and Stenmark, 
1997). They play important roles in vesicle transport, tethering with target membranes and 
exocytosis (Zerial and McBride, 2001; Novick and Zerial, 1997; Schimmoller et al., 1998; 
Jahn et al., 2003). Although they are not involved in the components of the core complex, Rab 
proteins are considered to function in facilitating the formation of SNARE complexes 
(Sogaard et al., 1994; Schimmoller et al., 1998) and modulate the activity of SNAREs 
(Novick and Zerial, 1997; Johannes et al., 1996).  
The Rab3 subfamily comprises Rab3A-D. Rab3A is the most abundant Rab protein in the 
brain and play an essential role in the regulation of neurotransmitter release (Fischer et al., 
1990). As the other Rab proteins, Rab3A is able to cycle between the active GTP-bound 
Rab3A on the membrane and the inactive GDP-bound form in the cytoplasm. This process is 
controlled by the specific regulatory protein GDP dissociation inhibitor (GDI, Chou and Jahn, 
2000; Ullrich et al., 1993; Pfeffer, 1994). The cycle of Rab3A is closely linked to the 
recycling of synaptic vesicles. Triggering of synaptic vesicle exocytosis leads to the 
dissociation of Rab3A from synaptic vesicles and dramatically increases the GDP/GTP ratio 
of Rab3A (Fischer et al., 1991; Stahl et al., 1994; Fischer et al., 1994a). Rab3A is thought to 
to play a role in the recruitment of synaptic vesicles for exocytosis (Geppert et al., 1994). In 
addition, there is also evidence that Rab3A acts as a negative modulator of exocytosis and 
limits the extent of Ca
2+-triggered vesicle fusion (Johannes et al., 1994; Holz et al., 1994; 
Lledo et al., 1994). Recently, a post-docking role for Rab3A has been proposed. Rab3A has 
been shown to regulate a late step in exocytosis, associated with the fusion reaction (Schluter 
et al., 2002; Geppert et al., 1997; Geppert and Sudhof, 1998). The GTP-bound form of Rab3 
interacts with at least two effector proteins, Rabphilin and Rim (Bean and Scheller, 1997). 
Rabphilin is a vesicle-associated protein (Mizoguchi et al., 1994) which is recruited to 
synaptic vesicles by Rab3A and is dissociated from synaptic vesicles after GTP hydrolysis Introduction  7
(Stahl et al., 1996; McKiernan et al., 1996; Li et al., 1994). Rabphilin has been revealed to 
have a positive effect on secretion (Chung et al., 1995). Rim proteins exclusively localize to 
the presynaptic active zones in synapses (Wang et al., 1997b). The interaction between Rim 
and Rab3A occurs only when synaptic vesicles approach the presynaptic membrane which 
can play an important role in maintaining docking specificity (Zheng and Bobich, 1998; 
Benfenati et al., 1999). In addition, recent study has indicated that Rab3A also has a classical 
transport role in the trafficking of synaptic vesicles to their target at the active zone in mouse 
brain nerve terminals (Leenders et al., 2001). 
Participation of N-type and P/Q-type Ca
2+ channels in fast neurotransmitter release 
Exocytosis in synaptic nerve terminals is rapidly triggered by the influx of Ca
2+ through 
voltage-operated Ca
2+ channels (Trimble et al., 1991; VOCC, Zimmermann, 1990). Neural 
Ca
2+ channels are heteromeric proteins constituted by a α1 subunit, which forms the 
transmembrane ion-conducting pore. Depolarization of the nerve terminal by an action 
potential results in the opening of VOCC. By controlling the entry of Ca
2+ necessary for 
exocytosis, Ca
2+ channels can regulate excitation-secretion coupling. Under physiological 
conditions, multiple types of Ca
2+ channels with different biophysical and pharmacological 
properties are involved in the regulation of neurotransmitter release in the mammalian central 
nervous system (Dunlap et al., 1995). Different Ca
2+ channel subtypes serve distinct roles in 
neuronal excitation and transmission of signals (Elliott et al., 1995). The presence of various 
types of Ca
2+ channels in different regulatory sites would permit a high degree of flexibility of 
regulation under diverse conditions of stimulation and modulation (Turner et al., 1993). N- 
and P/Q-type Ca
2+ channels, containing the pore-forming α1B or α1A subunits, respectively, 
are preferentially coupled to the exocytosis of rapid neurotransmitters in fast synapses. 
Pharmacological evidence suggests that N-type Ca
2+ channels are selectively blocked by the 
marine snail-derived toxins ω-conotoxin GVIA or MVIIA (Ellinor et al., 1994; Woppmann et 
al., 1994). P/Q-type Ca
2+ channels are inhibited by ω-conotoxin MVIIC and spider toxin ω-
agatoxin IVA (Takahashi and Momiyama, 1993; Sather et al., 1993; Stea et al., 1994).  
The short latency between Ca
2+ influx and exocytosis of synaptic vesicles in fast synapses 
suggests that Ca
2+ channels are positioned in close proximity to the synaptic release sites 
(Goda and Sudhof, 1997; Llinas et al., 1992). Furthermore, biochemical experiments 
demonstrate that Ca
2+ channels are closely associated with the exocytotic apparatus at 
synaptic terminals (Seagar and Takahashi, 1998; Martin-Moutot et al., 1996; Rettig et al., 
1996). Both N- and P/Q-type Ca
2+ channels have been purified from brain with SNARE Introduction  8
proteins as a stable complex (Sheng et al., 1998; Martin-Moutot et al., 1996). This assures the 
exposure of the docking complex to inflowing extracellular Ca
2+. Moreover, at the molecular 
level N- or P/Q-type Ca
2+ channels have been revealed to bind directly to syntaxin I, SNAP-
25, and synaptotagmin I through a synaptic protein interaction (synprint) site in the 
intracellular loop domains II and III of both the α1B and α1A subunits (Sheng et al., 1994; 
Kim and Catterall, 1997). By altering SNARE protein function, the interaction of the synprint 
site of N-type Ca
2+ channels with SNARE proteins has been demonstrated to enhance 
neurotransmitter release (Mochida et al., 1998). In addition, this interaction also contributes to 
excitation-secretion coupling by optimally locating the calcium sensors to allow a close 
temporal relationship between Ca
2+ influx and evoked release. On the other hand, direct 
interactions between Ca
2+ channel proteins and the exocytic machinery may have important 
effects on the behavior of the presynaptic Ca
2+ channels themselves by regulating their 
function in response to depolarization. Therefore, Ca
2+ channels play a crucial role in the 
nerve terminal, not only by mediating the entry of calcium across the plasma membrane to 
initiate transmitter release but also by providing structural elements that are integral to vesicle 
release processes (Sheng et al., 1998; Stanley, 1997).  
The active zone and the related protein Bassoon 
The active zone in the presynaptic nerve terminals constitutes the principal site for 
regulated neurotransmitter release from nerve cells (Landis et al., 1988; Zhai et al., 2001). It is 
the specialized region of the presynaptic plasma membrane situated exactly opposite to the 
postsynaptic neurotransmitter reception apparatus (Hirokawa et al., 1989). At the active zone, 
a small pool of synaptic vesicles docks and fuses with the presynaptic plasma membrane in a 
highly coordinated way (Betz and Angleson, 1998; Dresbach et al., 2001). The active zone 
material has been thought to help the docking of the vesicles and the anchoring of the 
channels (Harlow et al., 2001; Burns and Augustine, 1995). At the ultrastructural level, it has 
been recognized that the presynaptic active zone carries highly organized electron dense 
structures on the cytoplasmic side of the presynaptic membrane (Gray and Guillery, 1966; 
Pfenninger et al., 1969). Moreover, a regularly arranged hexagonal array is located at the 
active zone plasma membrane that is referred to as the presynaptic dense projection (Peters et 
al., 1991; Akert, 1972; Pfenninger et al., 1972). Until now, its protein composition is 
essentially unknown. However, this structure plays a critical role in synaptic vesicle 
attachment and the release of the neurotransmitters (Zimmermann, 1993).  Introduction  9
Bassoon has recently been identified as a novel 420-kDa protein of the presynaptic nerve 
terminals (tom et al., 1998). It was found extensively in both excitatory glutamatergic 
synapses and inhibitory GABAergic synapses throughout the brain (Richter et al., 1999). 
Strikingly, Bassoon has a very restricted distribution, mainly interspersing between clear 
synaptic vesicles in the vicinity of the active zone (tom et al., 1998). Biochemical studies 
suggest that it has a tight association with the cytomatrix. Thus, as a scaffold protein of the 
presynaptic cytomatrix at the active zone, Bassoon may play a fundamental role in 
neurotransmitter release and therefore potentially be involved in the regulation of the synaptic 
vesicle cycle (Gundelfinger and tom, 2000; Dresbach et al., 2001).  
1.1.3. Secretion of messenger substances in neurosecretory endings of 
the neurohypophysis 
Like all other terminals, the neurosecretory endings of the neurohypophysis contain two 
types of vesicular organelles. However, in contrast to fast synapses, a large number of 
electron dense neurosecretory granules occurs in the neurohypophysis (Russell, 1981). These 
granules, with a diameter of 150-230 nm, contain arginine vasopressin (AVP) or oxytocin 
(OT) (Van Leeuwen and Swaab, 1977) that are secreted directly into the blood stream (Morris 
et al., 1978). In addition, there is a considerable number of electron-lucent microvesicles 
(MVs) among the granule populations (Tweedle, 1983). These microvesicles are ~50 nm in 
diameter and indistinguishable in morphology from synaptic vesicles. Under normal 
physiological conditions, microvesicles segregate into a morphologically separate population 
from the granules. Short linking strands of 30-60 nm are found specifically between 
microvesicles that make them clustered to each other (Hayashi et al., 1994b).  
So far, little is known concerning the role of the microvesicles in the neurohypophysis. 
Microvesicles were first postulated to be vesicles formed during membrane recycling of 
neurosecretory granules (Douglas et al., 1971; Nagasawa et al., 1971). Later, it was evidenced 
that they were functionally independent of the neurosecretory granules and  under high 
potassium stimulation they were redistributed towards the plasma membrane facing the basal 
lamina (Morris and Nordmann, 1980). Moreover, after electrical stimulation microvesicles 
showed a scattered distribution over the neurosecretory terminals and some labels of 
synaptophysin were found near the plasma membrane (Hayashi et al., 1994b). This implied 
that microvesicles might perform regulated exocytosis upon stimulation. Microvesicles were 
revealed to be able to store glutamate (Meeker et al., 1991) as well as norepinephrine Introduction  10
(Moriyama et al., 1995). Furthermore, many synaptic vesicle proteins have been demonstrated 
to be associated with microvesicles (Navone et al., 1989; Jurgutis et al., 1996). Recently, it 
has been demonstrated by capacitance measurements that microvesicles can undergo Ca
2+-
triggered exocytosis in response to membrane depolarization in the neurohypophysis 
(Klyachko and Jackson, 2002).  
The terminals of the neurohypophysis possess no structurally defined release sites. 
However, similar to the secretion of peptides from typical synapses, the release of the 
neurohypophysial hormones vasopressin and oxytocin from the granules into the blood stream 
has been known to be also Ca
2+-dependent and to require enhanced axonal action potentials 
(Legendre and Poulain, 1992). The release process is much slower, reflecting the integration 
of Ca
2+ influx over many action potentials. Patch-clamp experiments in isolated 
neurohypophysial terminals have identified multiple types of Ca
2+ channels, containing N-,  
L-, P/Q- and R-type Ca
2+ channels (Fisher and Bourque, 1995; Wang et al., 1997a; Wang et 
al., 1999). It has been revealed that N- and L- type Ca
2+ channels may control the secretion of 
both vasopressin and oxytocin (Wang et al., 1993; Wang et al., 1999). The N-type Ca
2+ 
channel blocker ω-conotoxin GVIA is able to block 50-70% of electrically evoked release 
(Obaid et al., 1989). P/Q- and R-type Ca
2+ channels appear to be selectively involved in 
vasopressin and oxytocin release, respectively (Wang et al., 1997a; Wang et al., 1999). Up to 
now, little is known about the exocytosis of microvesicles.  
1.2. Release of messenger substances from astrocytes  
In the mammalian central nervous system (CNS), the neurons are surrounded by a 10-fold 
higher number of glial cells. According to the classical view of the nervous system, glial cells 
are incapable of conducting action potentials and have only an inferior role in neural cell 
function, in that they support the physiology of associated neurons. However, in the recent 
years, it has been shown that glial cells are dynamic and have more complicated functions in 
intercellular signaling processes of the nervous system. 
1.2.1. Involvement of astrocytes in the synaptic transmission  
Astrocytes represent a major sub-type of glial cell. They make up nearly forty percent of 
the cell composition of the total CNS and fill most of the spaces between neurons. They are 
intimately associated with neurons in the brain to form a connected network. Their processes 
intermingle with neuronal processes and closely enwrap the synapses. It has been well Introduction  11
established that astrocytes serve multiple homeostatic function in the brain including 
maintaining extracelluar pH and ionic composition at a low physiological level, taking up and 
degrading neurotransmitters that are released from neurons into the extracellular space, such 
as excitatory amino acids (EAAs) glutamate and aspartate. They were thought to be 
responsible mainly for maintenance of an ideal environment for neural cell function and for 
regulation of interactions among neurons or between neurons and the blood stream. 
However, more recently increasing evidence suggests that astrocytes are able to actively 
participate in the processing of brain information other than  simply providing structural, 
metabolic and trophic support (Araque et al., 2001; Haydon, 2001; Bezzi and Volterra, 2001; 
Volknandt, 2002).  The  proximity to neuronal synapses makes them in an advantageous 
position to receive the released neurotransmitters from the synaptic cleft. Astrocytes have 
been indicated to possess not only a number of transporters for the neurotransmitters, but also 
voltage-gated ionic channels (Carmignoto, 2000; Latour et al., 2003) and a variety of 
membrane receptors for different classical neurotransmitter substances and peptides, such as 
receptors for glutamate, ATP, GABA, noradrenaline, or neuropeptides (Porter and McCarthy, 
1997). Their membrane-bound receptors can be activated during synaptic activity. Astrocytes 
have been reported to be able to respond directly to various synaptically released 
neurotransmitters, leading to an increase of their intracellular Ca
2+ concentration.  
Astrocytes have been indicated to be able to synthesize and release many neuroactive 
substances containing different neurotransmitters, neuropeptides and growth factors. Ca
2+ 
elevation in astrocytes has been demonstrated to lead to receptor-mediated release of these 
signaling substances, for example, the release of glutamate and aspartate by the neuroligand 
bradykinin or by glutamate receptor agonists (Parpura et al., 1994; Bezzi et al., 1998; Jeftinija 
et al., 1996), of ATP by glutamate receptor agonists (Queiroz et al., 1999) and of 
secretogranin II, a typical marker for regulated secretory granules, by several secretagogues 
(Calegari et al., 1999). Similar to neurons, astrocytes contain a dual secretory pathway for the 
release of both the low molecular substances and the peptide constituents (Volknandt et al., 
2002).  
Interestingly, the released messenger substances from astrocytes can in turn act as a 
signaling substance and feedback to the surrounding neurons to produce functional changes. 
Studies performed in both cell culture  and isolated hippocampal slices in situ (Bezzi et al., 
1998; Parpura et al., 1994; Bezzi et al., 1998) have indicated that a Ca
2+-dependent glutamate-
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intracellular Ca
2+ levels and modulate neuronal activity. In addition, GABA has also been 
revealed to be able to enhance Ca
2+ levels in astrocytes and start back signaling to neurons 
(Kang et al., 1998). Therefore, a continuous bi-directional signal communications between 
neurons and astrocytes takes place during synaptic activity (Vesce et al., 1999; Carmignoto, 
2000). Furthermore, recent experiments have also demonstrated the presence of an astrocyte-
to-astrocyte signaling system through the astrocyte network. The neuron-induced elevation of 
Ca
2+ levels in astrocytes can spread as astrocytic excitation to adjacent astrocytes in the form 
of slow Ca
2+ waves which are likely to be mediated by the release ATP from astrocytes 
(Haydon, 2001; Guthrie et al., 1999; Cotrina et al., 1998). Moreover, a distal response away 
from the original stimulus is generated by affecting synapses located at a distance, leading to 
lateral signal transfer between synapses. Thus, by way of an astrocytic propagating circuit of 
Ca
2+ wave, astrocytes may communicate extensively with neurons. Evidently, through the 
Ca
2+-dependent transmitter release, astrocytes play an active role in regulating neuronal 
activity and in modulating synaptic transmission, which provide the additional spatial and 
temporal complexity in the information processing in the brain and should have significant 
effects on the function of the nervous system.  
1.2.2. Regulated exocytosis as the possible astrocytic release pathway  
Up to now, little is known about the underlying molecular mechanisms responsible for this 
receptor-mediated astrocytic messenger release. It has been evidenced that the cellular release 
of glutamate from astrocytes is not mediated by the reverse operation of glutamate 
transporters, because transport inhibitors fail to affect Ca
2+-dependent glutamate release 
(Araque et al., 2000). Astrocytes have been reported to have a developed endocytic vesicular 
system that is mainly composed of caveolae, clathrin-coated pits and vesicles, a variety of 
endosomal structures and lysosome (Megias et al., 2000). Proliferating astrocytes reveal a 
large number of vacuoles and vesicles of different size and shape (Lindo et al., 1993). Despite 
the fact that astrocytes neither exhibit a large number of small clustered vesicles nor form 
apparent synapses with special organized release site as neural cells do, there is increasing 
evidence demonstrating that the astrocytic release process of messenger substance shares 
some common properties with the neurotransmitter release from synaptic terminals as given 
in the following:  
At first, similar to the neuronal exocytosis, the cellular release of low molecular glutamate 
and the secretory granule protein secretogranin II from cultured astrocytes has been indicated Introduction  13
to occur in a Ca
2+-dependent manner (Calegari et al., 1999; Parpura et al., 1994). Moreover, it 
has been recently shown that the  Ca
2+-regulated astrocytic glutamate release pathway is 
engaged at physiological Ca
2+ levels (Parpura and Haydon, 2000).  
In addition, it has been demonstrated in various experiments that the released messenger 
substances from astrocytes are probably stored in a vesicular compartment and that a 
vesicular exocytotic pathway underlies Ca
2+-dependent release: 1) In the presence of 
extracellular calcium, the vertebrate neurotoxin α-latrotoxin was found to cause sustained 
release of glutamate from cultured astrocytes (Parpura et al., 1995b). α-Latrotoxin is an active 
component of black widow spider venom and has been known to induce massive vesicle 
exocytosis of transmitters from nerve terminals (Petrenko et al., 1991). 2) Bafilomicin A1, a 
well-known vacuolar ATPase inhibitor, was indicated to reduce the release of glutamate from 
astrocytes by dissipating a vesicular electrochemical proton gradient necessary for transmitter 
uptake into vesicles (Araque et al., 2000). 3) At the ultrastructural level the granule protein 
secretogrnin II was found to be stored in dense core vesicles and released in response to 
secretagogues (Calegari et al., 1999).  
Moreover, the release of messenger substances in astrocytes has been shown to be 
impaired by some clostridial neurotoxins that cleave specific protein components of the 
synaptic vesicle fusion machinery, just as their blocking function in neurons. Botulinum toxin 
B and tetanus neurotoxin, which selectively cleave the v-SNARE VAMP II and thereby block 
exocytosis in neurons, result in a decrease in VAMP II immunoreactivity and abolish Ca
2+-
dependent bradykinin-induced glutamate release in astrocytes (Jeftinija et al., 1997). 
Botulinum B has also been demonstrated to inhibit strongly the astrocyte-induced glutamate 
response in neurons (Araque et al., 2000);  Pretreatment of astrocytes with botulinum 
neurotoxin A and C, which cleave t-SNARE SNAP-25 and syntaxin I in neurons, 
respectively, diminish or abolish bradykinin-induced release of glutamate from astrocytes 
(Jeftinija et al., 1997). Additionally, tetanus toxin and botulinum toxins were found to cleave 
the ubiquitous v-SNARE cellubrevin, a homologue of synaptobrevin in astrocytes (Parpura et 
al., 1995a; Verderio et al., 1999). These results implicate that SNARE proteins are involved in 
the Ca
2+-dependent astrocytic release process of messenger substances.  
Cultured astrocytes were also found to express some members of the SNARE proteins such 
as the v-SNAREs VAMP II and cellubrevin, and the t-SNAREs syntaxin I (Parpura et al., 
1995a) and SNAP-23, a analogue of the neuronal SNAP-25 (Hepp et al., 1999). In our 
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from cerebral cortices of newborn rats (Maienschein et al., 1999). They are the synaptic 
vesicle proteins SV2, synaptophysin, synaptotagmin I, synapsin I, Rab3A, and the t-SNARE 
SNAP-25. Thus, almost all of the proteins thought to be essential for the synaptic 
transmission have been identified in cultured astrocytes.  
In conclusion, a large body of experimental work implicates that astrocytes may release 
their messenger substances in a similar way as neurons. Moreover, the SNARE protein-
regulated vesicular exocytosis is probably involved also in the astrocytic secretory process. 
1.3. Aims of the study 
1.3.1. Localization of synaptic proteins in the hippocampal mossy fiber 
terminals and the neurohypophysial endings  
Although members of the SNARE family have been implicated in the process of vesicle 
docking and fusion by means of a combination of genetic and biochemical approaches, strong 
morphological evidence for a preferential association of SNARE proteins with release sites at 
synapses in situ is lacking. In addition, even though numbers of proteins that are involved in 
synaptic vesicle exocytosis have been identified,  the accurate molecular mechanism 
restricting the fusion of synaptic vesicles to the active zone remains unclear. The function of 
the proteins is dependent on their precise subcellular localization. Elucidation of the 
ultrastructural localization of these proteins should provide invaluable information for a 
thorough understanding of their roles in vesicular exocytosis.  
In the present study, using the immunogold labeling method on frozen ultrathin sections, 
the localization of SNARE and other exocytosis-relevant synaptic proteins would be 
investigated in two different types of nerve terminals. One is the identifiable type of central 
synapse, the mossy fiber synapse with multiple special release sites in the hippocampal CA3 
subfield; the other is the neurosecretory endings of the neurohypophysis that are not provided 
with special release sites. The purpose is to compare the distribution of synaptic proteins in 
two different types of nerve terminals and particularly to address the question whether 
SNARE proteins are preferentially associated with active zones in fast synapses and to what 
extent the localization of these proteins in terminals lacking defined release sites is different 
from that in synaptic terminals.  Introduction  15
1.3.2. Localization of synaptic proteins in primary astrocyte culture 
A large number of data have indicated that astrocytes may release messenger substance 
using a mechanism resembling the neuronal secretory process. The regulated vesicular 
exocytosis and, especially, the classical SNARE mechanism are probably involved in their 
secretory process.  However, alternative hypotheses for this Ca
2+-dependent release way 
cannot be rule out. Further studies are required to elucidate thoroughly the molecular 
mechanism in this process. Ultrastructural studies can exhibit the precise localization of the 
proteins responsible for regulated exocytosis at their functional site, providing further 
evidence for biochemical and physiological studies. The aim of the present study is to 
investigate the subcellular localization of synaptic proteins on the endogenous vesicular 
organelles and the stimulation-induced endocytotic compartments using electron microscopy, 
so as to verify their function in the astrocytic vesicle cycle. 
1.3.3. Expression and localization of the transfected synaptic proteins in 
the astrocytoma cell line U373 MG 
In the studies of regulated exo- and endocytosis of neural cells the rat pheochromocytoma-
derived PC12 cell line has been evidenced to be a very effective experimental tool. 
Obviously, a permanent cell line with astrocytic secretory properties would play an important 
role in the investigation of the molecular mechanisms of astrocytic messenger release. The 
cell line U373 MG derives from a human astrocytoma. It was revealed to express glial 
fibrillary acidic protein (GFAP), the most specific marker for cells of astrocytic origin, and 
has been widely applied in a variety of studies of astrocytic functional properties. 
Interestingly, U373 has also been shown to be able to release nerve growth factor NGF 
(Emmett et al., 1997), glutamate (Ye and Sontheimer, 1999) and GABA (Soria-Jasso and 
Arias-Montano, 1996). However, it remains unknown whether the secretion of these 
substances in U373 MG possess the same characteristic as that in astrocytes, and particularly, 
whether regulated vesicular exocytosis is also involved in the secretory processes of U373 
MG as in astrocytes and neurons. 
To clarify the secretory characteristics of permanent U373 cells and to determine whether 
the U373 MG cell line can be used as an effective experimental tool for further studies of the 
astrocytic exocytosis mechanism, this part of the study focused on the expression and 
localization of several important proteins responsible for regulated exocytosis and 
intercellular membrane fusion in U373 cells. Multiple engineered constructs coding for these Introduction  16
proteins as well as relevant additional tags would be transiently transfected into these cells 
and the expressed recombinant proteins would be immunolocalized by means of fluorescence 
and cryo-electron microscopy.  Materials and Methods  17
2. Materials and Methods 
2.1. Localization of synaptic proteins in the hippocampus and 
neurohypophysis using the cryo-immunogold technique  
In the present study, an improved cryo-immunogold technique, which combines the 
Tokuyasu thawed cryosection technique (Tokuyasu, 1973) with the immunogold method, was 
adapted to localize various synaptic proteins in mossy fiber terminals of the hippocampus and 
neurosecretory endings of the neurohypophysis. With the aid of the cryo-protectant and the 
special contrasting and drying method, the Tokuyasu thawed cryosection technique has been 
demonstrated as a excellent method for preservation of the ultrastructural details and high 
resolution of the fine structure. Moreover, cryosections prepared according to this technique 
have been evidenced to be a good substrate for immunolabeling (Griffiths et al., 1984).  
2.1.1. Experimental animals and perfusion fixation 
Adult wistar rats (Charles River, Sulzfeld Germany) between 200 g and 300 g in body 
weight were used for the experiments. They were anaesthetized lightly by inhalation of CO2, 
then injected with Nembutal (60 mg/kg) intraperitoneally. After several minutes, when 
animals were deeply anaesthetized, transcardial perfusion that ensured rapid access and even 
distribution of fixative into the tissue was immediately performed.  
Because formaldehyde is a toxic and hazardous chemical by inhalation and skin contact, 
perfusion was carried out in a well-ventilated hood. At first, the lines were checked for 
absence of air bubbles that would seriously impair the perfusion. Then the thorax was opened 
with scissors. The cannula that was connected to the perfusion apparatus was inserted into the 
left ventricle of the heart and clamped in place with a pair of hemostats. The right atrium was 
severed immediately. The animal was first preperfused with 50 ml phosphate buffered saline 
(PBS) containing heparin (0.5 mg /ml) to flush the blood from the vascular system. Heparin 
prevented clotting of the blood that would impede the distribution of fixative. Then the two-
way-tap was turned and the animal was perfused with 200 ml freshly prepared fixative 
solution. Once the perfusion was completed, hippocampus and neurohypophysis were 
immediately dissected out and immersed in the same fixative for 2 hours at room temperature. 
Phosphate buffered saline (PBS)  
137 mM NaCl, 3 mM KCl, 100 mM Na2HPO4, 18 mM KH2PO4, pH 7.4. Materials and Methods  18
Fixative solution  
4% paraformaldehyde, 0.05% glutaraldehyde and 0.2% picric acid in PBS, made up freshly 
every time. 
For 200 ml fixative: dissolve 8 g of paraformaldehyde powder in 150 ml of distilled water 
while heating on a stir plate to ~60°C in a well-ventilated area. Add several drops of 1 N 
NaOH until the solution becomes clear. Cool the solution and then filter. Add 20 ml 10x PBS 
and 0.4 ml saturated aqueous picric acid and bring the total volume to 200 ml. Adjust the pH 
with 1 N HCl to 7.4. Before use, add 400 µl EM-grade 25% aqueous glutaraldehyde and mix.  
2.1.2. Cryoprotection and freezing  
After rinsing the fixed specimens in PBS three times, each for 5 min, to remove unbound 
fixative, small pieces of tissue (~2 mm
3) containing the CA3 region were carefully cut out in a 
drop of PBS, avoiding any mechanical squeezing or pulling that might damage the subcellular 
morphology of the tissue. Then these small tissue blocks were infiltrated with the 
cryoprotectant, 2.3 M sucrose in PBS or a mixture of 1.8 M sucrose and 20% PVP (polyvinyl 
pyrrolidon), for ~3 hours. Infiltration with cryoprotectant permits rapid freezing and prevents 
the formation of ice crystals within the tissue (Tokuyasu and Singer, 1976). It is essential for 
vitrification of the tissue pieces during freezing. The cryoprotectant solution was changed 
several times during infiltration. Cryo-protected tissue blocks were embedded in a droplet of 
fresh solution, and then quickly mounted onto specimen pins. They were orientated under a 
stereo microscope and frozen by rapid plunging into liquid nitrogen. The blocks were 
solidified so that sections could be cut thin enough for examination under the electron 
microscope. The specimens should be mounted and frozen as quickly as possible to avoid 
dehydration. The frozen specimens were placed into a small plastic storage container 
individually and kept in liquid nitrogen. They could be repeatedly sectioned and stored 
without problem.  
A mixture of 1.8 M sucrose and 20% (w/v) PVP (for 10 ml)  
2 g PVP (MW 10000, Sigma) 
8 ml of 2.3 M sucrose in PBS 
0.4 ml of 1.1M Na2CO3 in PBS 
stirred at the room temperature for at least 1 hour. Air bubbles were then removed in a 
desiccator under vacuum at 25 mbar for ~15 minutes.  Materials and Methods  19
2.1.3. Preparation of support films 
Because the cryo-sections were somewhat unstable under the electron beam, the grids were 
covered with a thin film beforehand to support the specimen and to avoid serious damage. 
The film should be strong enough to remain attached to the grids throughout all 
manipulations. In this study, grids were coated with pioloform as a support film.  
The preparation was carried out under a ventilated hood. 70-80 ml of a 1.8% pioloform 
solution dissolved in chloroform was poured into a glass cylinder, which had a tap at the 
bottom. All glass slides were wiped with a tissue to remove the dust before use. A clean glass 
slide was placed into the solution, the cap of the glass cylinder was covered and the tap was 
opened. The solution was allowed to drain slowly into the stock bottle under the cylinder. The 
draining speed greatly affected the film thickness. Rapid draining made the film too thick. 
When the solution was completely drained out of the cylinder, the slide was taken out and 
allowed to dry in the air in vertical position. Scores were made with a scalpel blade ~1.5 mm 
off the edge of the slide to define the limits of film. The slide should be dipped carefully at an 
angle of 45° into a deep glass trough filled with distilled water, letting the film float slowly 
off the slide. The interference color of the pioloform film should be silver, gray or gold. Other 
colors indicated that the film was too thick. Thereafter hexagonal 200 mesh nickel grids were 
placed orderly with the matte side down in contact with the film onto the pioloform film 
floating on the water surface. A piece of parafilm was placed carefully onto the pioloform 
film with the attached grids and the pioloform film was adhering to the parafilm. The grids 
were now sandwiched between the parafilm and the pioloform. The parafilm together with the 
pioloform film and the grids was lifted slowly off the surface of the water and placed with the 
pioloform film lying on the parafilm in a dry Petri dish to exclude dust. The filmed grids were 
allowed to dry at room temperature and before use they were coated with carbon and glow-
discharged for 60 seconds using a vacuum coating device (BAL-TEC, MED 020 coating 
system, Leica, Germany). The carbon coating was used for stabilizing the pioloform film 
under the electron beam and the glow discharge for improving the hydrophilicity of the grid 
surface that facilitated the spreading of the sections more evenly over the grid. 
2.1.4. Trimming and sectioning  
Cryosectioning was performed with an ultramicrotome (Reichert Ultracut) equipped with a 
FCS cryo-attachment system (Leica, Germany). The system consisted of a cryochamber, a 25-
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mounted onto the knife support of the ultramicrotome and cooled by constantly flooding 
liquid nitrogen from the Dewar flask via an automatic pump (Fig.1A).   
Prior to sectioning, the cryochamber was precooled to the operating temperature   
(–100°C or –110°C). Then the specimen pin with the attached specimen was quickly 
transferred with precooled forceps from the liquid nitrogen into the cryochamber, keeping the 
specimen still under liquid nitrogen in its small storage container. The specimen pin was 
taken out and inserted into the sample holder. Then the sample holder was tightened to lock 
the specimen pin in place. The specimen was at first trimmed carefully with the metal 
trimming knife, which was advanced in 1 µm steps.  The specimen was moved up and down 
manually to result in a approx. 0.5 x 0.8 mm rectangular sectioning surface that included the 
area of interest, such as hippocampus or neurohypophysis. Then this front sectioning face of 
the block was trimmed smooth with a 45° glass knife. At last, the ultra thin sections were cut 
automatically with a dry cryodiamond knife (Diatome, Switzerland) at a clearance angle of 
6°. The sectioning speed was set at 1 mm/s. The thickness setting was adjusted to section at 
85 or 90 nm. Good sections yielded gold, purple, or blue interference colors.  
Because the cryo-sectioning was performed dry in the cryochamber, the static electricity 
built up by friction in the dry nitrogen atmosphere made the sectioning and manipulating of 
sections difficult. Therefore, an anti-static device, Static Line Ionisator (Diatom Company, 
Switzerland) was used during sectioning. The static charges could be neutralized by the small 
electric current emitted from the anti-static device to facilitate sectioning. Serial sections were 
usually obtained with this device.  
The sections were manipulated with an eyelash mounted on a stick and collected in small 
groups on the knife surface under the binocular microscope. 4-6 Sections from the ribbon of 
sections were picked up with a platinum loop containing a droplet of pick-up solution, a 
mixture with 2.3 M sucrose in PBS and 2% methylcellulose in distilled water (1:1 volume 
ratio) which resulted in improved preservation of ultrastructure (Liou et al., 1996). The 
picking-up of the sections should be finished before freezing of the droplet. The loop with 
frozen droplet and sections was removed from the cryochamber. The droplet and sections 
were allowed to thaw at room temperature for a while. Then the sections that were situated on 
the lower surface of the droplet were attached directly to a 200 mesh nickel grid. The grids 
were covered with pioloform film beforehand and prior to use coated with carbon and glow-
discharged. The grids were placed section-side down on the surface of PBS. The pick-up 
solution was allowed to diffuse out of the sections in the PBS. (Fig.1B).  Materials and Methods  21
Fig.1. (A) The FCS cryo-
ultramicrotome system. 
The FCS cryoattachment 
consists of a cryochamber, 
a control device and a 25 
liter Dewar flask with an 
automatic pump system 
(Leica, 1997). The cryo-
chamber is mounted onto 
the knife support of the 
ultramicrotome.  
(B) Schematic diagram of 
the sectioning and picking-
up of the sections  in the 
cryoimmunogold technique 
(from Liou. et al, 1996). 
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2.1.5. Immunolabeling for electron microscopy 
An immunogold procedure modified from Griffiths (1993) was used in this study for 
immunolabeling of the synaptic proteins in nerve terminals. The grids with ultrathin sections 
were floated sequentially on droplets of the various solutions at the surface of a piece of 
parafilm, keeping the section side of the grid down in the liquid and the back side of the grid 
up and dry. The entire labeling process was performed at room temperature unless it is 
specifically mentioned.  
At first, the sections were incubated in droplets of 50 mM glycine in PBS for 10 minutes to 
quench the remaining free aldehyde groups. The amino group of the glycine would bind to 
free aldehyde groups left on the specimens and prevent them from binding to the antibody, 
reducing the nonspecific background. Then they were floated in 5% bovine serum albumin 
(BSA) in PBS for 20 minutes to block non-specific binding sites. The immunolabeling was 
carried out by incubating the sections on the droplets of the immunoreagents inside a Petri 
dish, which ensured a dust-free moist environment. Because of the small volume of the 
antibody solution, a piece of water-soaked tissue paper was placed within the petri dish to 
minimize evaporation of the immunoreagents. The grids were placed directly from 5% BSA 
onto the droplets of primary antibody diluted appropriately in PBS containing 1% BSA in a 
moist Petri dish and incubated for 2 hours or overnight at 4°C to locate the protein of interest. 
After washing intensively in PBS (6 times for 30 minutes) to remove the unbound primary 
antibodies, sections were incubated with colloidal gold-conjugated (10 nm, in some cases also 
5 nm) secondary antibody diluted 1:20 with 1% BSA for 2 hours or overnight at 4°C in a 
moist petri dish. Thereafter the sections were washed in PBS buffer 6 times for 30 minutes to 
remove the unbound secondary antibodies and postfixed in 2.5% glutaraldehyde in PBS for 
10 minutes. The glutaraldehyde was washed out in PBS for 3 x 5 minutes. Then the grids 
were rinsed in double-distilled water for 4 x 2 minutes to remove the phosphate. Phosphate in 
the sections would precipitate the uranyl ions during the following staining. 
Control experiments 
Control experiments were always performed with sections adjacent to those showing a 
positive reaction with the normal immunocytochemical staining. These sections were 
processed precisely as described above, with the only exception that the primary antibody was 
replaced by 1% BSA in PBS. The sections were incubated with 10 nm colloidal gold-
conjugated secondary antibody, goat anti-mouse IgG or goat anti-rabbit IgG, in order to 
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Double immunolabeling  
The double immunolabeling method was applied to compare the localization of two 
synaptic proteins of interest on the same tissue section. Two primary antibodies raised in 
different donor species and directed against different synaptic proteins were applied. The 
monoclonal antibody (from mouse) and the polyclonal antibody (from rabbit) used in the 
present study bound to the corresponding secondary antibodies that were conjugated to two 
differentially sized gold particles markers (5 nm or 10 nm). The availability of different-sized 
gold particles makes the immunogold method particularly suitable for the ultrastructural 
demonstration of various proteins in the same preparation.  
Immunostaining for the two antibodies was performed sequentially on the cryo-sections. 
After blockade of the non-specific binding sites with 5% BSA for 20 minutes, the first 
primary antibody, washing buffer PBS and the corresponding immunogold-conjugated 
secondary antibody were used one after another as described above. Then the sections were 
washed intensively with PBS and blocked again with 5% BSA for 20 minutes. The 
immunolabeling procedure was repeated by sequential application of the second primary 
antibody, washing buffer PBS and the corresponding immunogold-conjugated secondary 
antibody. Thereafter, the specimens were treated as mentioned above.  
Immunolabeling with 1.4-nm Nanogold and silver enhancement 
In order to improve the density of immunolabeling, 1.4 nm Nanogold with Fab fragments 
and silver enhancement were employed in the localization of synaptic proteins in the CA3 
region of the hippocampus. The small 1.4 nm Nanogold with Fab fragments reveal excellent 
penetration into the tissue (Sun et al., 1995) and have been shown to be able to pass easily 
through 1-2 µm thick cryosections (Takizawa and Robinson, 1994). Therefore, they would be 
expected to penetrate completely through the 90 nm thick ultra-thin cryosections used in the 
present study. These immunogold particles are too small to be resolved in thin sections by 
normal observation with electron microscopy, but can be visualized after silver enhancement 
(Danscher, 1981b; Burry et al., 1992). Silver enhancement is a process in which gold 
catalyzes the silver reduction that leads to the deposition of silver around the gold particles, 
such that the small gold particle can be grown to a useful size for electron microscopic 
observation (Danscher, 1981c). The silver enhancement procedure does not deteriorate 
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The practical experimental procedure in the present study is as following: the cryosections 
were at first treated as described above. After the incubation with the primary antibody anti-
VAMP II, the sections were washed intensively with PBS and incubated in 1.4 nm gold 
particles with covalently attached goat anti-mouse Fab. The 1.4-nm gold probes were diluted 
1:200 in PBS containing 1% BSA. After washing with PBS six times in 30 minutes, the 
sections were postfixed with 2.5% glutaraldehyde in PBS for 10 minutes. The grids were 
washed with double-distilled water for three times in 15 minutes. Then the 1.4-nm gold 
particles were silver-enhanced. The developer solution was prepared according to Danscher 
(1983). The sections were incubated with developer solution in a dark chamber for 20 
minutes. The reaction was stopped by washing the samples in double-distilled water. 
Thereafter, the samples were negatively stained as described in 2.1.6.   
Developer solution  
A.  Protective colloid: 25 g gum arabic is dissolved in 50 ml double-distilled water by 
stirring, and then the solution is aliquoted and stored at -20°C. 
B.  Citrate buffer (pH 3.5): 2.35 g dehydrated sodium citrate and 2.55 g citric acid   
in 10 ml double-distilled water. 
C.  Reducing agent: 0.85 g hydroquinone in 15 ml double-distilled water. 
D.  Silver ion supply: 0.11 g silver lactate in 15 ml double-distilled water.    
The developer solution was prepared by mixing 60 parts of solution A, 10 parts solution B, 
15 parts solution C, and 15 parts solution D. Solution D was protected from light and added 
immediately just before use (Danscher, 1981a). 
Antibodies 
1)  Primary antibodies  
Table I listed the used primary antibodies against various proteins and the information 
about their type, donor animal, and the working concentration as well as the source of the 
antibodies.  
2)  Secondary antibodies 
The type, donor animal, working concentration and the source of the appropriate secondary 
antibodies used in this part are listed in Table II. Secondary antibodies conjugated with 10 nm 
gold particles was used for normal immunostaining, 5 nm and 10 nm gold particles were used 
for double staining, and the 1.4 nm nanogold was used only for silver enhancement. Materials and Methods  25
Table I. Primary antibodies for localization of synaptic proteins in hippocampus and neurohypophysis 
Antigen  Type/Signature  Donor  Dilution  Source 
VAMP II  mono/ 
cl 69.1  mouse 1:50  Synaptic Systems, 
Göttingen, Germany 
SNAP-25  mono/  
cl SMI 81, IgG1  mouse 1:20  Biotrend,  
Köln, Germany 
SV2  mono/ 
CKK 10H4  mouse 1:10  Dr.R.B. Kelly, 
San Francisco, USA 
Rab3A  mono/ 
cl 42.2, IgG2b  mouse 1:20  Synaptic  Systems 
α/β SNAP  mono/  
cl 77.1 IgG2b  mouse 1:20  Synaptic  Systems 
NSF  poly/ 
733-744aa  rabbit 1:20  Synaptic  Systems 
NTCC  poly/ 
 anti-α1B 851-867aa  rabbit 1:20  Alamone labs 
Jerusalem 
PQTCC  poly/ 
anti-α1A  rabbit 1:20  Alamone labs  
Jerusalem 
Bassoon  Poly/ 
-  rabbit  1:50  tom Dieck et al. 1998   
Oxytoxin  Poly/ 
-  rabbit 1:500  Prof. F. Nürnberger, 
Frankfurt, Germany 
 
Table II. Secondary antibodies for detection of synaptic proteins in hippocampus and neurohypophysis 
Name  Type   Donor  Dilution  Source 
Goat anti-mouse IgG 
(10 nm gold)   
mono  goat  1:20  British BioCell International 
(Cardiff, UK) 
Goat anti-mouse IgG  
(5 nm gold)   
mono  goat  1:20  British BioCell International 
(Cardiff, UK) 
Goat anti-mouse Fab 
(1.4 nm nanogold)   
mono  goat  1:200  British BioCell International 
(Cardiff, UK) 
Goat anti-rabbit IgG 
(10 nm gold)   
Poly  goat  1:20  British BioCell International 
(Cardiff, UK) 
Goat anti-rabbit IgG  
(5 nm gold)   
Poly  goat  1:20  British BioCell International 
(Cardiff, UK) 
 
2.1.6. Staining and examination of ultrathin sections 
A “Positive-Negative” Staining method modified from Griffiths (1984) was used to reveal 
the ultrastructure of mossy fiber terminals in the hippocampus and neurosecretory endings in 
the neurohypophysis. After immunolabeling and postfixing, the specimens were rinsed with 
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drops of a mixture of 2% uranyl acetate and 1.5% methylcellulose in the dark on ice for 10 
minutes. This mixture was prepared immediately prior to use and kept on ice in the dark at all 
times. Then the grids were individually taken out using a 3.5 mm-diameter wire loop. The 
excess solution was drawn off with filter paper so that a thin film was left over grid and 
sections. Finally, the grids were allowed to dry at room temperature in the air. The 
methylcellulose was introduced to protect thawed frozen sections against the damage from 
surface tension caused by air-drying. Together with the initial aldehyde fixation, the treatment 
with methylcellulose determines the structural preservation of the thawed cryosection. In 
addition, it was reported that sections with a thickness of approximately 80-110 nm would 
yield an average thickness of 70 nm after they were thawed and dried under the protection of 
methyl cellulose (Griffiths et al., 1984). This proved suitable for examining the sections under 
the transmission electron microscope. With this method a mixture of positive and negative 
contrast was finally produced. The nucleus and microtubules were usually positively stained, 
whereas the membranes gave a strong negative contrast. 
Specimens were examined under a Zeiss EM 902 electron microscope operated at 80 kV. 
In order to obtain a higher contrast for the cryosections a small objective aperture (30 µm in 
diameter) were used.  
Stock solution of methylcellulose 
2% methyl cellulose (25 centipoise viscosity, Sigma, Germany) was mixed in double 
distilled water at 4°C. When completely dissolved, the solution was centrifuged at 100,000 g 
with Beckman ultracentrifuge (Optima™ TLX, rotor TLA45) at 4°C for 1 hour. Then they 
were stored carefully in the refrigerator without disturbing the insoluble pellet at the bottom 
of the tube.  
Stock solution of uranyl acetate  
8% uranyl acetate was fully dissolved in double distilled water under constant stir in the 
dark, then stored at 4°C in the refrigerator.  
The mixture of 1.5%  methylcellulose and 2% uranyl acetate 
The mixture was freshly prepared by completely mixing three parts of 2% methylcellulose 
stock solution with one part of 8% uranyl acetate stock solution. The mixture was kept on ice 
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2.1.7. Quantitative analysis of immunolabeling 
The number of gold particles was used as an indicator for evaluating the labeling density of 
various synaptic proteins. The electron microscopy images were inputted into a computer 
using a CCD camera and the quantitative analysis was carried out with the image analysis 
software MCID from Imaging Research (ST. Catharines, Ontario, Canada).  
In mossy fiber terminals, the density of the immunolabeling in the active zone area (A.z. 
area, the selected cytoplasmic part within 100 nm of the active zone membrane) and in the 
vesicle area (V. area, the other area outside the active zone area) was determined, 
respectively. Every area of interest was measured and the number of gold particles falling 
within this area was counted. The density was calculated as the number of gold particles per 
square micrometer (number of gold particles/µm
2). For area analysis a total of 15 to 38 
random profiles were taken for every synaptic proteins. Then the comparative ratio of the 
immunolabeling density in these two areas (A.z. area/V. area) was calculated.  Similarly, the 
linear density of gold particles at the plasma membrane of the active zone (p.m. at A.z) and 
outside the active zone (p.m. outside A.z) was obtained and compared. The length of the 
selected plasma membrane and the number of the gold particles on it were measured and 
counted, respectively. The linear density of gold particles was expressed as the number of 
gold particles per micrometer (number of gold particles/µm). Gold particles situated within a 
distance of 10 nm (the size of a gold particle) from the plasma membrane were assigned to 
membrane labeling. Random lengths for different proteins ranging from 16 to 41 samples 
were analyzed for the linear density. The ratio of the linear density of gold particles at the 
plasma membrane of the active zone and outside the active zone was calculated (P.m. at 
A.z./P.m. outside A.z.). 
In neurosecretory terminals of the neurohypophysis the immunolabeling density over 
clustered microvesicles and over the secretory granule population (number of gold 
particles/µm
2) were examined and compared. In addition, the linear labeling density of the 
terminal plasma membrane was determined (number of gold particles/µm). In total 15 to 28 
and 16 to 22 independent analyses for various proteins were performed for area and linear 
density, respectively.  
The same quantitative analysis was performed for the related control samples with 
monoclonal and polyclonal antibodies, respectively. The statistical evaluation was carried out 
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2.2. Study of synaptic proteins in primary astrocytic culture  
The conventional preembedding immunocytochemical technique and the novel LR Gold 
postembedding method were employed in the investigation of the subcellular localization of 
synaptic proteins in primary astrocytic cultures. In addition, horseradish peroxidase (HRP) 
was used as a marker for the study of endocytic structures.   
2.2.1. Primary culture of astrocytes 
Working rules 
An aseptic technique was followed throughout. All glassware was first sterilized by 
autoclaving, all metal preparation devices were sterilized by dry heat at 190°C for 4 hours, 
and all the solutions and reagents for cell culture were subjected to autoclaving or sterile 
filtration. All manipulations for the cell culture were performed under a sterile hood. The 
work surface was decontaminated with 70% ethanol before and after manipulation. Bottles 
and other similar items were wiped with 70% ethanol when they were placed into the hood. 
All solutions and media were prewarmed to 37°C before use.  
Preparation of astrocyte cultures 
The primary astrocytic culture was prepared according to Queiroz et al. (1997) and 
Maienschein et al. (1999). Cerebral cortices of four newborn (postnatal day 1) wistar rats 
were dissected out and placed into ice-cold PBS. Meninges and larger blood vessels were 
removed under the stereo-microscope. Then the tissue was cut into small pieces in a drop of 
culture medium and dissociated by trituration in 10 ml same medium. The cell suspension 
was passed through nylon gauze (50 µm) and then centrifuged at 200 g for 5 minutes (Fa. 
Hermle ZK 380). The cell pellet was resuspended in 10 ml medium and recentrifuged at 200 g 
for 5 minutes. This was repeated twice. Then the cell number was determined and cells were 
plated at a density of 200.000/ml in poly-L-lysine-coated Permanox chamber slides (Nunc, 
Wiesbaden, Germany). The cell culture was incubated in astrocyte culture medium at 37°C 
with 5% CO2. The culture medium was changed on the next day.  
Astrocyte culture medium  
Dulbecco’s Modified Eagle Medium (DMEM, GIBCO/ BRL, Germany) containing 4 mM 
L-alanyl-L-glutamine was supplemented with 10% fetal calf serum (FCS), 100 U/ml 
penicillin and 100 µg/ml streptomycin, and 10 ng/ml lipopolysaccharid.  Materials and Methods  29
Determination of cell number 
In order to estimate the concentration of the cells, the cell number was determined in a 
standard manner using a Neubauer hemocytometer and a Trypan blue solution. At first, the 
cells were resuspended by pipeting up and down to give a uniform cell suspension. Then an 
aliquot of the cell sample was diluted 1:4 for the counting. A drop of diluted cell suspension 
was added immediately to either chamber of the hemocytometer and the viable cells were 
counted using an inverted microscope. Viable cells were remained unstained because of their 
intact cell membrane, whereas the dead cells were stained blue. Cell counting was completed 
within 2-3 minutes, since longer observation time led to additional cell death. Each large 
square on the Neubauer hemocytometer has 16 small squares and gives an area of 1 mm
2 and 
a depth of 0.1 mm. Thus its volume is 0.1 mm
3, i. e. 10
-4 ml. The cells of four large squares in 
the chamber were counted and added up. The sum was divided by 4 to obtain the mean 
number of cells in one large square, then divided by 10
-4 ml (volume of one large squares) and 
finally multiplied by 4 (the ratio of the dilution) to get the number of the cells per milliliter 
(cells/ml) in the probe.  
2.2.2. Preembedding immunocytochemical method 
The conventional preembedding immunocytochemical method was first applied in the 
cultured astrocytes for the study of the subcellular localization of synaptic proteins and the 
stimulation-induced endocytotic structure using HRP as a marker. The cells were stimulated 
with different stimuli including 1 mM glutamate, 1 µM brandykinin as well as 500 µM N-
methyl-D-aspartate (NMDA) in the presence of HRP (5 mg/ml, sigma, Germany). The HRP 
reaction was performed after fixation but before immunolabeling. For the 
immunocytochemical analysis the cells were fixed for 20 minutes with 3% paraformaldehyde 
and 0.05% glutaraldehyd either in the hypotonic phosphate buffer (5 mM PB) that led to the 
rupture of the plasma membrane so that the antibodies could get access to the binding sites 
(Marxen et al., 1999) or in normal PBS buffer and then treated with the bacterial toxin 
streptolysin-O (1 µg/ml). Streptolysin-O binds cholesterin on the plasma membrane at 0°C. 
Through a temperature change from 0°C to 37°C the membrane-bound monomeres of 
streptolysin-O fuse into oligomeres, resulting in the formation of ~30 nm pores in the plasma 
membrane (Bhakdi et al., 1993). These pores allow the antibodies to diffuse into the 
cytoplasm. Cultured 4-day-old astrocytic cells were used for the experiments. The 
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Stimulation, fixation and DAB reaction 
•  Wash with physiological saline at 37°C for 5 minutes to remove excess medium  
•  Stimulate the cells at 37°C in the presence of HRP (5 mg/ml) for 1 minute 
•  Wash twice with physiological saline solution at 37°C 
•  Fix with 3% paraformaldehyde and 0.05% glutaraldehyde either in hypotonic 
phosphate buffer (5 mM PB) or in normal buffer (PBS) * for 20 minutes 
•  Wash with PBS 3 x 5 minutes 
* Cells fixed in normal buffer were treated with the bacterial toxin streptolysin-O  
(1 µg/ml) at 0 °C for 5 minutes and then at 37°C for 10 minutes. 
•  Incubate with 0.05% diaminobenzidine (DAB, sigma, Germany) and 0.01% H2O2 in 
60 mM Tris-HCl (PH 7.6) for 20 minutes 
•  Wash with Tris-buffered saline (TBS) for 5 minutes 
•  Wash with PBS 2 x 5 minutes 
Immunolabeling, postfixation and embedding 
•  Incubate in 5% BSA for 20 minutes to block non-specific binding sites  
•  Incubate in primary antibody diluted in PBS containing 1% BSA at 4°C for 4 hours  
•  Wash with PBS 3 x 20 minutes 
•  Incubate in 10 nm gold-conjugated secondary antibody (1:20) at 4°C overnight 
•  Wash with PBS 6 x 10 minutes 
•  Postfix with 2.5% glutaraldehyde in PBS for 30 minutes   
•  Wash with PBS 3 x 5 minutes 
•  Fix with 1% osmium tetroxide (OsO4) in PBS for 2 hours 
•  Wash with PBS 3 x 5 minutes 
•  Dehydrate in 50% ethanol 2 x 5 minutes 
•  In 70% ethanol for 5 minutes 
•  Stain with 2% uranyl acetate in 70% ethanol for 20 minutes in the dark 
•  Dehydrate in increasing ethanol series 70, 80, 90, 96, 100, 100%, 5 minutes each 
•  In propylenoxid for 15 min 
•  Propylenoxid / Epon (1:1) for 1 hour 
•  Infiltrate in Epon in gelatin capsules overnight and polymerize at 60°C for 24 hours 
•  Trim and section 
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Physiological saline 
120 mM NaCl, 4.8 mM KCl, 1.22 mM KH2PO4, 25.5 mM NaHCO3, 14.3 mM glucose,  
1.5 mM MgSO4 and 2 mM CaCl2. pH adjusted to 7.4 
Composition of the Epon-mixture 
Epon 812  17.44 ml (Fa. Serva, Heidelberg, Germany) 
DDSA      16.0 ml 
MNA      6.96 ml 
DMP           1 ml 
2.2.3. LR Gold postembedding immunocytochemical method 
A modified LR Gold postembedding immunocytochemical method from Migheli et al. 
(1992) was used for the localization of synaptic proteins in astrocytic cells. The polar acrylic 
resin “LR Gold” has been introduced for postembedding immunocytochemistry because its 
hydrophilic property provides a better penetration for antibodies in aqueous solution (Klinger, 
1994). Moreover, optimal preservation of both ultrastructure and antigenicity of the tissue has 
been obtained by staining with uranyl acetate, total dehydration in acetone and embedding at 
low temperature (Berryman and Rodewald, 1990).  
In the present study, 4-day-old cultured astrocytic cells were used for the experiment. At 
first, the cells were washed in physiological saline for 5 minutes at 37 °C to remove excess 
medium. Then they were fixed with 4% paraformaldehyde and 0.05% glutaraldehyde in 0.1 
M phosphate buffer (PB) for 2 hours. After washing, the samples were incubated in 50 mM 
ammonium chloride for 30 minutes to quench the remaining free aldehydes and then treated 
with 2% uranyl acetate at 0°C for 2 hours. Thereafter they were dehydrated in an acetone 
series at -20°C and infiltrated with LR Gold resin at -20°C overnight. The cells were 
polymerized in LR Gold containing 0.5% diberzoylperoxide in gelatin capsules at -20°C for 
24 hours. Then the sample blocks were trimmed and sectioned and the ultrathin sections were 
collected on 200 mesh nickel grids.  
Immunolabeling was carried out by floating the grids with ultrathin sections sequentially 
on droplets of the various solutions on a piece of parafilm at room temperature (see 2.1.5.). 
After floating on 5% BSA for 20 minutes the sections were incubated with the primary 
antibody and the corresponding gold-conjugated (10 nm) secondary antibody (1:20) for 3 
hours, respectively. After washing with double-distilled water for 6 x 5 minutes the sections 
were counterstained with lead citrate solution for 2 minutes.  
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Lead citrate solution (Reynolds, 1963) 
Dissolve 1.33 g lead nitrate Pb(NO3)2 and 1.76 g sodium citrat Na3(C6H5O7)
.2H2O in 30 ml 
freshly prepared double-distilled water (CO2-free), then add 8 ml 1 N NaOH and shake until 
the solution becomes clear. Fill with the same double-distilled water up to 50 ml. The entire 
process should be protected from CO2 to avoid the precipitation of lead carbonate.  
2.3. Expression and localization of synaptic proteins in the 
astrocytoma cell line U373 MG 
The cell line U373 MG was used in this study as a model system to investigate the 
expression and localization of synaptic proteins in astrocytoma cells. Various recombinant 
DNAs encoding different synaptic proteins were transfected into the U373 cells and detected 
by immunocytochemical methods via immunofluorescence and electron microscopy.  
2.3.1. Constructs  
cDNAs encoding VAMP II-, SNAP-25-, syntaxin I- and cellubrevin (generously supplied 
by Prof. Niemann) were linked to the tags myc (oncogene of myelocytomatosis virus), HA 
(hemagglutinin), VSVG (the vesiclar stomatitis virus glycoprotein) and flag at their 5´-ends, 
respectively, and all of the resulting recombinant cDNAs were then cloned into an expression 
vector pcDNA3 (Invitrogen, Holland) by Dr. Alexander Wilhelm in our laboratory. The tags 
myc, HA, VSVG and flag, are all small peptides consisting of 8-12 amino acids and are 
expressed at N-terminus of VAMP II, SNAP-25, syntaxin I and cellubrevin, respectively. The 
pcDNA3 vector has a high rate of expression for both the cDNAs of interest and the linked 
tags. By use of a monoclonal antibody raised against the corresponding tag, the detection of 
these recombinant proteins could be then carried out immunocytochemically. 
In addition, by means of the green fluorescent protein (GFP) and the red fluorescent 
protein (RFP), the expression and localization of the transfected proteins Rab5 and syntaxin I 
were investigated in the U373 cells. The Rab5-cDNAs in the GFP-containing expression 
vector pEGFP C3 were kindly provided by prof. Dr. Marino Zerial (Dresden). The syntaxin I-
cDNAs were cloned to the RFP-encoding expression vector pDsRed1-N1 (Clontech, 
Germany) by Friederike Küster in our laboratory. GFP, originally identified in the jellyfish 
Aequorea victoria, displays an inherent green fluorescence (Prasher, 1995; Kendall and 
Badminton, 1998). RFP has recently been isolated from an Indo Pacific sea anemone-relative, 
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fluorescence. The fusion protein with fluorescent GFP or RFP can be directly observed under 
a fluorescent microscope, without the help of the antibodies. Therefore, the background due to 
nonspecific binding of either primary or secondary antibodies can be eliminated greatly at the 
level of light microscopy. GFP and RFP have been reported in many studies to serve as 
excellent fluorescent markers for analysis of gene expression and protein localization and 
dynamics. 
2.3.2. Bacterial culture 
The bacteria Escherichia coli (E. coli) DH5α was used as host strain to propagate plasmid 
DNA. Small ice pieces of bacteria from a frozen glycerol bacterial stock (stored in -80°C) 
were picked up using an inoculating loop under sterile conditions and inoculated immediately 
into 400 ml LB-medium/ampicillin in a 1-liter sterile flask. Under constant, suitable shaking, 
the inoculated cultures were grown in a 37°C incubator over night. Then the culture was ready 
for use. 
LB-medium  
10 g bacto tryptone, 5 g bacto-yeast extract and 10 g NaCl were dissolved in 1 liter double 
distilled water, pH 7.5 and autoclaved 
LB-medium/ampicillin 
A sterile stock solution of the antibiotic ampicillin (50 mg/ml) was added into the LB-
medium at a final concentration of 0.1 mg/ml. 
2.3.3. Maxi-preparation of plasmids 
The plasmid DNA from E. coli was extracted with the Maxi-Prep-kit Nucleobond AX from 
the company Macherey-Nagel (Germany). The preparation was carried out according to the 
manufacture’s standard protocol for the purification of plasmids. The cartridge AX 500 was 
applied for the maxi-preparation. 
The bacterial culture was harvested by centrifuging at 2100 g, 4°C, for 10 minutes 
(Kontron Hermle: Centrikon T324, rotor A6.14). The bacterial pellet was then carefully 
resuspended in 12 ml resuspension buffer S1. After complete resuspension, 12 ml lysis buffer 
S2 was added and the suspension was mixed gently and thoroughly. Then the mixture was 
incubated at room temperature for 5 minutes, so that the bacterial cells could be lysed 
completely by NaOH/SDS in buffer S2. The chromosomal and plasmid DNA were denatured 
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RNase A contained in buffer S1. Thereafter 12 ml neutralization buffer S3 was added and 
mixed gently. The homogeneous suspension was incubated on ice for 5 minutes. The acidic 
buffer S3 neutralized the lysate and the high concentration of potassium acetate caused the 
white precipitate containing chromosomal DNA and other cellular compounds. The plasmid 
DNA remained in solution and renatured to its supercoiled structure. During the incubation a 
Necleobond cartridge AX 500 was prepared. The cartridge was equilibrated with 5 ml 
equilibration buffer N2. The incubated bacterial lysate was loaded onto a prewetted filter to 
remove completely the precipitated debris from the plasmid samples. The cleared lysate 
passed directly through the cartridge by gravity flow and the plasmid DNA in the solution 
was adsorbed by the cartridge. The cartridge was then washed twice with 12 ml wash buffer 
N3 to remove all contaminating substances. Thereafter, the bound plasmid-DNA in the 
cartridge matrix was eluted with 12 ml elution buffer N5. The eluate was collected in a 
centrifuge tube. 8.4 ml isopropanol was added to precipitate the purified plasmid DNA. The 
plasmid DNA was pelleted by centrifugation at 12,000 rpm and 4°C for 45 minutes (Hermle 
Z.360K, rotor 22078 V01). The DNA pellet was washed with 5 ml 70% ethanol to remove 
precipitated salt and centrifuged again for 30 minutes. The DNA pellet was allowed to dry 
under vacuum at 20 mbar for 15 minutes. Then the DNA was redissolved in 200 µl double 
distilled water and stored at 4°C. 
Buffer solutions 
S1: 50 mM Tris/HCl, 10 mM EDTA, 100 µg/ml RNase A, pH 8.0 (stored at 4°C) 
S2: 200 mM NaOH, 1% sodium dodecyl sulfate (SDS) 
S3: 2.8 M potassium acetate, pH 5.1 
N2: 100 mM Tris/H3PO4, 15% ethanol and 900 mM KCl, 0.15% Triton X-100   pH 6.3 
N3: 100 mM Tris/H3PO4, 15% ethanol and 1150 mM KCl, pH 6.3 
N5: 100 mM Tris/H3PO4, 15% ethanol and 1000 mM KCl, pH 8.5 
2.3.4. Determination of the DNA concentration 
The concentration and the purity of the DNA were determined with a spectrophotometer 
(Hitachi U2000, Japan). The harvested DNA was first diluted 500 folds with double-distilled 
water. The optical density (OD) of the DNA solution was measured at the wavelengths of 260 
nm and 280 nm in a Quarz curvette (d = 1 cm) and expressed as absorbance units. The 
concentration of DNA was determined at 260 nm. According to Sambrook et al. (1989) the 
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(1A260nm unit = 50 ng/µl DNA). The purity of DNA was then estimated by the ratio between 
the measured ODs at 260 and 280 nm. A preparation with acceptable  purity has an 
OD260/OD280 value between 1.6 and 2.0. 
2.3.5. Cell culture  
Cells 
The cell line U373 MG derived from a human astrocytoma was used as a model system for 
the study of the expression and localization of transfected synaptic proteins. It was kindly 
provided by Prof. Dr. Frank Fahrenholz from the University of Mainz. 
The U373 cell line was maintained in 35-mm-diameter culture dishes with growth medium 
in a humidified 37°C incubator with 5% CO2. The U373 cell culture grew and proliferated 
rapidly. Every 2-3 days the cells became 80-90% confluent and were ready for subculture. 
An aseptic technique was applied according to the working rules detailed in 2.2.1. The 
waste of wash buffer and the medium from the transfected cells were inactivated by 
autoclaving.  
Growth medium for the U373 cells 
Dulbecco´s modified Eagle medium (DMEM, GIBCO/BRL, Germany) containing 4 mM 
L-alanyl-L-glutamine was supplemented with 10% fetal calf serum, 100 U/ml penicillin and 
100 µg/ml streptomycin.  
Cell splitting  
The culture medium was first aspirated completely with a Pasteur pipette. Then the cells 
were rinsed twice with prewarmed PBS to remove cell debris and the rest of the medium. 2 ml 
trypsin/EDTA (ethylenediaminetetraacetic acid) solution (0.05% trypsin and 0.53 mM EDTA 
in PBS, Gibco BRL, Germany) was added and the dishes were then swirled to make sure that 
the entire bottom surface of the dish was covered with a thin layer of trypsin/EDTA solution. 
The proteolytic enzyme trypsin digests the extracellular matrix protein responsible for cell 
adhesion to the substratum. EDTA was used in combination with trypsin to remove the 
cultured cells from the bottom of the dish. The cells were incubated in trypsin/EDTA for 2 
minutes and then detached mechanically from the bottom by gently tapping the dishes against 
a solid object. Thereafter, 4 ml growth medium containing natural trypsin-inhibiting factor 
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gentle sweeping the dish bottom with growth medium and dispersed by gentle and repeated 
pipetting to provide a single cell suspension. An aliquot of this cell suspension à 1.5-2 ml 
depending on the concentration of the cells was distributed directly to the new culture dish 
containing 20 ml fresh medium. Then the cells were returned to the incubator.  
2.3.6. Transfection of U373 cells by electroporation 
Physical transfection through electroporation was adopted in this study for the expression 
of synaptic proteins in U373 cells. The cells in suspension were exposed to a pulsed electric 
field that caused transient formation of pores in the cell membrane and provided a local 
driving force for transport of the plasmid DNA constructs through these transient pores into 
the cells. Then the DNA molecules reached the nucleus and were expressed. 
Exponentially growing 50-80% confluent cultures of U373 cells were used for 
electroporation. The cells were harvested using the standard trypsin detachment procedure as 
described above. The resuspended cells were centrifuged at 200 g for 5 minutes. Then the cell 
pellet was resuspended in 800 µl of electroporation buffer. 50 µg of plasmid DNA was added 
carefully to the resuspended cells and mixed gently. The cell-DNA mixture was then 
transferred into a sterile electroporation cuvette with a 4-mm electrode gap. The cuvette was 
rocked gently several times to homogenize the mixture and placed immediately into the 
electroporation chamber. The electroporation was performed at the room temperature with an 
electroporation apparatus (Electro cell manipulator 600, BTX-Genotronics, San Diego, USA) 
with the following parameters: 2250 µF capacitance, 500V/capacitance-resistance, 186 Ω 
resistances and 240V charging voltageThe pulse lasted for 30-40 ms. The transfected cells 
were transferred to a centrifuge tube containing 20 ml of prewarmed (37°C) recovery culture 
medium and incubated with the slightly opened cap to allow gas exchange at 37°C with 5% 
CO2 for 30 minutes, such that the cells could recover from the electroporation shock. Then the 
cells were centrifuged at 200 g for 5 minutes and resuspended in 2-4 ml culture medium.  
Cell number was determined with Trypan blue and the cells were plated immediately as 
described in 2.2.1. Cells intended for immunofluorescence experiments were plated onto 
poly-D-lysine coated cover slips in 24-well tissue culture plates at a density ranging from 
20,000-30,000 cells/cm
2. Each well contained 1 ml prewarmed (37°C) growth medium and 
one cover slip. For electron microscopy, cells were plated into 35-mm-diameter culture dishes 
with prewarmed growth medium at a density of 1-5 x 10
6 cells/dish. The plated cells were 
allowed to grow and settle in the incubator at 37°C with 5% CO2 for 24 hours.  Materials and Methods  37
Electroporation buffer 
137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mM dextrose and 20 mM Hepes  
were dissolved in triple-distilled water, pH 7, autoclaved and stored at 4°C. 
Recovery-medium  
3 mM EGTA in U373 growth medium 
Cotransfection 
For double immunolabeling, the U373 cells were cotransfected with two types of DNA 
constructs simultaneously to express two different synaptic proteins in the same cell, each 
type with 50 µg plasmid DNA.  
Control for the transfected proteins 
The pcDNA3 vector alone without any inserts was transfected into U373 cells to control 
for the expression of the transfected proteins. The process of the electroporation was the same 
as described above. 
2.3.7. Preparation of cover slips 
Cover slips (1cm in diameter, Fisher) were cleaned and sterilized before use as follows: 
they were first boiled in 1 N HCl solution for 1 hour. After cooling, the cover slips were 
rinsed in triple-distilled water to remove the HCl, and then cleaned in 70% ethanol. The 70% 
ethanol solution was replaced by fresh triple-distilled water. At last, they were dried at 60°C 
in a dry oven for 1 hour. The dry cover slips were packed in a piece of aluminum foil, 
avoiding mutual contact. The packets were placed into a cleaned glass Petri dish and sterilized 
by heating at 190°C for 3 hours. 
Then the cover slips were coated with poly-D-lysine under sterile conditions to facilitate 
the adherence of cells. A long piece of sterilized parafilm was attached onto the surface of the 
sterile bench. The sterile cover slips were placed orderly onto the hydrophobic parafilm. 100 
µl of a poly-D-lysine solution with a concentration of 5 µg/ml
 was added to each cover slip. 
After 30 minutes incubation, the cover slips were washed 3 times with sterile distilled water, 
each for 5 minutes, and then allowed to dry under the sterile flow hood for ~1 hour. 
Thereafter the coated cover slips were placed individually into a 24-multiwell plate with the 
coated side up.  Materials and Methods  38
2.3.8. Immunocytochemical methods 
Two methods were used in the immunocytochemical analysis of transfected synaptic 
proteins in U373 cells. One was immunofluorescence microscopy for detecting the 
distribution pattern of the transfected protein in the entire cell; the other was the cryo-
immunogold technique with electron microscopy for determining the subcellular localization 
of the proteins. After 24 hours in culture medium at 37°C, the electroporated cells, which still 
stayed in the transient expression phase, were processed for immunocytochemical analysis. 
The transfected proteins were detected with the respective primary antibody directed against 
the corresponding tag, but in some cases also with the antibodies against the proteins 
themselves. The former recognized only the recombinant proteins, whereas the latter detected 
both the recombinant and the endogenous proteins. Generally, 10 nm gold-conjugated 
secondary antibodies were applied for the detection of the various recombinant proteins, 
unless mentioned otherwise. 
2.3.8.1. Immunofluorescence microscopy 
In the present study, immunofluorescence microscopy was used to reveal the entire 
distribution of the transfected synaptic proteins at the cellular level. In addition, it was also 
very helpful for establishing suitable conditions of fixation and antibody binding for a 
successful labeling of ultrathin sections.  
The immunofluorescence labeling was performed in a Petri dish lined with hydrophobic 
parafilm. The cells were washed twice in prewarmed physiological saline solution to remove 
the culture medium and fixed either in absolute methanol at –20°C for 7 minutes or in a 
fixative containing 4% paraformaldehyde and 0.05% glutraraldehyde in PBS for 20 minutes. 
The methanol was able to permeabilize the cells directly. However, cells fixed with 4% 
paraformaldehyde and 0.05% glutraraldehyde must be treated with 0.1% Triton X-100 in PBS 
for 10 minutes, which dissolves lipid membranes and enhances penetration of antibody. Then 
the cells were washed with PBS three times for 15 minutes and incubated with 5% BSA in 
PBS for 20 minutes to block nonspecific binding sites. Afterwards the cells were incubated 
without further washing directly with the primary antibody diluted in 1% BSA for 20 minutes. 
The unbound primary antibody was drained off and the cells were washed three times in PBS, 
5 min each. From then on, the cells were manipulated in the dark and protected from light. 
The cells were incubated with the corresponding FITC- or Cy3-conjugated goat anti-mouse or 
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PBS for 20 minutes, the excess wash buffer was withdrawn from the coverslips and the glass 
coverslips were mounted onto a clean slide with a small drop of anti-fading-medium, cell-side 
down. At last, the glass coverslips was sealed with nail varnish around the margin to prevent 
leakage of the mountant and the specimens were stored in the refrigerator avoiding exposure 
to light.  
Fixative  
4% paraformaldehyde and 0.05% glutaraldehyde in PBS 
Freshly prepared paraformaldehyde (see 2.1.1.) or its frozen aliquot was used.  
Anti-fading reagent 
6 g glycerol and 2.4 g mowiol were stirred in 6 ml double-distilled water in the dark for 2 
hours. 12 ml 0.2 M Tris-buffer (pH 8.5) was added, and the solution was stirred and incubated 
in 50°C for further 2 hours, then stored at –20°C. Prior to use, the solution should be thawed, 
2.5% DABCO (1,1-diazobicyclo-(2,2,2)-octane) added, and then stirred for 20 minutes in the 
dark.  
Control experiment  
In control experiments, the primary antibody was omitted to examine if the 
immunolabeling was specific or merely resulted from nonspecific binding of the secondary 
antibody.  
To control for the expression of transfected proteins, cells transfected only with the empty 
pcDNA3 vector were incubated with primary antibody raised against the respective tag or 
protein and the corresponding secondary antibodies, respectively. The other procedure was as 
described above. 
Double immunolabeling  
The double labeling method was applied to localize simultaneously two different synaptic 
proteins in the same cell. Two noncross-reacting immunostainings were performed 
sequentially on the coverslips. Every time after the incubation with the antibody the cells 
were intensely washed with PBS for three times. Before application of the secondary primary 
antibody the cells were blocked again with 5% BSA for 20 minutes. Two corresponding 
secondary antibodies, goat-anti-mouse and goat-anti-rabbit, were conjugated with the 
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Localization of fluorescent fusion proteins  
Cells transfected with the construct GFP-Rab5 or RFP-syntaxin I displayed an inherent 
green or red fluorescence of GFP or RFP. No antibody was needed. From the beginning, all 
handling was performed in the dark to reduce fluorescence bleaching. 24 hours after 
electroporation, the transfected cells were visualized directly under the fluorescent 
microscopy. For extended storage, the cells were washed once with physiological saline to 
remove the remaining culture medium and fixed in absolute methanol at –20°C for 7 minutes. 
After washing with PBS three times for 15 minutes, the cells on the glass coverslips were 
mounted with anti-fading-medium onto a glass slide and stored in the refrigerator. For double 
protein localization, when both constructs containing GFP or RFP were used simultaneously, 
the cells were treated as described above. However, when a GFP- or RFP-construct and 
another construct with nonfluorescent tag were transfected simultaneously, the nonfluorescent 
tag had to be immunolabeled. The specimens were treated as for the single antigen detection 
in the dark. 
Observation  
The samples were examined under the fluorescence microscope (Zeiss, Germany) 
equipped with an MCID 4 imaging analysis system (Imaging Research, St. Catharines, 
Canada). Emission signals were filtered with a Zeiss Axiophot I 450-490 nm filter for FITC 
excitation and 510-560 nm for Cy3. Confocal images were obtained with a laser assisted 
confocal scanning microscope (Leica TCS4D, Germany). FITC and GFP were excited with 
the 480 nm laser; Cy3 and RFP with the 580 nm laser. All micrographs were processed with 
Adobe Photoshop 6.0. 
2.3.8.2. Immunoelectron microscopy 
The cryo-immunogold technique was applied for the subcellular localization of 
recombinant synaptic proteins. Transfected U373 cells for use in electron microscopy were 
grown on 35-mm tissue culture dishes for 24 hours. Thereafter, the cells was rinsed twice 
with prewarmed physiological saline solution (37°C) to discard floating cells and cell debris, 
and then fixed directly in the dish at the room temperature by adding fixative containing 4% 
paraformaldehyde and 0.05% glutaraldehyde in PBS. After 90 minutes, the fixed cells were 
scraped off the substratum and centrifuged for 15 minutes at 3000 rpm (Hermle Z.360K, rotor 
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pellet of the cells was taken out and then treated as for tissue blocks during further processing. 
Small pieces of the cell pellet were infiltrated with 2.3 M sucrose in PBS or a mixture of 1.8 
M sucrose and 20% PVP for 3 hours. During that time the cryoprotectant solution was 
changed carefully several times. Small pieces of nitrocellulose were used to aid the transport 
of the cells. Cryo-protected cell pellets were mounted on specimen holders and immediately 
frozen in liquid nitrogen. The preparation of ultrathin cryosections, immunolabeling and 
staining of sections was the same as for treatment of tissue blocks (see 2.1.4. 2.1.5. and 2.1.6., 
respectively). 
Control experiments  
Control sections were processed as described above (see Control experiments in 2.1.5.). 
For double labeling control, goat anti-mouse IgG conjugated with 10 nm colloidal gold and 
goat anti-rabbit IgG with 20 nm colloidal gold were applied.  
In control experiment for the expression of transfected proteins, sections obtained from the 
cells transfected with the pcDNA3 vector only were incubated with various primary 
antibodies and the corresponding with 10 nm gold particles conjugated secondary antibodies, 
respectively. The samples were treated as for the normal immunolabeling procedure described 
above.  
2.3.8.3. Antibodies 
1) Primary antibodies: Antibodies against the following proteins (Table III) were applied 
for light and electron microscopy of U373 cells.  
Table III. Primary antibodies for localization of recombinant synaptic proteins in U373 cells 
Antigen  Type/Signature  Dilution  Donor  Source 
Myc  mono   5 µg/ml   mouse  Our laboratory 
VSVG mono   1:100  mouse  Sigma 
HA mono    1:50  mouse  Sigma 
Flag mono    1:100  mouse  Sigma 
Syntaxin I  mono/78.2  1:50  mouse  Sigma 
SNAP-25  mono/SMI 81  1:20  mouse  Biotrend , Köln. 
cellubrevin  poly  1:100  rabbit  Dr. McMahon (Cambridge; UK) 
GFP poly 1:50  rabbit  Clontech,Heidelberg 
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2) Secondary antibodies: The following secondary antibodies were used to detect the 
recombinant synaptic proteins in U373 cells. Their properties are listed in the Table IV. 
Table IV. Secondary antibodies for detection of recombinant synaptic proteins in U373 cells 
Name  Type   Dilution  Donor  Source 
Anti-mouse-FITC mono   1:100  goat  Dianova 
Anti-rabbit -FITC  poly   1:100  goat  Sigma 
Anti-mouse-Cy3 mono    1:800 goat  Sigma 
Anti-rabbit-Cy3 poly    1:400  goat  Sigma 
Goat anti-mouse IgG 
(5 nm gold)   
mono   1:20  goat  British BioCell International 
(Cardiff, UK) 
Goat anti-mouse IgG 
(10 nm gold)   
mono   1:20  goat  British BioCell International 
(Cardiff, UK) 
Goat anti-rabbit IgG 
(10 nm gold)   
poly   1:20  goat  British BioCell International 
(Cardiff, UK) 
Goat anti-rabbit IgG 
(20 nm gold)   
poly   1:20  goat  British BioCell International 
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3. Results 
3.1. Localization of synaptic proteins in mossy fiber terminals and 
neurohypophysial endings  
The cryo-immunogold technique was successfully applied in the present study to reveal the 
distribution of various synaptic proteins in two different types of nerve terminals, the mossy 
fiber terminals of the CA3 region of the hippocampus and the typical neurosecretory endings 
in the neurohypophysis. The modified “positive-negative” staining method results in a strong 
negative contrast for membranes and a positive staining for the nucleus.  
3.1.1. Morphology of mossy fiber terminals and neurohypophysial endings  
Mossy fiber terminals 
In the hippocampal CA3 field, the distinctive mossy fiber axons arising from the granule 
cells of the dentate gyrus occupy the narrow stratum lucidum which is located adjacent to the 
pyramidal cell layer (Blackstad et al., 1970; Gaarskjaer, 1978), as shown in Fig.2A. The 
pyramidal cells contain thick spiny thorns on their dendrites that extend into the stratum 
lucidum (Gaarskjaer, 1986; Frotscher, 1988).  
Under the electron microscope, the terminals of the mossy fibers in the stratum lucidum 
were easily recognized by their unique structural characteristics. They appeared as giant, 
vesicle-rich profiles and made several synaptic contacts with dendritic spines, which were 
frequently observed to be embedded in the presynaptic terminals (Fig.2B). It has been 
evidenced that the mossy fibers use glutamate as a primary transmitter substance (Storm-
Mathisen et al., 1983; Garthwaite and Brodbelt, 1990). Enormous numbers of densely packed, 
electron-lucent small vesicles, which measured ~50 nm in diameter, filled the presynaptic 
terminals of mossy fibers. In addition, a few LDCVs that ranged in size between 100-150 nm 
were intermingled with clear small vesicles. Mitochondria were usually observed clustered 
together. Using this technique the presynaptic active zones that are characterized by electron 
dense material in conventional electron microscopy (Peters et al., 1991) were recognized as 
negatively-stained thickened presynaptic membranes that made widened contacts with the 
juxtaposed thickened postsynaptic membranes.  
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The neurohypophysis 
The neurohypophysis, the posterior lobe of the pituitary, is mainly composed of nerve 
endings of magnocellular neurosecretory neurons of the hypothalamus. The long axons of the 
neurons in the supraoptic and paraventricular nuclei terminate on fenestrated capillaries in the 
neurohypophysis as shown in Fig.2C.  The  secreted  neuronal  substances are then further 
transported via blood vessels. The terminal varicosities of the axons were characterized by 
densely populated neurosecretory granules and microvesicle clusters (Fig.2D). In the present 
study, axonal terminals were often found to be surrounded by collagen-rich extracellular 
space or small processes of pituicytes, the specialized astroglial cells of the neurohypophysis. 
The oxytocin- (OX) or vasopressin- (VP) containing large dense core granules were 150-230 
nm in diameter and almost occupied the entire ending. They are assembled in the neuronal 
perikarya and transported to the neurohypophysis along the hypothalamo-hypophyseal tract 
(Brownstein et al., 1980). Small electron-lucent microvesicles segregated into a 
morphological distinct cluster separated from the granules. They were similar to synaptic 
vesicles in morphology and size. The clustered microvesicles were often seen beneath the 
plasma membrane, facing the extracellular space or adjacent to the endothelial wall of the 
fenestrated capillaries. Obviously, active zones comparable to those in the central synapses 
could not be observed in neurosecretory endings. However, synaptoid contacts between axons 
and pituicytes were occasionally observed. They differ from interneuronal synaptic contacts 
in that the axonal presynaptic membrane appears to be slightly thicker than that in 
neighboring areas, whereas the postsynaptic membrane of the pituicyte showed no post-
synaptic specialization (Fig.2E).  
3.1.2. Immunolabeling of synaptic proteins in mossy fiber terminals of 
the hippocampus and neurosecretory terminals of the neurohypophysis 
Cryosections prepared according to Tokuyasu’s method are considered suitable for 
immunocytochemistry. In the present study, both the ultrastructure and the protein 
antigenicity were relatively well preserved. For all the investigated synaptic proteins, the 
immunolabeling was specially allocated to well-contrasted organelles and could be quantified 
simply by counting the gold particles. Nevertheless, it was obvious that using this procedure 
not all sites or organelles of interest could be labeled.  
VAMP II  
On the cryosections of the CA3 region, abundant labeling of VAMP II was detected Results  45
selectively over the densely packed electron-lucent vesicles in mossy fiber terminals (Fig.3A, 
B). The gold particles were associated extensively with the synaptic vesicles. At active zones, 
some gold particles were localized at docked vesicles and in close proximity to the 
presynaptic membrane, suggesting that VAMP II was integrated into a docking complex. In 
contrast, mitochondria and dendrites were free of gold particles.  
It is worthy mentioning, that with conventional cryo-immunogold technique VAMP II 
labeling was detected only over part but not over all synaptic vesicles.  By comparison, a 
higher labeling density was obtained in the samples that were labeled with the 1.4 nm 
nanogold particles and then treated with silver enhancement (Fig.3C, D). Moreover, more 
gold particles were found at the active zone. The ultrastructural detail in these samples was 
similar to that observed without silver enhancement. However, the size of particles after silver 
enhancing was rather irregular and merging of growing silver/gold particles often occurred.   
In the neurohypophysis, the immunolabeling of VAMP II was localized specifically at the 
clustered microvesicles (Fig.4). The gold particles were scattered over the microvesicle 
populations. These labeled clustered microvesicles were often found near the plasma 
membrane, facing the interstitial space. Especially, the immunolabeling could be frequently 
detected at the plasma membrane,  where contact between the microvesicles and the 
membrane was observed (Fig.4A, C, D). This immunolabeling was not restricted to special 
domains of the membrane, but more or less randomly distributed over the plasma membrane. 
In contrast, the large granules were mostly unlabeled. Only minor labeling was found in the 
vicinity of clustered microvesicles which might be mainly derived from closely adjacent 
microvesicles. Mitochondria and extracellular space showed no apparent labeling.  
SNAP-25 
Labeling of the t-SNARE SNAP-25 was localized at the presynaptic plasma membrane of 
the active zone (Fig.5A, B) and also at the plasma membrane outside the active zone (Fig.5B). 
According to the quantitative analysis (Table V), the labeling density of SNAP-25 at the 
plasma membrane of the active zone (5.8 particles/µm) was about two folds higher than that 
outside active zone (2.2 particles/µm). In addition, some gold particles were also found to be 
associated with synaptic vesicles. The labeling close to synaptic vesicles at the active zones 
implied the association of SNAP-25 with the presynaptic docking complex (Fig.5C). In 
addition, Golgi complex was labeled in neuronal soma, suggesting that SNAP-25 was first 
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In neurosecretory endings, gold particles were found to be associated with the plasma 
membrane adjacent to the clustered microvesicles (Fig.5E, F). However, no increased 
membrane labeling related to certain membrane domains was observed. In addition, there was 
also some microvesicle labeling with a density similar to that observed for synaptic vesicles in 
mossy fiber terminals. Especially some microvesicles adjacent to the plasma membrane were 
labeled. The neurosecretory granules and the mitochondria were obviously free of gold 
particles (Fig.5F). 
SV2  
In mossy fiber terminals, labeling of the integral synaptic vesicle protein SV2 was 
extensively localized at the synaptic vesicle population including some docked vesicles at the 
active zone of the plasma membrane as shown in Fig.6A and B. In addition, some labeling 
was observed at the presynaptic membrane. The labeling was very specific. No binding sites 
were detected elsewhere such as at dendrites or mitochondria.  
The immunolabeling in neurosecretory endings was restricted to the region of the 
microvesicle clusters (Fig.6C, D). The gold particles were scattered over the microvesicles 
similar to those over synaptic vesicles. The microvesicles near the plasma membrane were 
often labeled (Fig.6E). However, few gold particles occurred on the plasma membrane. 
Granules were evidently devoid of gold particles, although SV2 has been found on the 
granules of PC12 cells (Marxen et al., 1997; Tanner et al., 1996). 
Rab3A  
In mossy fiber terminals the immunolabeling of the small GTP-binding protein Rab3A was 
associated mainly with synaptic vesicles including the vesicles near the active zones (Fig.7A, 
B). Mitochondria and other areas were free of gold particles. In neurosecretory endings of the 
neurohypophysis the clustered microvesicles were always labeled with a labeling density 
similar to that of synaptic vesicles (Fig.7C-E). However, two different types of granule 
populations could be unexpectedly differentiated according to labeling. One was unlabeled, 
even though the clustered microvesicles in the same terminal carried the gold particles 
(Fig.7C, D). The other population was intensively labeled but some gold particles were 
located somewhat in the interior of the granules (Fig.7D, E). These two types of granules 
were obviously assigned to two different terminals. As shown in Fig.7D, unlabeled granules 
surrounding labeled microvesicle clusters were situated in one terminal whereas the granules 
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microvesicles were observed in the same terminal, but granules in the adjacent terminal were 
free of gold particles. Both examples show that the labeled granules and microvesicles are in a 
sharp contrast with the unlabeled granule populations. In addition, gold particles were also 
found at the plasma membrane (Fig.7F) close to the labeled granules. Double labeling 
suggested that Rab3A labeling was associated with the oxytocin-containing granule 
population (Fig.7G, H). Two different-sized gold particles, 10 nm for Rab3A and 5 nm for 
oxytocin, were detected over the same granules. Neither of them was observed on the other 
granule population in the nearby terminal (Fig.7H).  
α/β-SNAP and NSF 
α-SNAP is the receptor protein for NSF when both of them are recruited to the trimeric 7S 
SNARE complex to form a 20S particle. Both are essential components for the initiation of 
vesicle fusion (Sollner et al., 1993b). In the present study, however, there was little labeling of 
α/β-SNAP at the central synapse, either in the cytoplasm or on synaptic vesicles and plasma 
membrane (Fig.8A). In the neurohypophysial terminals, microvesicles were not labeled either, 
as for the synaptic vesicles. However, the gold particles of α/β-SNAP were associated 
intensely and specifically with neurosecretory granules, forming a sharp contrast to the 
unlabeled microvesicles (Fig.8B). Some gold particles also occurred in the interior of the 
granules. Granules located close to the plasma membrane and the plasma membrane itself 
were labeled too (Fig.8C).  Furthermore, gold particles were even associated with the 
membrane of a granule forming an Ω-like opening at the plasma membrane (Fig.8D). In 
analogy to the localization of α/β-SNAP, some labeling of NSF was detected on the granules 
in the neurohypophysis (Fig.9A). But no gold particles were found over the microvesicle area. 
However, low labeling of NSF was observed on synaptic vesicles (Fig.9B) and some gold 
particles were seen on the Golgi complex at the central synapse (Fig.9C).  
N-types Ca
2+ channel  
The N-type Ca
2+ channel is thought to be located to the plasma membrane and to interact 
with the SNARE proteins at active zones to assure the exposure of the docking complex to 
inflowing extracellular calcium ions (Stanley, 1997). In the present study, significant 
immunolabeling was found at the plasma membrane of active zones and, unexpectedly, also 
on the synaptic vesicles in mossy fiber terminals (Fig.10A-C). Also some docked vesicles 
were evidently labeled with gold particles. The labeling density revealed some differences 
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particularly intensely. In addition, there was also some labeling at the plasma membrane 
outside the active zone. 
In neurosecretory endings, the N-type Ca
2+ channel was largely confined to the clustered 
microvesicles (Fig.10D, E). Moreover, the gold particles were also observed at the plasma 
membrane, especially at sites, where the clustered microvesicles approached the axonal 
membrane. Mitochondria and interstitial space were obviously devoid of gold particles, 
demonstrating that the labeling was very specific. No labeling was detected over the granule 
population, in clear contrast to the labeled microvesicles.  
P/Q-type Ca
2+ channels 
As N-type Ca
2+ channels, P/Q-type Ca
2+ channels have been implicated in neurotransmitter 
release in presynaptic nerve terminals of a wide variety of neurons (Dunlap et al., 1995; 
Westenbroek et al., 1995). In the present study, overall, less immunolabeling was detected in 
central synapse (Fig.11A, B). Few gold particles were present on synaptic vesicles. 
Nevertheless, some gold particles were found specifically on the plasma membrane at and 
outside the active zone.  
In the neurohypophysis, labeling for P/Q-type Ca
2+ channels was associated intensively 
with the granule population (Fig.11C-E). Some gold particles were also found in the interior 
of the granules. Interestingly, the high density of immunolabeling over the granules occurred 
apparently only in a subset of terminals. An involvement of P/Q-type Ca
2+ channels 
selectively in vasopressin release has been proposed previously (Wang et al., 1997a). 
Additionally, some gold particles were also observed on the plasma membrane. By contrast, 
no significant labeling was found over the clustered microvesicles (Fig.11C).  
Bassoon 
In the present study, Bassoon displayed its own special distributive feature in presynaptic 
terminals.  In contrast to the extensive distribution of the other proteins over the entire 
presynaptic terminal, abundant labeling for Bassoon was mainly concentrated at the active 
zone region (Fig.12). According to the quantitative analysis, the labeling density was about 
nine fold higher at the active zone area than that outside the active zone area (Table V). 
However, although gold particles were exquisitely localized proximal to the active zone, they 
were barely found directly associated with the presynaptic membrane. The majority of gold 
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the active zone plasma membrane. In addition, some particles were also found at vesicles 
outside the active zone region. No immunolabeling was observed in neurosecretory terminals 
that lack obvious active zones.  
Controls 
In control experiments primary antibody was omitted. Instead, the sections were incubated 
with 1% BSA in PBS followed by 10 nm colloidal gold-conjugated secondary antibody, either 
goat anti-mouse IgG or goat anti-rabbit IgG. Negative results were obtained. No specific 
labeling was detected on the organelles in the nerve terminal profiles in the control samples 
from the CA3 region of hippocampus and the neurohypophysis (Fig.13). 
Quantitative analysis of immunolabeling 
The immunolabeling of various synaptic proteins was assessed quantitatively to compare 
their distribution pattern in the mossy fiber terminals of the hippocampal CA3 region and in 
the typical neurosecretory terminals of the neurohypophysis. Table V presents the quantitative 
data for the various proteins at different sites, revealing differences or similarities of labeling 
density either in a given site among the various proteins or for a certain protein at different 
sites. The intensity of immunostaining presumably reflects both the abundance of the antigen 
investigated and the labeling efficiency with the corresponding antibody under the given 
experimental conditions. The variance results from changes in labeling efficacy for a given 
antibody between different samples. The respective ratios compare the distribution of a given 
antigen between two different sites/compartments.  
In mossy fiber terminals the immunolabeling density in active zone area (A.z. area) was 
compared to that in the vesicle area (V. area) outside the active zone. The active zone area 
included all docked synaptic vesicles and the vesicles located in close proximity to the active 
zone. The vesicle area relates to the reserve pool of synaptic vesicles. Evidently, the labeling 
densities for all antigens investigated were higher in the active zone area than in the 
remainder vesicle area (Fig.14A). For VAMP II, SV2, Rab3A and the N-type Ca
2+ channel 
this increase varied between 50% and 80%. The t-SNARE SNAP-25 revealed a near five-fold 
increase in the active zone area and Bassoon was increased nine fold. Furthermore, a 
comparison of linear density of gold particles on the plasma membrane at the active zone 
(P.m. at active zone) and outside the active zone (P.m. outside active zone) revealed a 
preferential association of these synaptic proteins with the active zone plasma membrane. As 
shown in Fig.14B, increased immunolabeling, especially for VAMP II, SNAP-25, SV2 and Results  50
N-type Ca
2+ channel, was shown at the active zone membrane. It should be noted, however, 
that it is difficult to differentiate between endogenous labeling of the plasma membrane and 
of antigens  situated at closely adjacent docking or fusion vesicles. The number of gold 
particles here might include both of them.  
In neurohypophysial terminals, the immunolabeling over the microvesicles for the synaptic 
proteins VAMP II, SNAP-25, SV2, Rab3A and the N-type Ca
2+ channel was similar to that 
over the synaptic vesicles in mossy fiber terminals. The labeling density for VAMP II, SNAP-
25, SV2 and the N-type Ca
2+ channel over microvesicles was by far higher than that over the 
granules. The granules showed very low labeling for these proteins (Fig.15A). In contrast, the 
intense labeling for Rab3A on only one subset of granules was not quantified. In addition, 
these proteins, especially VAMP II, SNAP-25 and the N-type Ca
2+ channel, were also 
detected at the plasma membrane of neurohypophysial terminals, but with a clearly lower 
density than that at the active zone membrane in the presynaptic terminals (Fig.15B). The 
labeling for α/β-SNAP, NSF and the P/Q-type Ca
2+ channel was not included in this 
quantitative analysis because they showed significant labeling density only on the granules 
and some gold particles were situated in the interior of the granules. Labeling for the 
secondary antibodies alone in control samples was very low in all cases and not subjected to 
this evaluation.    VAMP II  SNAP-25  SV2  Rab3A  N-CaCh  Bassoon  Control-M  Control-P 
Mossy  fiber  terminals             
Active zone area  231.4 ± 163.6 65.3 ± 32.2  69.4 ± 39.1  51.2 ± 48.4  91.1 ± 62.1  140.8 ± 58.6 1.5 ± 2.7  0 
Vesicle area  128.5 ± 106.3
* 14.0± 14.3
*** 43.2 ± 22.0
*  33.1± 17.1  59.9 ± 29.4
*  15.1 ± 13.3
*** 1.3 ± 2.3  1.7 ± 3.4 
A.z. area / V. area  1.8  4.7  1.6  1.6  1.5  9.3  -  - 
P.m. at active zone  11.9 ± 7.9  5.8 ± 4.0  5.3 ± 4.1  1.3 ± 2.3  5.2 ± 4.4  1.2 ± 2.3  0  0 
P.m. outside active zone  2.0 ± 1.7
***  2.2 ± 1.5
**  1.8 ± 2.2
**  0.3 ± 0.6  2.1 ± 1.3
**  0.1 ± 0.5
**     
             
0 0
P.m. at A.z. / P.m. outside A.z.  6.0  2.6  2.9  4.3  2.5  12.0  -  - 
Neurosecretory  terminals
Microvesicle area  179.5± 68.2  15.9 ± 5.0  95.9 ± 36  48.9 ± 11.7  62.9 ± 40.2  n.d.  1.4 ± 2.9  0.9 ± 2.3 
Granule area  4.4 ± 3.2
***  1.2 ± 1.4
***  0.5 ± 0.7
***  1.4 ± 1.4
***  1.4 ± 1.5
***  n.d.  0.1 ± 0.3  0.2 ± 0.4 
Microvesicle area / Granule area  40.8  13.3  191.8  34.9  44.9  n.d.  -  - 
P. m.  3.7 ± 1.8  1.6± 1.1  0.6 ± 0.7  0.7 ± 1.1  1.8 ± 1.2  n.d.  0  0.1 ± 0.3 
Values represent the number ± standard deviation of gold particles per unit area (µm
2) or in the case of the plasma membrane (P.m.) per unit 
length (µm). The active zone area relates to the cytoplasmic area within 100 nm of the active zone (A.z.). The vesicle area (V. area) is located 
outside the active zone area. The number of gold particles at the plasma membrane of the active zone (P.m. at active zone) was compared to the 
number of gold particles of the nerve terminal plasma membrane outside the active zone (P.m. outside active zone). In the neurosecretory 
terminals the number of gold particles was determined in domains highly enriched in microvesicles (microvesicle area) or granules (granule area) 
or at the plasma membrane (P.m.). For mossy fiber synapses the number of area and length profiles analyzed was between 15 and 38, and 16 and 
41, respectively. For neurosecretory terminals it was between 15 and 28, and 16 and 22, respectively. Control-M and Control-P, controls for 
secondary antibodies used for the localization of monoclonal and polyclonal antibodies, respectively. N-CaCh, N-type Ca
2+ channel; n.d. not 
determined. 
*, 
**, 
***: P values smaller than 0.05, 0.01 and 0.001, respectively when values are compared to those shown in the line above. 
Table V. Distribution of synaptic proteins as revealed by colloidal gold labeling in mossy fibber terminals and neurosecretory terminals. 
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Fig.2. General observation of mossy fiber terminals in the hippocampus and of neurosecretory terminals in the 
neurohypophysis. (A) Position of mossy fiber terminals in the rat hippocampus. The mossy fiber terminals are 
located in the narrow stratum lucidum just next to the pyramidal cell layer in CA3 region. (Modified from Anaral 
and Witter, 1995). (B) Ultrastructure of the mossy fibers terminals in the CA3 region. (C) Neurosecretory system 
in the rat hypothalamus und neurohypophysis (modified from Brownstein et al., 1980). The insert shows a 
neurosecretory terminal contacting a blood capillary (modified from Navone et al., 1989). (D) Large dense core 
neurosecretory granules and clustered electron-lucent microvesicles in axonal terminals. Microvesicles are often 
clustered beneath the plasma membrane facing the collagen-rich interstitial space. (E) Synaptoid contact (arrows) 
between nerve terminal and pituicytes. d, dendritic spines; DG, dentate gyrus; GL, granule cell layer; gr, granules; 
is, interstitial space; LDCV, large dense core vesicles; ME, median eminence; mi, mitochondria; ML, molecular 
layer; mv, microvesicles; OC, optic chiasma; p, i and a, posterior, intermediate and anterior lobe of the pituitary, 
respectively; pc, pituicytes; pcl, pyramidal cell layer; PL, polymorphic layer; PVN, paraventricular nuclei; sc, 
synaptic contact; SCN, suprachiasmatic nuclei; sl, stratum lucidum; SON, supraoptic nuclei; sv, synaptic vesicle. 
Scale bar = 200 nm Results    Photographic Plate I  53
 
 
 
Fig.3. Immunolabeling for VAMP II in mossy fiber terminals of the hippocampal CA3 field. (A, B) Abundant 
VAMP II gold particles are located selectively over the densely packed electron-lucent vesicles. Some gold 
particles occur at docked vesicles and in close proximity to the presynaptic membrane at active zones (arrows). No 
gold particles on dendrites and mitochondria. (C, D) As compared with A and B, higher labeling density in 
synaptic vesicle area and more gold particles at the active zone (arrows) displayed by the cryo-immunogold 
technique with the silver enhancement method. d, dendrite; mi, mitochondria; sc, synaptic contacts; sv, synaptic 
vesicle. Scale bar = 200 nm Results    Photographic Plate I  54
 
 
Fig.4. Immunolabeling for VAMP II in neurosecretory terminals of the neurohypophysis. (A) Overview in the area 
next to the intersititial space. Labeling occurs selectively in the region of the clustered microvesicles and is absent 
from granules, mitochondria and interstitial space. Some gold particles are present at microvesicles very close to 
or at the plasma membrane (arrows). (B) Labeled clustered microvesicles and the surrounding unlabeled granules. 
Sparse labeling also on the granules adjacent to microvesicles. (C, D) Labeled microvesicle cluster near the axonal 
plasma membrane facing the intersititial space and some labeling on the microvesicles closely adjacent to and on 
the plasma membrane (arrows). A and D with 5 nm gold particles. gr, granule; is, interstitial space; mi 
mitochondria; mv, microvesicle; pm, plasma membrane. Scale bar = 200 nm  Results    Photographic Plate I  55
 
Fig.5. Immunolabeling for the t-SNARE SNAP-25 in hippocampal nerve terminals and neurohypophysial nerve 
terminals. (A) Immunolabeling is localized at the plasma membrane of the active zone (arrows) and at synaptic 
vesicles. (B) Gold particles are also found at the plasma membrane outside the active zone (arrowheads) besides 
the active zone membrane (arrows) and synaptic vesicles in the small nerve terminals of the hippocampus. (C) 
Gold particles at synaptic vesicles near the active zone of the mossy fiber terminal (arrows) implying the 
association of SNAP-25 with the presynaptic docking complex. (D) Gold particles are located at the Golgi 
complex. (E) Dispersely distributed gold particles at the plasma membrane (arrows) of neurosecretory endings. (F) 
Immunolabeling on microvesicles adjacent to the plasma membrane and at the plasma membrane (arrows). 
Granules and mitochondria are unlabeled. d, dendrite; G, Golgi complex; gr, granule; is, interstitial space;   
mi, mitochondria; mv, microvesicle; pm, plasma membrane; sc, synaptic contact; sv, synaptic vesicle.   
Scale bar = 200 nm 
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Fig.6. Immunolabeling for SV2 in hippocampal mossy fiber terminals and neurohypophysial nerve terminals. (A, 
B) Gold particles in mossy fiber terminals are associated extensively with synaptic vesicles. Some of them are 
located at docked vesicles or at the active zone membrane (arrows). 5 nm gold particles was used in A. Dendrites 
and mitochondria are free from the gold particles. (C, D) Immunolabeling in neurosecretory endings is restricted 
only to the clustered microvesicles and absent from granules. (E) Immunolabeling at clustered microvesicles near 
the plasma membrane. Few gold particles occur at the plasma membrane. d, dendrite; gr, granule; is, interstitial 
space; mi, mitochondria; mv, microvesicle; pm, plasma membrane; sc, synaptic contacts; sv, synaptic vesicle. 
Scale bar = 200 nm   Results    Photographic Plate I  57
 
Fig.7. Immunolabeling for Rab3A in mossy fiber terminals of the hippocampus and neurosecretory terminals of 
the neurohypophysis. (A) Immunolabeling is localized specifically to synaptic vesicles. Mitochondria and dendrite 
are clearly devoid of gold particles. (B) Randomly distributed immunolabeling near the active zone of a mossy 
fiber terminal. (C) Clustered microvesicles selectively carry gold particles, whereas granules surrounding the 
labeled microvesicles in the same terminal have no labeling. (D, E) Two adjacent terminals showing two types of 
granule populations with or without immunolabeling, respectively. Clustered microvesicles are always labeled. 
Mitochondria in (D) were obviously free of gold particles. (F) Gold particles are present on granules close to the 
plasma membrane and some of them on the plasma membrane (arrows). The granules and the plasma membrane in 
the nearby terminal are devoid of gold particles. (G, H) Double labeling for Rab3A and oxytocin, showing 
colocalization of these two proteins in the same granules, 10 nm gold particle for Rab3A and 5 nm for oxytocin.  
Neither of them occurs on the other group of granules in the nearby terminal. d, dendrite; gr, granule; is, interstitial 
space; mi, mitochondria; mv, microvesicle; sc, synaptic contacts; sv, synaptic vesicle. Scale bar = 200 nm. Results    Photographic Plate I  58
 
 
 
Fig.8. Immunolabeling for α/β SNAP in hippocampal mossy fiber terminals and neurohypophysial nerve 
terminals. (A) Little labeling occurs in the synaptic terminal. (B) Gold particles are associated specifically with 
neurosecretory granules in the neurohypophysial terminals, forming a clear contrast to the unlabeled 
microvesicles. (C) Labeled granules close to the plasma membrane, showing the gold particles at docked granules 
or at the plasma membrane (arrows). (D) Gold particles are associated with the connecting part of a granule that 
shows an Ω-formation with the plasma membrane (arrow). The interstitial space and mitochondria are free of gold 
particles. gr, granule; is, interstitial space; mi, mitochondria; mv, microvesicle; pm, plasma membrane;  sc, 
synaptic contacts; sv, synaptic vesicle. Scale bar = 200 nm Results    Photographic Plate I  59
 
 
Fig.9. Immunolabeling for NSF. (A) Some labeling is located at the granules in the neurohypophysis. (B) Low 
labeling with 5 nm gold particles at synaptic vesicles of the central synapse. (C) Some gold particles occur   
at a Golgi complex in the CA3 region. d, dendrite; G, Golgi complex; gr, granule; sv, synaptic vesicle.   
Scale bar = 200 nm Results    Photographic Plate I  60
 
 
 
Fig.10. Immunolabeling for the N-type Ca
2+ channel in the hippocampal mossy fiber terminals and 
neurohypophysial nerve terminals. (A-C) Immunolabeling in mossy fiber terminals with gold particles located to 
the synaptic vesicles and the presynaptic membrane at the active zone (arrows) and outside the active zone 
(arrowhead). (D, E) Immunolabeling in neurosecretory endings is confined to microvesicles and the plasma 
membrane (arrows). Granules and mitochondria are free of gold particles. d, dendrite; gr, granule; is, interstitial 
space; mi, mitochondria; mv, microvesicle; pm, plasma membrane; sc, synaptic contacts; sv, synaptic vesicle. 
Scale bar = 200 nm 
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Fig.11. Immunolabeling of P/Q-type Ca
2+ channels in hippocampal mossy fiber terminals and neurohypophysial 
nerve terminals. (A, B) Immunolabeling in mossy fiber terminals with a few gold particles specifically at the 
plasma membrane at the active zone (arrows) and outside the active zone (arrowhead). However, little labeling 
occurs at the synaptic vesicles. (C-E) Gold particles are associated intensively with a population of granules in 
some terminals of the neurohypophysis. Some are also present at the plasma membrane (D, E; arrows). No 
labeling occurs over microvesicles in a sharp contrast to the labeled granules (C). d, dendrite; gr, granule; is, 
interstitial space; mi, mitochondria; mv, microvesicle; pm, plasma membrane; sc, synaptic contacts; sv, synaptic 
vesicle. Scale bar = 200 nm 
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Fig.12. Immunolabeling for Bassoon in the synaptic nerve terminals of the hippocampus. Immunolabeling is 
localized specifically in proximity to the active zone in a small synaptic nerve terminal (A) and at large mossy 
fiber terminals (B, C). The majority of the gold particles are characteristically concentrated close to but at a clear 
distance away from the presynaptic plasma membrane (arrows). Little labeling for Bassoon is observed directly at 
the plasma membrane. A few particles are also found at vesicles outside the active zone region (arrowheads). d, 
dendrite; mi, mitochondria; sc, synaptic contacts, sv, synaptic vesicle. Scale bar = 200 nm Results    Photographic Plate I  63
 
 
 
 
Fig.13. Control experiments with application of goat anti-mouse IgG to mossy fiber terminals (A) and 
neurosecretory endings (B) or of goat anti-rabbit IgG to mossy fiber terminals (C) and neurosecretory endings (D). 
No significant labeling is detected. Scale bar = 200 nm Results    Photographic Plate I  64
 
Fig.14. Comparison of the density of immunolabeling of various synaptic proteins in mossy fiber terminals (A) 
Comparison of vesicle labeling between active zone area and vesicle area outside the active zone. All synaptic 
proteins investigated display increased labeling in the active zone area. (B) Comparison of labeling of plasma 
membrane between the active zone (P.m. at active zone) and outside the active zone (P.m. outside active zone). A 
Higher density of immunolabeling for synaptic proteins occurs at the active zone membrane. Almost no gold 
particles were detected in controls for both monoclonal (control-M) and polyclonal (control-P) antibodies.  Results    Photographic Plate I  65
 
Fig.15. Histogram of immunolabeling densities of various synaptic proteins in the neurohypophysis. (A) 
Comparison of immunolabeling densities for VAMP II, SV2, SNAP-25 and N-type Ca
2+ channel in the 
microvesicle area with those in the granule area. All of the proteins were more highly expressed in the 
microvesicle area than in the granule area. Immunolabeling in the granule area is very low. Controls for both 
monoclonal (Control-M) and polyclonal (Control-P) antibodies are almost zero in both areas. (B) Comparison of 
the immunolabeling densities for various synaptic proteins at the plasma membrane of neurohypophysial terminals 
with those at the active zone membrane in the presynaptic terminals. Overall, labeling at the former is much lower 
than that at the latter. 
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3.2. Localization of synaptic proteins in primary astrocyte cultures 
A variety of synaptic proteins essential for synaptic transmission have been found in 
cultured astrocytes and thought to be responsible for astrocytic vesicular exocytosis. In the 
present study, the conventional preembedding immunocytochemical method was applied to 
investigate the subcellular localization of these synaptic proteins and to examine whether these 
synaptic proteins were associated with stimulation-induced endocytotic organelles marked by 
HRP. However, in the present experiments HRP-filled vacuoles were seen in both stimulated 
and unstimulated cells, even if great care was taken not to activate cells. Nevertheless, 
consistent with the results of Maienschein et al. (1999), the vesicle protein VAMP II was 
localized at vesicular organelles of different size in cells fixed with 3% paraformaldehyde and 
0.05% glutaraldehyde in 5 mM hypotonic PB as shown in the Fig.16A. Vesicular organelles 
and some HRP-filled vacuoles were also labelled in cells that were stimulated with 1 mM 
glutamate in the presence of HRP and then fixed with the fixative diluted in 5 mM hypotonic 
PB (Fig.16B). In addition, labelled vesicular organelles were found in the cells treated with the 
bacterial toxin streptolysin-O (Fig.16C). Streptolysin-O increases the permeability of the cell 
membrance for the antibodies. The cells treated with streptolysin-O showed fewer vacuolar 
structures than those fixed in the hypotonic PB.  
In order to increase the accessibility of antibodies to antigens, the LR Gold postembedding 
method, an alternative to cryomicrotomy, was applied to localize the synaptic proteins in the 
astrocytic cells. The acrylic resin LR Gold has been employed in postembedding 
immunocytochemistry for the localization of a wide variety of plant and animal antigens 
(Anaral and Witter, 1995). This method has been considered to improve markedly the 
immunolabeling efficiency due to the hydrophilic property of LR Gold. Moreover, because the 
samples can be embedded with LR Gold at low temperature conditions (-20°C), the fine 
structure and the antigenicity of the proteins are better preserved (Netter and Ingram, 1957; 
Thorpe, 1999). In agreement with the results obtained with the preembedding 
immunocytochemical method, vesicular organelles labeled for VAMP II were observed in the 
cultured astrocytes (Fig.17A), in a clear contrast to the control samples (Fig.17B). 
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Fig.16. Immunolocalization of 
VAMP II in the primary 
astrocyte culture using the 
preembedding method. (A) 
Labelled vesicular organelles in 
cells fixed with 3% 
paraformaldehyde and 0.05% 
glutaraldehyde in hypotonic   
PB (5 mM). (B) VAMP II is 
localized to vesicular 
organelles in the cells that were 
stimulated with 1 mM 
glutamate in the presence of 
HRP and then fixed with the 
same fixative in 5 mM PB. A 
HRP-filled vacuole is also 
labelled (asterisk). (C) Labeled 
vesicular organelles in cells 
that with the same fixative 
diluted in PBS and then treated 
with the bacterial toxin 
streptolysin-O. f, filaments. 
Scale bar = 200 nm. Results    Phtographic Plate II  68
 
 
 
 
Fig.17. Localization of VAMP II in the primary astrocyte culture using the LR Gold postembedding method.  
(A) Labeled vesicular organelles of different size. (B) The control sample with application of goat anti-mouse IgG. 
f, filaments. Scale bar = 200 nm 
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3.3. Expression and localization of transfected proteins in the 
astrocytoma cell line U373 MG 
3.3.1. Observation of U373 cells by light and electron microscopy  
U373 MG cells generally had very flat shape. Similar to astrocytes in morphology they also 
showed both protoplasmic and fibrous cellular forms. The protoplasmic cells had a large cell 
body, whereas fibrous cells were provided with relatively small cell body but long processes. 
Phase-contrast microscopy revealed many dark punctuate organellar structures throughout the 
cytoplasm.  
Under the electron microscope, multiple morphologically distinct intracellular compartments 
could be distinguished: the nucleus, endoplasmic reticulum, Golgi apparatus, endosomes, 
mitochondria, heterogeneously sized and shaped electron-lucent vesicular structures, and a few 
electron dense granules. In particular, U373 MG cells contained a large number of tubules and 
vesicles throughout the cytoplasm (Fig.18A). Most of the electron-lucent vesicles had a 
diameter of 40-120 nm. The tubular structures of various lengths were between 40 and 60 nm 
in diameter. They were intermingled with small vesicles or dispersed individually. In cryo-
sections it was difficult to distinguish between cross-sections through the tubules and vesicles. 
Some vesicular profiles most likely included both tubules and small vesicles. These mixed 
tubulovesicular structures were often found in close proximity to the TGN areas and 
endosomes as well as in the peripheral cytoplasm of the cell. Tubular structure in the periphery 
of the U373 cells could derive from the plasma membrane. They were also observed to be in 
direct association with the plasma membrane (Fig.18B).  
The relatively uniform vesicle populations, consisting mainly of numerous clustered small 
vesicles with an average diameter of ~50 nm, were often found in the cytoplasm (Fig.19A). In 
the periphery of the cells some vesicular buds appeared to be budding from tubule-like 
invaginations of the plasma membrane (Fig.19B). Many clustered small round vesicles were 
clearly generated from plasma membrane-associated tubulovesicular structures or the 
endosome-vacuole-like structure in the periphery of the cells (Fig.19C, D) and in the cytoplasm 
(Fig.19E, F). These structures might therefore represent donor compartments of these small 
vesicles.  
Many endosomes were found to distribute among these vesicular organelles. They were 
comprised of vacuolar and tubulovesicular subdomains (Fig.25B). The large electron-lucent Results      70
endosomal vacuoles were round, oval or oblate in shape. They were empty or contained some 
material and a few internal vesicles. The tubulovesicular membrane profiles were observed to 
be  in close association with endosomal vacuoles. In addition, multivesicular bodies and 
lysosomes occurred among clustered tubulovesicles. The spherical multivesicular bodies (300-
600 nm) were full of internal small vesicles and enclosed by a limiting membrane (Fig.25A, G, 
H). The abundant internal vesicles were relatively uniform in size and shape and measured 50-
70 nm in diameter. However, the oval or irregularly shaped lysosomes were filled mainly with 
electron dense material, sometimes together with obscure degraded internal membrane vesicles 
(Fig.25E, F; Fig.27F).  
3.3.2. Immunolocalization of recombinant proteins 
The very weak immunosignal for the endogenous proteins VAMP II, syntaxin I, SNAP-25 
and Rab5 in immunoblots of subcellular fractions obtained in our laboratory implied that 
endogenous contents of these proteins are very low in U373 cells. Therefore, only the cells that 
had been transfected with tagged recombinant proteins were used in the present experiments. 
Transiently transfected cells revealed intense immunoreactivity in immunofluorescent 
microscopy. All proteins investigated exhibited a punctuate cellular distribution pattern. The 
differently sized immunopositive dots corresponded largely to the dark punctuate structures in 
phase contrast optics. To more precisely characterize the subcellular compartments occupied by 
these recombinant proteins, the cryo-immunogold technique was adopted in the further study. 
At the ultrastructural level, every protein exhibited its own unique distribution pattern with 
electron-lucent vesicular organelles. The nucleus and mitochondria were clearly free of the 
gold particles for all proteins.  
VAMP II 
VAMP II is an essential member of the synaptic SNARE complex. As a v-SNARE, VAMP 
II is associated mainly with the membrane of vesicular structures. The transfected U373 cells 
revealed a high expression level of the recombinant myc-VAMP II protein, which was 
immunolocalized via monoclonal antibody directed against the myc-tag in the present study. 
The immunoreactivity of myc-VAMP II showed a diffuse punctuate staining pattern throughout 
the cell body under the immunofluorescent microscope. Myc-VAMP II was associated with 
large and numerous fine puncta scattered in the cytoplasm and more concentrated in the 
perinuclear area. Furthermore, the immunolabeling not only occurred in the cell body, but also Results      71
in the cellular processes (Fig.20A, B). The immunopositive dots were detected in the long 
processes of fibrous U373 cells up to their tips.  
The immunoelectron microscopy on cryo-sections revealed that the expressed myc-VAMP 
II was organelle-associated. The labeled clustered vesicles, tubulovesicular organelles, Golgi 
apparatus, endosomes, multivesicular bodies, and lysosomes are likely to correspond to the 
various puncta observed with the fluorescence microscopy. Strikingly, the gold particles were 
predominantly localized at the membrane of the numerous electron-lucent vesicular structures 
of various sizes and shapes (round, oval and tubular) that were distributed individually or 
clustered in the cytoplasm (Fig.21A-C). Clearly, it is difficult to distinguish morphologically 
between VAMP II-carrying vesicles and cross-sectioned tubules in the cryosections. The 
extensively distributed VAMP II-containing tubulovesicular organelles were often observed in 
the cell periphery (Fig.21D) and in the vicinity of the nucleus (Fig.21E, F). And particularly, 
some populations of relatively regular-sized small vesicles with a diameter of 50-70 nm were 
usually labeled intensively (Fig.22A, B). Furthermore, fragmenting tubules were labelled 
(Fig.22C). Gold particles were also seen on some smaller vesicular profiles that were budding 
from tubules in the cytoplasm (Fig.22D-F). This indicated the formation of small vesicles by 
budding from these tubular structures. In addition, in the perinuclear part of the U373 cells, the 
endoplasmic reticulum (ER, Fig.23A) and the Golgi apparatus  were intensively labeled 
(Fig.23B, C). Myc-VAMP II was observed to selectively accumulate at TGN vesicles of the 
Golgi apparatus, but there was only low labeling on the Golgi cisternae. Gold particles were 
occasionally found on the membrane of the electron dense granules that were dispersed in the 
cytoplasm (Fig.23D, E). In some overexpressed cells a high density of gold particles was 
located at the plasma membrane (Fig.24A-D). The clustered or individually distributed 
tubulovesicular organelles close to the plasma membrane were also clearly labeled. These 
labeled organelles beneath the plasma membrane possibly correspond to the donor 
compartments of synaptic-like microvesicles in PC12 cells (Schmidt et al., 1997). 
Occasionally, gold particles were also detected on omega-shaped structures at the plasma 
membrane (Fig.24E) and filopodial membrane processes (Fig.24F). In addition, gold particles 
are observed over presumptive endosomes, multivesicular bodies, and  lysosomes (Fig.25). 
Myc-VAMP II was localized to the membrane of the large, oval or oblate shaped vacuoles and 
especially to associated tubulovesicles of the endosomes situated in the cell periphery 
(Fig.25A) and scattered in the cytoplasm (Fig.25B-F). The more regular, round multivesicular 
bodies were also immunopositive for myc-VAMP II. The gold particles were found on the Results      72
membrane of the internal vesicles and some of them on the limiting membrane (Fig.25A, G, H). 
In addition, the membrane of the electron dense lysosomes was usually labeled, showing partial 
targeting of VAMP II to the degradative pathway (Fig.25E, F).  
Syntaxin I 
The transfected U373 cells were intensely labeled for the recombinant t-SNARE syntaxin I 
as revealed by fluorescence microscopy. VSVG-syntaxin I was immunolocalized via 
monoclonal antibodies raised against either the VSVG-tag or snytaxin I itself. In addition, 
syntaxin I was also directly visualized under fluorescence microscope by RFP fused to syntaxin 
I. Immunofluorescent puncta for syntaxin I were revealed throughout the entire cell body and 
accumulated in the perinuclear region (Fig.26A, C, D). Furthermore, immunolabeling was 
detected along long processes of the fibrous cells (Fig.26B). Immunoelectron microscopy on 
the cryo-sections showed that VSVG-syntaxin I was associated mostly with vesicles (40-100 
nm in diameter) in the cytoplasm including the area near the plasma membrane (Fig.27A, B). 
However, no significant gold labeling of the plasma membrane was observed.  In addition, the 
gold particles were visible on the long and thin tubular structures with a diameter of 40-60 nm 
(Fig.27C, D). Endosomes were also labeled (Fig.27E). Gold particles were located on the 
membrane of the round endosomal vacuoles and surrounding vesicles around. Electron dense 
lysosomes containing electron dense material and some obscurely degraded internal vesicles 
beneath the limiting membrane was virtually devoid of gold particles, whereas the vesicles next 
to it were clearly labeled (Fig.27F).  
SNAP-25 
In the experiments with the recombinant t-SNARE HA-SNAP-25, the expression of the 
protein was limited to only a few transfected cells. The majority of U373 cells revealed no 
immunoreactivity by immunofluorescence microscopy. The transfected small cells were 
intensely labeled, showing a relatively high expression level. Recombinant HA-SNAP-25 was 
immunolocalized by monoclonal antibodies directed against the HA-tag or the SNAP-25 
protein. Immunofluorescence of HA-SNAP-25 was associated with numerous fine puncta 
throughout the entire cell and revealed an enhanced perinuclear location, similar to the pattern 
of immunoreactivity observed for other transfected proteins (Fig.28A-C). No 
immunofluorescent fibrous cells with long processes were detected. At the ultrastructural level, 
the labeling of HA-SNAP-25 was observed only on some electron-lucent vesicular organelles 
of varing size and form (Fig.28G, H). No gold particles were found at the plasma membrane.  Results      73
Cellubrevin  
Cellubrevin belongs to the v-SNARE family. It is a synaptobrevin/VAMP-related protein. 
The recombinant flag-cellubrevin was immunolocalized with fluorescence microscopy by both 
the anti-flag monoclonal antibody and the anti-cellubrevin polyclonal antibody. However, only 
the anti-cellubrevin antibody was applied at the ultrastructural level because the anti-flag 
antibody failed to detect flag-cellubrevin. Immunoreactivity for cellubrevin was present 
throughout the cytoplasm but was accumulated more in the perinuclear region (Fig.29A-D). 
The latter probably corresponded to the labeling of the Golgi complex, as indicated in many 
other cell types (Parpura et al., 1995a; McMahon et al., 1993). Fig.29A shows that the 
punctuate staining was especially concentrated around the nucleus in some cells. Moreover, the 
immunostaining extended into the processes of fibrous cells (Fig.29B). Immunofluorescence 
was enhanced at the ruffling edge of the cell (Fig.29D). As expected, immunoelectron 
microscopy confirmed the association of the cellubrevin immunoreactivity with the Golgi 
apparatus in the perinuclear area (Fig.30A-C). The  immunogold labeling was detected 
predominantly at small round vesicles and buds of TGN, but only few gold particles were 
found directly on the flattened cisternae of Golgi apparatus. In addition, the gold particles were 
observed at clusters of round vesicles in the cytoplasm (Fig.30D) and the tubulovesicular 
organelles in the vicinity of the nucleus (Fig.30E). Some dispersed small vesicles and small 
clusters of tubules and vesicles in the cytoplasm were specifically labeled (Fig.30F, G). No 
obvious endosomal labeling was found at the ultrastructural level.  
Rab5 
Rab5, a low molecular weight GTP-binding protein, is involved in endocytic vesicle 
trafficking and endosome fusion. With the aid of GFP-fused Rab5, the distribution of the Rab5 
fusion protein could be visualized directly under the fluorescence microscope. GFP-Rab5 was 
observed in association with numerous fine puncta and especially many larger punctuate 
structures that appeared as clearly discernible fluorescent spots throughout the cytoplasm 
(Fig.31A-C). Moreover, immunopositive dots were located more densely in the perinuclear 
region of some cells that might derive from the overexpression of GFP-Rab5. The 
immunopositive dots were not confined to the cell body; they were also present in the long 
processes of the fibrous cells where GFP-Rab5 was allocated to large puncta (Fig.31C). 
Immunogold studies with the polyclonal anti-GFP primary antibody showed that the GFP-Rab5 
fusion protein occurred over clusters of small vesicles (Fig.32A, B) and larger vesicular 
structures of round, oval and tubular shape (Fig.32.C-E). GFP-Rab5 was also localized to Results      74
endosomal structures and the surrounding vesicles (Fig.32F). Probably, the labeled endosomes 
and clustered vesicular structures corresponded to the large puncta observed under the 
fluorescence microscope.  
Double labeling 
Double labeling experiments were performed in order to further analyze and compare the 
distribution pattern of these recombinant proteins and in particular to investigate whether the 
proteins that exhibited a similar labeling pattern were colocalized on identical organelles. This 
would be helpful for analyzing their potential functional relations.  
VAMP II and cellubrevin: The monoclonal antibody anti-myc and the polyclonal antibody 
anti-cellubrevin were used for the double labeling of myc-VAMP II and flag-cellubrevin. A 
partial colocalization of these two recombinant proteins was revealed under the scanning laser 
confocal microscope (Fig.33A-C). Some yellow or orange puncta of different sizes were 
scattered throughout the cytoplasm, indicating that myc-VAMP II was colocalized with flag-
cellubrevin to some extent (Fig.33C). Increased labeling of flag-cellubrevin (green) was 
observed in the perinuclear area. Under the immunoelectron microscope the colocalization of 
these two proteins on clustered vesicular organelles of various sizes was detected, which may 
correspond to the yellow or orange puncta under the fluorescence microscope. Moreover, 
differentially sized gold particles were located at the same vesicles (Fig.33D, E).  
VAMP II and syntaxin I: Double labeling for the two recombinant SNAREs proteins myc-
VAMP II and RFP-syntaxin I was carried out by means of the monoclonal anti-myc antibody 
and by the inherent red fluorescence of RFP with fluorescence microscopy. Myc-VAMP II and 
RFP-syntaxin I exhibited very similar labeling patterns (Fig.34A, B). A high level of 
colocalization was indicated by the large number of yellow staining on punctuate structures in 
the cell body (Fig.34C). Moreover, myc-VAMP II was colocalized with RFP-syntaxin I even in 
the cellular processes. It appeared, however, that myc-VAMP II immunoreactivity was more 
intensely expressed in the peripheral cytoplasm than RFP-syntaxin I. Because only monoclonal 
antibodies were available for the immunolocalization, double labeling under ultrastructural 
level was not performed. The single staining of immunoelectron microscopy showed that both 
myc-VAMP II and RFP-syntaxin I were localized to vesicular organelles (as described above). 
VAMP II and Rab5:  Double labeling for the recombinant proteins myc-VAMP II and GFP-
Rab5 was performed with the aid of the monoclonal anti-myc antibody and the inherent green 
fluorescence of GFP. A partial colocalization of myc-VAMP II with GFP-Rab5 was revealed Results      75
under fluorescence microscope (Fig.35A-C). Many differentially sized yellow or orange puncta 
were dispersed in the cytoplasm. GFP-Rab5 (green signal) was more intensely expressed in the 
perinuclear region. However, the red labeling of myc-VAMP II was distributed  more 
extensively and intensively towards the cell periphery. By immunoelectron microscopy myc-
VAMP II and GFP-Rab5 were found to colocalize to the same vesicle clusters, but only a small 
number of vesicles were found to be labeled with both proteins (Fig.35D, E). The labeled 
vesicle clusters probably corresponded to the yellow or orange puncta observed under the 
fluorescence microscope. However, no colocalization on the endosomes was found.  
Controls  
In control sections, scarce immunogold particles were seen when the first antibodies were 
omitted and only the 10 nm gold-conjugated secondary antibody goat anti-mouse IgG 
(Fig.36A) or goat anti-rabbit IgG (Fig.36B) was applied to the sections. The control sections 
for double labeling were simultaneously treated with 10 nm gold conjugated goat anti-mouse 
IgG and 20 nm gold conjugated goat anti-rabbit IgG. Similarly, little labeling was obtained 
(Fig.36C). This suggests that the immunogold staining is specific for the proteins investigated. 
The specificity of immunolabeling was further verified in experiments where cells were 
transfected with the empty pcDNA3 vector alone and incubated with primary antibodies and 
the corresponding 10 nm gold particles conjugated to secondary antibodies.  No significant 
labeling was detected (Fig.36D). Negative results were also obtained in the control experiments 
for immunofluorescence microscopy (Photographs were not shown). Results    Photographic Plates III  76 
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Fig.18. Ultrastructure of vesicles and tubules in U373 cells. (A) Ultrathin cryosections showing abundant vesicles 
and tubules in the cytoplasm of U373 cells. (B) The tubular structure in the periphery of a U373 cell directly 
connected to the plasma membrane (pm). Scale bar = 200 nm. Results    Photographic Plates III  77 
 
 
 
Fig.19. Morphology and the formation of small vesicles in U373 cells. (A) Relatively uniform population of small 
vesicles with an average diameter of 50-70 nm in the cytoplasm. (B) Some small vesicles are budding from a thick 
tubule-shaped invagination of the plasma membrane (pm). (C) Many round and clustered vesicles appear to be 
generated from a plasma membrane-associated tubular structure. (D) Clusters of round small vesicles in the cell 
periphery. (E, F) Small clustered vesicles are appearantly formed from vacuole-like structures (asterisk) in the 
cytoplasm. Scale bar = 200 nm.  Results    Photographic Plates III  78 
 
 
 
 
Fig.20. Immunofluorescence localization of myc-VAMP II in U373 cells (A) Localization of myc-VAMP II to 
numerous fine and larger punctuate structures in the cytoplasm. Immunostaining is more concentrated in the 
perinuclear region. (B) Labeled fibrous cell exhibiting immunopositive dots in its long cellular process up to the 
tip. (C, D) Corresponding phase contrast images for A and B. Scale bar = 10 µm.  Results    Photographic Plates III  79 
 
 
Fig.21. Immunogold  labeling for myc-VAMP II at electron-lucent organelles in U373 cells. (A-C) Numerous 
electron-lucent vesicular structures of various size and shape (round, oval and tubular) are intensely labeled in the 
cytoplasm. (D) Myc-VAMP II-containing tubulovesicular structures located in the peripherial cytoplasm. (E, F) 
Immunolabeling of tubulovesicular structures in the vicinity of the nucleus (n). Scale bar = 200 nm.  Results    Photographic Plates III  80 
Fig.22. Immunogold labeling for myc-VAMP II of the small vesicles and tubular organelles showing the potential 
formation of small vesicles in U373 cells. (A, B) The population of relatively regular-sized small vesicles is 
selectively labeled. (C) Labeling of a long tubule that is exhibiting fragmentation (arrow) and many other vesicular 
organelles. The large mitochrondium (mi) is free of gold particles. (D-F) A lot of labeled tubules and vesicles in 
the cytoplasm. Some smaller vesicular profiles (arrowheads) are budding from labeled tubular organelles in the 
cytoplasm. Note the labeling of buds (arrowheads) from a tubular organelle in F. Scale bar = 200 nm. Results    Photographic Plates III  81 
 
 
 
Fig.23. Immunogold labeling for myc-VAMP II of endoplasmic reticulum (ER), Golgi apparatus (G) and granules 
in U373 cells. (A) Overview of the labeling in the perinuclear area. The endoplasmic reticulum and various 
vesicular and tubular structures are intensively labeled. (B, C) Gold particles occur selectively at TGN vesicles of 
the Golgi apparatus. There is only low labeling over the Golgi cisternae. (D, E) Labeling at the membrane of 
electron dense granules dispersed in the cytoplasm. Myc-VAMP II is also clearly detectable on tubular and 
vesicular structures in the vicinity of the nucleus (n). Scale bar = 200 nm. Results    Photographic Plates III  82 
 
 
 
Fig.24. Myc-VAMP II immunolabeling at the plasma membrane (pm) of U373 cells. (A-D) Gold particles are 
localized at high density to the plasma membrane and the adjacent tubulovesicular structures. B and C show 
labeled populations of tubulovesicular organelles in the peripheral cytoplasm. (E) Gold particles are occasionally 
detected at Ω-like structures at the plasma membrane (arrow). (F) Labeling of the membrane of filopodia at a 
cellular process (arrowheads). Scale bar = 200 nm. Results    Photographic Plates III  83 
 
Fig.25. Immunolocalization of myc-VAMP II on endosomal structures, multivesicular bodies and electron dense 
lysosomes in U373 cells (A) Various immunoreactive organelles in the cell periphery. Gold particles occur on a 
spherical multivesicular body with many internal small vesicles and the tubulovesicular organelles around, an 
oblate endosomal vacuole (asterisk) and associated tubulovesicles, and a cluster of vesicles. The plasma membrane 
(pm) is labeled too. (B-D) Labeled endosomal structures in the cytoplasm. Gold particles are localized to the 
membrane of large electron-lucent endosomal vacuoles (asterisk) and especially to the associated tubulovesicles. 
Some internal vesicles situated in the periphery of the vacuoles are also labeled in C and D. (E, F) Next to the 
immunopositive endosomal vacuoles (asterisk) and the surrounding tubulovesicles, the membrane of electron 
dense lysosomes (ly) are labeled. (G, H) Labeled regular, round shaped multivesicular bodies. The gold particles 
are found specifically on internal vesicles and the limiting membrane as well as at the tubulovesicles around, but 
not on the mitochondrium (mi). Scale bar = 200 nm. Results    Photographic Plates III  84 
 
Fig.26. Immunofluorescence labeling for VSVG-syntaxin I in U373 cells (A) VSVG-syntaxin I is labeled with an 
anti-VSVG monoclonal primary antibody and visualized by a Cy3-conjugated secondary antibody, showing 
immunofluorescent puncta throughout the entire cell body and more enhanced in the perinuclear region. (B) The 
same as in A, but the immunofluorescent long processes of a fibrous cell is specially shown. (C, D) The cells are 
labeled with an anti-syntaxin I monoclonal primary antibody and a FITC-conjugated secondary antibody and 
display the same labeling pattern as in A. Nevertheless, the immunolabeling is more intense in the perinuclear 
cytoplasm. (E-H) Corresponding phase-contrast images of A-D, respectively. Scale bar = 10 µm.  Results    Photographic Plates III  85 
 
 
 
Fig.27. Immunolabeling for VSVG-syntaxin I by electron microscopy in U373 cells. (A, B) VSVG-syntaxin I is 
associated with the vesicles (40-100 nm) in the peripheral cytoplasm. Few gold particles appear at the plasma 
membrane itself. (C, D) Immunogold labeling occurs on long and thin tubules (30-50 nm in diameter). The 
vesicles clustered adjacent to the long tubules are also labeled in C. (E) Gold particles at the membrane of a large 
round endosomal vacuole and the surrounding vesicles. (F) An electron dense irregular-shaped lysosome with 
some obscure degraded internal vesicles is devoid of gold particles, whereas the adjacent small vesicles are labeled. 
Scale bar = 200 nm.  Results    Photographic Plates III  86 
 
Fig.28. Immunolocalization of HA-SNAP-25 in U373 cells. (A-C) Immunofluorescence of HA-SNAP-25 in small 
transfected U373 cells. Numerous fine puncta of HA-SNAP-25 are distributed throughout the cell and are 
concentrated in the perinuclear area. The cells are labeled with the monoclonal primary antibody anti-HA in A and 
anti-SNAP-25 in B and C. (D-F) Corresponding phase-contrast images of A-C, respectively. (G, H) Immunogold 
localization of HA-SNAP-25 by electron microscopy. HA-SNAP-25 is localized to electron-lucent vesicular 
organelles of various sizes. The cells are labeled with the monoclonal antibody anti-HA in G and anti-SNAP-25 in 
H. Scale bar in A-C = 10 µm, in D and E = 200 nm.  Results    Photographic Plates III  87 
 
Fig.29. Immunofluorescence localization of flag-cellubrevin in U373 cells. (A) High magnification of an 
immunopositive cell labeled with the polyclonal anti-cellubrevin antibody, revealing that punctuate staining is 
concentrated around the nucleus. (B) Cells were treated as same as in A, showing immunofluorescence labeling in 
a fibrous cell with a long process. (C) Immunofluorescence in cells labeled with the monoclonal anti-flag antibody. 
(D) The sample was treated as in C, especially revealing immunostaining on the ruffling edge of the cell. (E-H) 
Corresponding phase contrast images of A-D, respectively. Scale bar = 10 µm.  Results    Photographic Plates III  88 
 
 
 
Fig.30. Immunogold labeling for flag-cellubrevin by electron microscopy in U373 cells. (A-C) Gold particles are 
detected mainly at the small round vesicles in the TGN of the Golgi complex (G). Only few gold particles are 
associated directly with the flattened Golgi cisternae. (D) Gold particles are present in clustered round vesicles in 
the cytoplasm. (E) Labeled tubulovesicular organelles in the vicinity of the nucleus (n). (F, G) Labeling on some 
dispersed and clustered tubules and vesicles in the cytoplasm. Scale bar = 200 nm. Results    Photographic Plates III  89 
 
 
 
 
Fig.31. Localization of GFP-Rab5 by means of the inherent fluorescence of GFP in U373 cells. (A, B) GFP-Rab5 
in a protoplasmic form of U373 cells. Numerous fine and many larger fluorescent spots occur in the cytoplasm. 
The fine fluorescent dots are more densely located to the perinuclear region in A. (C) GFP-Rab5 in a fibrous U373 
cell. The fluorescent dots are present not only in the cell body but also in the process of the fibrous cell where 
GFP-Rab5 is allocated to large puncta. (D-F) Corresponding phase contrast images of A-C. Scale bar = 10 µm. Results    Photographic Plates III  90 
 
 
 
Fig.32. Immunogold localization of GFP-Rab5 by electron microscopy in U373 cells. (A, B) Labeling of clustered 
vesicles. (C-E) GFP-Rab5 is associated with vesicular structures of various sizes in the cytoplasm. (F) GFP-Rab5 
is localized to an endosomal vacuole (asterisk) and the vesicles around. Scale bar = 200 nm.  Results    Photographic Plates III  91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.33. Double 
immunolabeling for 
myc-VAMP II and 
flag-cellubrevin 
revealed by confocal 
laser microscopy and 
cryo-electron 
microscopy in U373 
cells.  
(A) Immunoabeling 
for VAMP II 
revealed by the anti-
myc primary 
antibody and Cy3-
conjugated secondary 
antibody.  
(B) Immunostaining 
for cellubrevin 
detected by a 
cellubrevin specific 
antibody and FITC- 
conjugated secondary 
antibody. 
(C) Overlay of A   
and B, exhibiting a 
partial colocalization 
of myc-VAMP II and flag-cellubrevin. Some scattered yellow or orange puncta of different size in the cytoplasm 
display partial colocalization of myc-VAMP II and flag-cellubrevin. More flag-cellubrevin (green) appears around 
the nucleus. (D, E) Double immunogold labeling for myc-VAMP II and flag-cellubrevin at the ultrastructural 
level. Two differently sized gold particles are colocalized to the same vesicle clusters and even to the same 
vesicles (asterisk). In D, 5 nm gold particles for myc-VAMP II and 10 nm for flag-cellubrevin; In E, 10 nm gold 
particles for myc-VAMP II and 20 nm for flag-cellubrevin. Scale bar in A-C = 10 µm, in D and E = 200 nm.  Results    Photographic Plates III  92 
 
 
 
 
Fig.34. Double immunofluorescence labeling for myc-VAMP II and RFP-syntaxin I in U373 cells. (A) The 
distribution of myc-VAMP II was detected with the anti-myc primary antibody and visualized with FITC–
conjugated anti-mouse IgG (green). (B) The distribution of RFP-syntaxin I was observed directly by means of the 
RFP fluorescence (red). (C) Overlay of the two images A and B. Myc-VAMP II and RFP-syntaxin I show a high 
level of colocalization in the cell body and the cell process. Myc-VAMP II was expressed more intensely than 
RFP-syntaxin I in the peripheral cytoplasm and in the process. (D) Phase-contrast image of the same sample. Scale 
bar = 10 µm. Results    Photographic Plates III  93 
 
 
Fig. 35. Double fluorescence and cryo-immunogold labeling for myc-VAMP II and GFP-Rab5 in U373 cells. (A) 
The distribution of myc-VAMP II was detected with the anti-myc primary antibody and visualized with Cy3–
conjugated anti-mouse IgG (red). (B) The distribution of GFP-Rab5 was visualized directly with the GFP 
fluorescence (green). (C) Overlay of the two images A and B. Myc-VAMP II and GFP-Rab5 reveal partial 
colocalization shown as many yellow or orange puncta of varous size in the cytoplasm. GFP-Rab5 is expressed 
more intensely in the perinuclear region than myc-VAMP II. (D, E) Double immunogold labeling for myc-VAMP 
II and GFP-Rab5. Myc-VAMP II and GFP-Rab5 are colocalized to the same vesicle clusters. Some vesicles are 
labeled for both proteins (asterisk). 10 nm gold particles for myc-VAMP II and 20 nm gold particles for GFP-
Rab5. Scale bar in A-C = 10 µm, in D and E = 200 nm. Results    Photographic Plates III  94 
 
 
 
 
Fig.36. Controls for antibody specifity and tranfection in U373 cells. (A) The primary antibody is omitted and only 
the colloidal gold-coupled secondary antibody goat anti-mouse IgG is applied. Rare immunogold particles occur in 
the cytoplasm. (B) Same as in A. However, instead of goat anti-mouse IgG, goat anti-rabbit IgG was used. (C) 
Identical results are obtained in control sections for double labeling where both secondary antibodies with 
differently sized gold particles, goat anti-mouse IgG (10 nm) and goat anti-rabbit IgG (20 nm) are used in the same 
section. (D) Control for the expression of the transfected proteins. The section was obtained from cells that had 
been transfected with the empty pcDNA3 vector alone and then incubated with the effective primary antibody 
anti-myc  and the corresponding monoclonal secondary antibody. No  significant labeling is obtained.   
Scale bar = 200 nm. 
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4. Discussion 
4.1. Using the cryo-immunogold technique for the subcellular 
localization of synaptic proteins  
The cryo-immunogold technique has been demonstrated as a suitable method for the 
immunolocalization of synaptic proteins in both nerve terminals and cultured cells. By 
comparison, an obvious advantage of this technique lies in the fact that no resin embedding is 
involved in the entire sample preparation processes. The molecules are not affected by the 
treatment with organic solvents. Thus, not only the structural integrity but also the peptide 
antigenicity is better preserved.  
Throughout this method, the only potential chemical denaturation step for antigens before 
labeling is the initial aldehyde fixation. In immunocytochemistry, the choice of fixative 
always represents a compromise between the preservation of morphology and the retention of 
antigenicity. The mixture of 4% paraformaldehyde and 0.05% glutaraldehyde in PBS is 
shown as an ideal fixative in this study which yields a good preservation for both tissue 
morphology and antigenicity.  
In the cryosection method, the cryo-protectant is not only essential for the vitrification of 
the tissue pieces to minimize cellular destruction by ice crystals during the freezing but it is 
also a determinant for the plasticity of the samples that is very important in the sectioning 
(Tokuyasu, 1980). 2.3 M sucrose or a mixture of sucrose and PVP which permits rapid 
freezing of the samples and provides enough preservation of ultrastructural details (Tokuyasu, 
1989) proved to be an excellent cryo-protectant in the present study.  
Like all other postembedding immunocytochemical methods, the Tokuyasu cryosection 
technique offers the advantage that the antibodies can easily get access to antigen epitopes in 
every cellular compartment at the surface of sections (Griffiths et al., 1984). In this study, as 
expected, the immunolabeling is especially allocated to defined organelles, verifying previous 
biochemical results. However, it is obvious that using this procedure, not all vesicles can be 
labeled, even for VAMP II that has the highest labeling efficiency in this study. Also at the 
active zone only part of the proteins that are thought to be involved in the docking complex 
could bind the gold particles. This suggests that not all epitopes in the samples are accessible 
to the antibodies. Although the cryo-immunogold method is referred to as the most sensitive Discussion  96 
postembedding technique for immunolabeling (Griffiths et al., 1983), it has been found that 
the colloidal gold probably does not penetrate equally into sections for detection of antigens at 
a distance from the cut surface of ultra-thin cryosection (Takizawa and Robinson, 1994). The 
immunocytochemical staining is mostly limited to the availability of epitopes exposed to the 
surface of the thin sections. Labeling efficiency has been known to vary significantly between 
compartments (Griffiths and Hoppeler, 1986). Thus, one possible explanation would be that 
the membranes in the present study usually appeared as a “line” on the surface of the thin 
sections.  Some membrane-bound antigenic sites that are not exposed themselves to the 
surface of the sections cannot be labeled. In addition, recent work has shown that antibody 
molecules can dissociate from IgG-colloidal gold on storage, leading to reduced 
immunolabeling (Kramarcy and Sealock, 1991; Vandre and Burry, 1992). It has been 
demonstrated that the density of gold particles is usually not identical with the biochemically 
determined concentration of an antigen (Griffiths and Hoppeler, 1986).  
There is extensive evidence that labeling efficiency is relative to the size of colloidal gold 
particles in immunoelectron microscopy (Horisberger, 1981). Differential penetration of the 
differently sized immunogold particles into ultra-thin cryosection has been reported (Slot and 
Geuze, 1981). Decreasing diameter of the gold probe results in an increase of labeling 
efficiency. In addition, the matrix density can affect the labeling efficiency (Slot et al., 1989). 
The sections with lower matrix density (such as thawed frozen sections) provide a better 
chance for smaller gold particles to penetrate (Humbel et al., 1995). The smaller 1.4 nm 
Nanogold particles with Fab’ fragments that are only one third the size of a full IgG molecule 
(Hainfeld and Powell, 2000), have been shown to penetrate further into the low density matrix 
of the cryosections than any of the larger colloidal gold particles employed (Takizawa and 
Robinson, 1994). Furthermore, the ultra-small gold particles are more stable than colloid gold 
immunoprobes, because the secondary antibody molecules are covalently linked to these 
ultra-small gold particles rather adsorbed as in IgG-colloidal gold (Hainfeld and Furuya, 
1992). 1.4 nm immunogold particles with the silver enhanced method have been shown to 
result in a more intense labeling than colloidal gold. This is verified in the present study with 
VAMP II immunolabeling. Evidently, these smaller gold particles yielded a higher labeling 
density in ultra-thin cryosections than 10 nm colloidal gold. However, there are still some 
problems with silver enhancement, such as the irregular size of the enhanced particles and the 
merging of growing silver/gold particles. The final effect is dependent on the time of 
enhancement, the gold particle density and some other factors (Humbel et al., 1995; Burry et Discussion  97 
al., 1992). Thus, further improvement is required.   
After immunolabeling, the cryosections were treated with the modified “Positive-Negative 
Staining Method”, in which the mixture of methylcellulose and uranyl acetate is used for both 
good preservation of cryosection ultrastructure and strong negative contrast of the membrane. 
By comparison, the negative contrast is a better method to delineate membrane structure, 
especially to show high-resolution detail, than any other methods, such as preembedding with 
Epon and postembedding with LR Gold. However, the presynaptic dense projection of the 
active zone, which has been revealed by special staining treatment with phosphotungstic acid 
(Akert et al., 1971), could not be recognized in this study. A further improvement of the 
staining method is required to display this structure with the docked vesicles on the 
cryosections for the analysis of the excytosis mechanism. 
Taken together, the cryo-immunogold technique has more advantages in displaying the 
ultrastructure and in the immunolabeling than the preembedding method with Epon and the 
postembedding method with LR Gold. In the present study it proved a more suitable method 
for the localization of the synaptic proteins on the membrane.   
4.2. Localization of synaptic proteins in hippocampal mossy fiber 
terminals and neurohypophysial endings 
The giant mossy fiber synapses in the hippocampal CA3 subfield possess multiple active 
zones for neurotransmitter release, whereas the neurosecretory endings of the 
neurohypophysis are not provided with special release sites. In the present study, by using the 
immunogold labeling method on frozen ultrathin sections, the localization of SNARE proteins 
and other exocytosis-related synaptic proteins is investigated in these two different types of 
nerve terminals. By comparing the distribution of these synaptic proteins in these two 
neuronal terminals their functional characteristics are discussed.  
4.2.1. Identities and differences in the distribution of synaptic proteins 
between two different types of nerve terminals  
Some identities and differences in the localization of the synaptic proteins investigated are 
revealed between the two different types of terminals. In the mossy fiber terminals, the V-
SNARE VAMP II and the other vesicle-associated proteins SV2 as well as Rab3A were 
extensively detected at the numerous small vesicles. The t-SNARE SNAP-25 and the N-type 
Ca
2+ channel were observed not only at the plasma membrane, but also at the vesicles in the Discussion  98 
central synapses. These proteins were also detected in the neurosecretory endings of the 
neurohypophysis. However, it is striking that the labeling of all these proteins shows a high 
preference for microvesicles over granules. Moreover, the immunolabeling intensities of these 
proteins over microvesicles corresponded to that over synaptic vesicles. In addition, 
significant labeling of SNAP-25, the N-type Ca
2+ channel and VAMP II was detected at the 
plasma membrane near the clustered microvesicles. Similar to their roles in regulating vesicle 
docking and fusion in presynaptic nerve terminals, they may also participate in exocytic 
events in neurosecretory nerve endings of the neurohypophysis. These results suggest that 
these synaptic proteins share an identical association with synaptic vesicles and microvesicles. 
To the contrary, no significant concentrations of VAMP II, SNAP-25, SV2 and N-type Ca
2+ 
channel were present in the membranes of neurosecretory granules. However, α/β-SNAP and 
some NSF were found to be associated with granules, and so did the P/Q-type Ca
2+ channels 
and Rab3A in a subset of the nerve terminals. α/β-SNAP did not revealed significant labeling 
in the central synapses. P/Q-type Ca
2+ channels were detected mainly at the active zone 
plasma membrane. The scarce peptide-storing granules in the central synapses were not 
included in the investigation. In addition, the novel protein Bassoon was only restricted to 
central synapses, no immunolabeling of Bassoon was detected in the neurosecretory terminals 
of the neurohypophysis, where active zones are lacking. Obviously, these clear differences in 
distribution of these proteins between the two different types of terminals reflect the special 
functional features of these proteins and are highly consistent with the distinct functional 
characteristics of the two terminals themselves.  
4.2.2. Evidence for increased immunolabeling of some exocytosis-related 
proteins at the active zone of central synapses 
Whereas many synaptic proteins including the members of the SNARE family have been 
strongly implicated in the processes of synaptic vesicle exocytosis by means of genetic, 
physiological and biochemical approaches (Zheng and Bobich, 1998; Sollner et al., 1993b), 
there is little morphological evidence available. Especially, evidence is still lacking for a 
preferential localization of these proteins at the active zone of synapses to demonstrate their 
association with fast neurotransmitter release in situ. The present study reveals an evidently 
increased immunolabeling of VAMP II, SNAP-25, Rab3A, SV2 and N-type Ca
2+ channels at 
active zones of fast synapses. The quantitative analysis exhibits a more concentrated 
localization of these proteins both in the active-zone-related vesicle area and at the active Discussion  99 
zone plasma membrane. This may reflect both the increase in synaptic vesicle density at 
release sites and a docking-related accumulation of the proteins. Of all these proteins VAMP 
II has the highest enrichment at both the vesicle membrane and the plasma membrane. The 
localization of VAMP II and SNAP-25 on many docked vesicles at the active zone indicates 
their participation in the docking complex. In addition, P/Q-type Ca
2+ channels are localized 
specifically at the active zone plasma membrane and Bassoon is concentrated particularly in 
the vicinity of the active zone. These results confirm the existence of these proteins in the 
neurotransmitter release sites and provide strong support for the direct participation of these 
proteins in synaptic vesicle exocytosis in the fast central synapse (Rizo and Sudhof, 1998; 
tom et al., 1998; Seagar et al., 1999).  
4.2.3. Distribution of SNAP-25 at nerve terminals  
According to the original SNARE hypothesis, the specificity of vesicle targeting during 
exocytosis at the presynaptic plasma membrane is assured by complex formation between the 
v-SNARE VAMP II and the t-SNAREs SNAP-25 and syntaxin I (Rothman, 1994b). The t-
SNAREs SNAP-25 and syntaxin I are essential presynaptic membrane components for the 
specific targeting of synaptic vesicles to the active zone (Sollner et al., 1993a). In this study, 
labeling for SNAP-25 was localized to the active zone plasma membrane of the central 
synapse, revealing its participation in synaptic vesicle exocytosis. In mossy fiber terminals, 
the labeling on the docked synaptic vesicles at the actives zones implies an association of 
SNAP-25 with the presynaptic docking complex. However, the gold particles do not appear to 
be restricted to the active zone. They were also found at the plasma membrane outside the 
active zone. The result is in agreement with the notion that t-SNAREs are not specifically 
associated with the presynaptic release sites but are located also at the remainder of the axonal 
membrane (Zimmermann, 1997; Kretzschmar et al., 1996). Labeling for SNAP-25 was also 
found along the entire axonal plasma membrane (Tao-Cheng et al., 2000; Garcia et al., 1995; 
Galli et al., 1995). The widespread distribution of this t-SNARE at axonal plasma membranes 
suggests that it could not be responsible for defining the release site for synaptic vesicles.  
Furthermore, in this study, SNAP-25 was also found to be partially associated with 
synaptic vesicles in the synaptic terminals and with microvesicles in the neurosecretory 
endings. Although the majority of the t-SNAREs were localized at the plasma membrane, 
significant amount was reported also on the vesicle membrane. Both SNAP-25 and syntaxin I 
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Kretzschmar et al., 1996; Schulze et al., 1995), chromaffin granules (Tagaya et al., 1995; 
Tagaya et al., 1996; Hohne-Zell and Gratzl, 1996), and the large dense core vesicles of PC12 
cells (Marxen et al., 1997). The functional significance of these t-SNAREs on vesicular 
organelles remains to be explained. It cannot be excluded that some of these vesicles 
represent constitutive carrier vesicles transporting newly synthesized SNAP-25 from the soma 
to the plasma membrane of the terminals. Moreover, in agreement with the other reports (Tao-
Cheng et al., 2000; Duc and Catsicas, 1995), the Golgi complex was also labeled with SNAP-
25 in neuronal soma in the present experiment, suggesting that SNAP-25 is first sorted at the 
trans-Golgi, then transported to the terminals via carrier vesicles. On the other hand, it has 
been demonstrated by subcellular fractionation that the major pools of t-SNAREs recycle with 
synaptic vesicles in the nerve terminals in order to reactivate them (Walch-Solimena et al., 
1995). SNAP-25 positive tubulovesicular structures are considered as endosome-related 
vesicles undergoing recycling between the plasma membrane and the early endosomes (Tao-
Cheng et al., 2000). Furthermore, it has been reported that not only all individual SNARE 
elements but also their complex can be associated with free undocked vesicular organelles 
(Otto et al., 1997; Hohne-Zell and Gratzl, 1996). SNARE complexes are not exclusively 
assembled between opposing membranes at the sites of exocytosis, but side by side in the 
same membrane (Otto et al., 1997). These complexes may even be present during fast axonal 
transport before reaching the nerve endings. They can be required to properly direct 
presynaptic membrane proteins to the neuronal ending (Shiff and Morel, 1997; Morel et al., 
1998). Before docking, these complexes may be disassembled by NSF and SNAP proteins in 
an ATP-dependent manner, priming the synaptic vesicles for exocytosis (Otto et al., 1997).  
Obviously, the localization of t-SNAREs and the specific v/t-SNARE interaction cannot be 
the sole determinants for membrane-targeting specificity (Yang et al., 1999).  Additional 
control components are required to define release sites and to restrict SNARE action to the 
appropriate site (Zhang et al., 2000; Galli et al., 1995; Pelham, 2001).  
4.2.4. Localization of α/β-SNAP and NSF on granules of the 
neurohypophysis 
The action of SNAPs is tightly associated with that of NSF. Both of them are known to be 
universally required for membrane fusion events (Sollner et al., 1993a; Hay and Scheller, 
1997). It has been thought that SNAPs and NSF interact with their membrane receptors only 
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synaptic SNARE complex to form a so-called large 20S particle. However, it has recently 
been shown that α-SNAP and NSF exist predominantly in a membrane-bound form. 
Chromaffin vesicles were found to specifically contain bound α-SNAP and NSF 
(Banaschewski et al., 1998). NSF was also observed on highly purified synaptic vesicles of 
rat brain (Hong et al., 1994).  And  α-SNAP was identified in synaptic vesicles at the 
neuromuscular junction (Nishiki et al., 2001). In addition, the analysis of the distribution of 
NSF and α-SNAP in fractionated organelles from the adrenal medulla indicated that NSF and 
α-SNAP are associated with chromaffin granules (Burgoyne and Williams, 1997). Moreover, 
immunoreactivity for α-SNAP and NSF has been reported in the rat neurohypophysis by 
immunofluorescence histochemistry (Jacobsson and Meister, 1996).  In the present study, 
labeling for α/β-SNAP is present neither on synaptic vesicles of fast synapses nor on the 
microvesicles of the neurohypophysis. Yet, the intensive labeling for α/β-SNAP on the 
granules and some labeling of NSF on the synaptic vesicles and granules support the idea that 
vesicular organelles can carry NSF and α-SNAP to the site of exocytosis. These proteins may 
also exert their function prior to vesicle docking. The α/β-SNAP labeling on the granules near 
the plasma membrane and the association of gold particles with the connecting stalk of the 
granules with the plasma membrane  further suggest that α/β-SNAP is involved in the 
regulation of the granule exocytosis.  
4.2.5. Association of Rab3A with both small clear vesicles and granules 
Rab3A, the predominant Rab protein in the brain, has been shown to be exclusively 
localized to the membrane of synaptic vesicles and function in the regulation of 
neurotransmitter release (Matteoli et al., 1991; Stahl et al., 1994; Oberhauser et al., 1992). In 
particular, Rab3A has been implicated in regulating the formation and stability of the SNARE 
complex (Oberhauser et al., 1992; Stahl et al., 1994). Rab3A has also been revealed to be 
associated specifically with bovine chromaffin granules and granules in rat PC12 cells (Lin 
and Scheller, 2000; Weber et al., 1996; Darchen et al., 1995; Darchen et al., 1990). 
Noticeably, some chromaffin granules remained unstained which is considered to be due to 
heterogeneity of the granule population (Darchen et al., 1995). In the present study, Rab3A is 
localized to both types of secretory vesicles. The presence of Rab3A at the membrane of 
synaptic vesicles in the central synapse and of microvesicles in neurohypophysial terminals 
reveals that Rab3A has an important role in the secretion of small vesicles. In addition, in the 
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containing granule population, implicating that the Rab3A protein is involved in the hormone 
secretory pathway in neurohypophysis. A similar observation has been reported for another 
Rab3 isoform Rab3B that shares 80% amino acid identity with Rab3A. Co-localization of 
Rab3B and oxytocin was revealed at electron dense granules of the sheep corpus luteum (Al 
Matubsi et al., 1999). However, the presence of the gold particles also in the interior of the 
granules remains to be elucidated. It is still questionable whether Rab3A is specially 
associated with the core material of the granules.  
4.2.6. Presence of N-type and P/Q-type Ca
2+ channels on both plasma 
membrane and secretory vesicles 
Rapid neurotransmitter release requires the localization of both synaptic vesicles and 
calcium channels at the presynaptic active zone. By specific molecular interactions of 
syntaxin I, SNAP25 and synaptotagmin I in a multiprotein complex both, N-type and P/Q-
type  Ca
2+ channels have been revealed to be coupled to the molecular machinery of 
exocytosis at presynaptic neurotransmitter release sites (Stanley, 1997; Sheng et al., 1998; 
Seagar et al., 1999). Consistent with their functional characteristics in regulated exocytosis, 
N-type and P/Q-type Ca
2+ channels have been found by light microscopy in a wide variety of 
presynaptic neural terminals (Westenbroek et al., 1995; Sheng et al., 1998). However, 
ultrastructural evidence for further defining the subcellular localization of these Ca
2+ channels 
is rather scarce. In the present study, the immunolabeling of N-type and P/Q-types Ca
2+ 
channels could be allocated to the active zone of mossy fiber terminals, providing further 
morphological evidence for their participation in the regulation of the rapid neurotransmission 
and for the hypothesis that these two Ca
2+ channels can interact with the trimetric SNARE 
complex. In addition, a few gold particles were also found on the remainder of the plasma 
membrane of the central synapse. N-type Ca
2+ channels have been previously reported to be 
associated not only with presynaptic neuronal terminals but also widely with the plasma 
membrane along the entire length of dendrites and cell bodies of a wide range of neurons 
(Westenbroek et al., 1992). Besides initiating neurotransmitter release they also have other 
functions, such as mediating dendritic calcium transients (Westenbroek et al., 1995). As 
compared to N-type Ca
2+ channels, P/Q-type Ca
2+ channels are considered to have a relatively 
low density in the membrane of dendrites and cell bodies of most central neurons implying a 
more prominent role in neurotransmitter release at central synapses (Westenbroek et al., 
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In neurohypophysial terminals multiple types of Ca
2+ channels containing N-, L-, P/Q-. 
and R-type Ca
2+ channels have been identified via physiological or biochemical approaches 
(Fisher and Bourque, 1995; Wang et al., 1999). However, less is known concerning their 
localization. The present study suggests that N-type Ca
2+ channel are associated with the 
plasma membrane of neurohypophysial terminals. The immunolabeling on the plasma 
membrane near the clustered microvesicles indicates the competence for the microvesicle 
exocytosis through N-type Ca
2+ channels. In addition, the presence of gold particles for P/Q-
type Ca
2+ channels on the granules and plasma membrane in some terminals supports 
physiological and pharmacological evidence that the P/Q-type Ca
2+ current component exists 
only in a subset of the neurohypophysial terminals (Wang et al., 1997a). In combination with 
N- and L-type Ca
2+ channels, they control vasopressin but not oxytocin peptide release in 
these terminals. In addition, present observation does not provide evidence for a clustered 
distribution of N- or P/Q-type Ca
2+ channels at the plasma membrane. This agrees with the 
notion that neurohypophysial terminals lack specialized release zones. The release of granules 
has been proposed to be dependent on a general elevation in sub-membranous Ca
2+, which is 
mediated by the summation of Ca
2+ influx through multiple dispersed Ca
2+ channels (Fisher 
and Fernandez, 1999).  
An unexpected finding in this study is that N-type Ca
2+ channels are present in the 
membrane of both synaptic vesicles in the central synapse and in microvesicles of 
neurosecretory terminals. In addition, P/Q-type Ca
2+ channels are specifically associated with 
neurosecretory granules in some terminals of the neurohypophysis. This suggests that these 
vesicular organelles might either be involved in the trafficking of Ca
2+ channels from the 
soma to the terminal membrane or serve as an internal reserve pool of N- and P/Q-type Ca
2+ 
channels. These internally stored Ca
2+ channels may be rapidly translocated to the plasma 
membrane to enhance the release of messenger substance when the physiological need is 
high. Up to now, however, few data are available regarding intracellular trafficking of N- or 
P/Q-type Ca
2+ channels in neuronal and endocrine cells. Interestingly, internal storage of N-
type Ca
2+ channels on the chromograin B-containing secretory granules has been 
demonstrated in neuroblastoma and PC12 cell line. These channels can be inserted into the 
plasma membrane  when  the cells are exposed to different  secretagogues, such as KCI, 
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4.2.7. Involvement of Bassoon in neurotransmitter release  
Bassoon is a high molecular weight protein that is considered to be specifically associated 
with the active zone area (tom et al., 1998; Gundelfinger and tom, 2000). This labeling pattern 
was confirmed in the mossy fiber terminals and other smaller synaptic endings by the cryo-
immunogold technique in the present observation. In sharp contrast with the random 
distribution of the other proteins in the presynaptic terminals, a preferential localization of 
Bassoon near the active zone was observed. The quantitative analysis shows that Bassoon, out 
of all proteins investigated, has the highest increase ratio of the immunolabeling at the active 
zone area. However, unlike the other proteins, little labeling of Bassoon appeared directly on 
the plasma membrane. The vast majority of the gold particles were characteristically observed 
at a distance (50-70 nm) from the active zone plasma membrane. This labeling pattern implies 
that Bassoon is intimately associated with the tips of presynaptic dense-projection (Zhang et 
al., 2000). The presynaptic dense projection is thought to function in the guiding of vesicles to 
their release sites (Zimmermann, 1993). Thus, Bassoon may be involved in the structural and 
functional organization of the neurotransmitter release site to assure preferential docking and 
exocytosis of synaptic vesicles at the active zones (tom et al., 1998; Zhang et al., 2000). It 
perhaps plays an important role in determining the specificity of vesicle docking and fusion. 
The absence of immunolabeling from neurohypophysial terminals confirms the specific role 
of Bassoon at the active zone from another angle.  
Bassoon has also been reported to be associated with membranous compartments in 
neurons by biochemical assay and electron microscopy performed on the same biochemical 
fractions (Sanmarti-Vila et al., 2000). In the present study, scarce immunolabeling was also 
found at the vesicles outside the active zone region. This might represent the transport of 
Bassoon to the presynaptic site.  
4.2.8. Microvesicles and neurosecretory granules in the 
neurohypophysis 
The present study indicates that some proteins essential for the docking and fusion of 
synaptic vesicles are present in the neurohypophysis. Nevertheless, the distribution pattern 
reveals that these proteins have obviously a differential association with the population of 
microvesicles and large granules. The immunolabeling for the synaptic proteins VAMP II, 
SNAP-25, SV2, Rab3A and the N-type Ca
2+ channels was found specifically on microvesicles 
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synaptic vesicles. Using either biochemical analysis or immunocytochemical methods many 
synaptic proteins including VAMP II, SNAP-25, syntaxin I, SV2, synapsin I, synaptophysin, 
synaptotagmin, and cysteine string proteins (csps,  serving  as a regulatory factor for 
exocytosis) have been found to be associated with microvesicles in the neurohypophysis 
(Walch-Solimena et al., 1993; Jurgutis et al., 1996; Pupier et al., 1997; Navone et al., 1989; 
Hayashi et al., 1994b). Thus, these microvesicles contain obviously the entire molecular 
machinery required for fast and Ca
2+-dependent exocytosis. The present results support the 
view that microvesicles have not only a similar size and appearance but also similar 
characteristics as typical synaptic vesicles (Navone et al., 1989).  
By contrast, only synaptotagmin and csps (Jacobsson and Meister, 1996; Pupier et al., 
1997; Walch-Solimena et al., 1993; Hayashi et al., 1994b) as well as small amounts of VAMP 
II (Pupier et al., 1997; Jurgutis et al., 1996) have been reported previously to be associated 
with neurosecretory granules. Recently, CAPS, Ca
2+-dependent activator proteins for 
secretion, have been reported to be essential proteins for LDCV exocytosis and not to be 
required for the exocytosis of synaptic vesicles (Berwin et al., 1998; Jurgutis et al., 1996). In 
the present study, little labeling for the synaptic proteins VAMP II, SNAP-25, SV2 and the N-
type Ca
2+ channel was observed at the membrane of the granules, in sharp contrast to the 
abundant labeling of microvesicles. On the other hand, α/β-SNAP and some NSF were found 
on the granules, and in some terminals also Rab3A and the P/Q-type Ca
2+ channels. The 
identification of P/Q-type Ca
2+ channels and Rab3A only in a subset of terminals in the 
present study reveals that there are probably some differences in the regulation of exocytosis 
even between granule subpopulations. Correspondingly, physiological and pharmacological 
experiments have indicated that P/Q-type Ca
2+ channels and R-type Ca
2+ channels selectively 
exist in vasopressin (Wang et al., 1997a) or oxytocin releasing nerve terminals (Wang et al., 
1999) and function only in controlling vasopressin or oxytocin release, respectively. 
However, the labeling of these proteins in the interior of the granules remains elusive. 
Whether the results from the experimental procedure or whether the antibodies against these 
proteins associate with the internal material of the granules is unknown. In any case, the lower 
contents  of multiple exocytosis-related synaptic proteins on neurosecretory granules   
indicated that the molecular basis for the exocytosis between synaptic vesicles and granules is 
different. This is consistent with the view that synaptic vesicles and secretory granules 
possess distinct regulatory protein components and are organelles related to two different 
secretory pathways. Although both types of organelles undergo Ca
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is quite likely that they have differential mechanisms for the regulation of exocytosis 
(Zimmermann, 1997; De Camilli and Jahn, 1990). In addition, the differential distribution of 
the various synaptic proteins investigated in the present study demonstrates that there are 
distinct differences in membrane composition between microvesicles and neurosecretory 
granules in the nerve terminals of the neurohypophysis. This agrees with the notion that 
microvesicles represent organelles different from granules (Navone et al., 1989; Meeker et al., 
1991). Recently, it has been revealed by capacitance measurement the that the exocytosis of 
these two vesicle types is differently mediated (Klyachko and Jackson, 2002).  
4.2.9. Exocytosis of microvesicles in the neurohypophysis  
The similarity in morphology and membrane composition of microvesicles to synaptic 
vesicles suggests that microvesicles are involved in the secretion of messenger substances 
(Meeker et al., 1991; Navone et al., 1989; Hayashi et al., 1994b). The present observation 
provides further support for this hypothesis. An accumulation of small clear vesicles was 
found along the membrane and some vesicles beneath the plasma membrane appeared to be in 
contact with the plasma membrane (Meeker et al., 1991; Hayashi et al., 1994b). The presence 
of VAMP II, SNAP-25, and N-type Ca
2+ channels at the plasma membrane facing the 
clustered vesicles indicates in particular the competence of microvesicles for docking and 
exocytosis along the extended plasma membrane in the absence of active zones. 
Physiologically, by measuring the capacitance of the microvesicles, microvesicles have 
recently been demonstrated to have similar functional capabilities as synaptic vesicles and to 
undergo Ca
2+-triggered exocytosis in response to membrane depolarization (Klyachko and 
Jackson, 2002).  
However, the physiological significance of the exocytotic release of messenger substances 
from microvesicles for the neurohypophysis is still unclear. Generally, the secretion from 
neurosecretory terminals of the neurohypophysis is considered to function in the direct release 
of peptide hormones from the granules into the blood stream and this release of 
neurohormones is restricted to the terminals lining the pericapillary space. However, 
neurosecretory axons have frequently been observed to actually terminate near pituicytes, the 
specialized astrocytes of the neurohypophysis (Tweedle and Hatton, 1982). Synaptoid 
contacts have been observed between neurosecretory axons and pituicytes as well as between 
axonal terminals themselves (Castel et al., 1996; Boersma et al., 1993; Van Leeuwen et al., 
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inhibition of hormone release and there is a dynamic relationship between the neurosecretory 
processes and pituicytes. When the hormones are at high demand, synaptoid contacts with 
pituicytes are increased and pituicytes apparently retract their processes from the 
neurosecretory terminals, allowing greater access for nerve terminals to the basal lamina 
surrounding the fenestrated capillaries (Boersma et al., 1993). Therefore, there are probably 
direct cellular interactions between them. The messengers released from microvesicles may 
be used as local regulatory factors such as to coordinate the secretion of the neurohypophysial 
terminal. Thus, messenger substance release from neurohypophysial nerve endings includes 
not only exocytosis from secretory granules but also from microvesicles. Evidently, further 
studies on the microvesicle secretion will be very important for a thorough understanding of 
the physiological function of the neurohypophysis.  
 4.3. Expression and localization of transfected proteins in the 
astrocytoma cell line U373 MG 
The astrocytoma-derived U373 MG cell line can express  GFAP and release NGF, 
glutamate and GABA (Emmett et al., 1997; Ye and Sontheimer, 1999; Soria-Jasso and Arias-
Montano, 1996). Therefore, it is a potential cell line for the study of the astrocytic messenger 
release mechanism. In the present study, the expression and localization of some essential 
proteins responsible for regulated exocytosis and intercellular membrane fusion was 
investigated and compared to that in astrocytes and neurons  
4.3.1. Expression of transfected proteins  
Using transient transfection and immunocytochemistry techniques, the expression and 
distribution of a variety of recombinant proteins were examined in U373 MG cells in order to 
investigate the potential release characteristics of the messenger substances. The results reveal 
that U373 MG cells are capable of expressing all three members of the synaptic SNARE 
complex (the v-SNARE VAMP II, the t-SNAREs syntaxin I and SNAP-25), the ubiquitous v-
SNARE cellubrevin and the small GTP-binding protein Rab5. The synaptic SNARE complex 
has been demonstrated to play a crucial role in regulated exocytosis at synaptic terminals 
(Sollner et al., 1993a; Jahn and Sudhof, 1999). Cellubrevin, a synaptobrevin (VAMP II) 
homologue, has been thought to be involved in both constitutive and regulated exocytosis in 
many different tissues (McMahon et al., 1993). Rab5 is an endosome-associated GTP-binding Discussion  108
protein. It has been known to serve critical regulatory roles in endosome fusion and was found 
also on synaptic vesicles (Jahn and Sudhof, 1999; Fischer et al., 1994b).  
A large body of experimental evidence indicates that the fundamental mechanism involved 
in membrane trafficking from yeast to neuron is very similar (Morgan, 1995; Ferro-Novick 
and Jahn, 1994; Bennett and Scheller, 1993). This evolutionary conservation in all eukaryotic 
cells implies that similar proteins can be used for controlling membrane fusion in neurons and 
the other non-neural cells. Moreover, recent data have shown that proteins originally thought 
to be specific for synaptic neurotransmitter release might also occur in non-neural cells.  In 
particular, cultured astrocytes have been shown to express some members of the SNARE 
proteins, such as VAMP II and syntaxin I (Parpura et al., 1995a). Furthermore, the t-SNARE 
SNAP-25 and the synaptic vesicle proteins SV2, Rab3A, synaptotagmin I, synaptophysin, and 
synapsin I have been identified in primary astrocyte cultures from cerebral cortices of 
newborn rats (Maienschein et al., 1999). Consistent with the results of Maienschein et al. 
(1999) VAMP II was localized in the present experiment to vesicular organelles of different 
size at the ultrastructural level. These experiments were performed with primary astrocytes 
cultured from cerebral cortices of newborn rats. All of the above proteins have been 
implicated in astrocytic messenger release (Parpura et al., 1995a; Jeftinija et al., 1997). The 
astrocytoma cell line U373 has been shown to secrete neurotransmitters such as glutamate and 
GABA (Soria-Jasso and Arias-Montano, 1996; Ye and Sontheimer, 1999). In view of the 
functional generality of these membrane fusion-related proteins, it is reasonable to expect that 
the proteins expressed in U373 cells also serve similar functions as in neurons and astrocytes. 
The present results suggest that U373 are competent to carry out regulated exocytosis by 
means of the classical vesicular SNARE mechanism. 
4.3.2. Association of expressed proteins with vesicular organelles  
All recombinant synaptic proteins investigated in U373 cells reveal a very similar 
punctuate cellular distribution under the fluorescence microscope. This implies that all of 
them are mainly associated with intracellular compartments. Furthermore, the punctuate 
staining patterns of these transfected proteins are essentially equivalent to those of their 
corresponding endogenous counterparts (Volknandt et al., 2002), indicating that the 
transfected proteins were appropriately targeted  in U373 cells. The distribution of the v-
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consistent with their labeling pattern in cultured astrocytes (Maienschein et al., 1999; Parpura 
et al., 1995a).  
Under electron microscope U373 cells reveal abundant vesicular organelles. The organellar 
association of the proteins investigated was further confirmed by cryo-immunoelectron 
microscopic analysis. All proteins including the v-SNAREs VAMP II, cellubrevin, the t-
SNAREs syntaxin I, SNAP-25 and the small GTPase Rab5 were found to be selectively 
localized at the membrane of vesicular organelles of low electron density. This direct 
morphologic evidence reveals their participation in the trafficking of these vesicular 
organelles, probably including vesicle exocytosis in U373 cells. However, every protein has 
its own distribution characteristics, indicating that all of these proteins serve own specific 
functions in the particular cycling stages.  
VAMP II: VAMP II was identified as a membrane protein of synaptic vesicles first in the 
rat brain (Baumert et al., 1989) and has been known to play a critical role as v-SNARE in 
synaptic vesicle fusion of nerve terminals (Rizo and Sudhof, 1998). In addition, it is also 
expressed in astrocytes and in a variety of other nonneuronal cells (Rossetto et al., 1996). The 
cryo-electron microscopy showed that the recombinant myc-VAMP II was expressed in U373 
cells at a higher level than the other investigated proteins. It was associated with various types 
of vesicular organelles throughout the entire cell body.  In particular, myc-VAMP II was 
localized to numerous small vesicles and tubulovesicular organelles, suggesting that myc-
VAMP II is involved in the trafficking of these vesicles in U373 cells as it is in neurons and 
astrocytes. The observation that myc-VAMP II was present especially at the TGN vesicles of 
the Golgi apparatus and at tubulovesicular compartments of endosomes indicates that myc-
VAMP II could be sorted into small vesicles from the dynamic TGN and possibly also from 
endosomes. In addition, the occasional labeling on granules in the cytoplasm is in agreement 
with subcellular fractionation experiments demonstrating a small pool of VAMP II in 
association with granules in U373 cells (Volknandt et al., 2002). However, the high 
expression of myc-VAMP II at multivesicular bodies and lysosomes most likely resulted from 
the overexpression of this recombinant protein, resulting in its targeting to the ultimately 
degradative pathway. In addition, the dense arrangement of gold particles for myc-VAMP II 
over the plasma membrane in some cells might also result from the overexpression of this 
transfected protein. A similar observation was made at the plasma membrane of the PC12 
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1996). Nevertheless, it has been reported recently that VAMP II is associated with the plasma 
membrane of nerve terminals of the Torpedo electric organ (Taubenblatt et al., 1999), and  
VAMP II can also be sorted into small vesicles directly from the plasma membrane (Shi et al., 
1998). This broad distribution of VAMP II indicates that VAMP II is involved in various 
stages of vesicular cycling in U373 cells. Double labeling of myc-VAMP II with flag-
cellubrevin and myc-VAMP II with GFP-Rab5 revealed a partial colocalization. By 
comparison, myc-VAMP II was located more extensively and intensively in the peripheral 
cytoplasm than flag-cellubrevin and GFP-Rab5, where more myc-VAMP II was probably 
associated with vesicles of various form and size. 
SNAP-25 and syntaxin I: Both t-SNAREs of the neuronal fusion complex SNAP-25 and 
syntaxin I were expressed in U373 cells. Many previous studies have failed to demonstrate 
the presence of SNAP-25 in cultured astrocytes. It seems that the expression of SNAP-25 is 
restricted to neurons and neuroendocrine cells. By contrast, its homologue SNAP-23 was 
found to be widely distributed in astrocytes and other glial cell types (Hepp et al., 1999). 
However, in primary cultures from cerebral cortices of newborn rats the expression of SNAP-
25 has recently been demonstrated to be time-dependent. It declines with prolonged culture 
time (Maienschein et al., 1999). In the present study, the expression of transfected HA-SNAP-
25 was limited to only a minority of small cells, but with a relatively high expression level. It 
appears that the transfection with HA-SNAP-25 itself inhibits the growth of the transfected 
cells. However, the immunofluorescence of the HA-SNAP-25 in the transfected cells 
exhibited a similar pattern of immunoreactivity as for the other transfected protein. By 
contrast, another transfected t-SNARE, syntaxin I, was intensively expressed in a large 
number of U373 cells. Syntaxin I has been identified in astrocytes in many previous studies 
(Maienschein et al., 1999; Hepp et al., 1999; Parpura et al., 1995a). The labeling pattern of 
syntaxin I in U373 cells is consistent with that in cultured astrocytes.  
It is noteworthy that, in accordance with results obtained from astrocytes, the 
immunolabeling of both presumptive t-SNAREs syntaxin I and SNAP-25 in U373 cells was 
confined to the vesicular organelles. No significant labeling was found on the plasma 
membrane of U373 MG cells by immunofluorescence microscopy and electron microscopy. 
In neurons, although SNAP-25 and syntaxin I are localized primarily to the plasma membrane, 
these proteins have also been observed on synaptic vesicles or granules (Walch-Solimena et 
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remains to be elucidated. The high level of fluorescent colocalization of the recombinant 
proteins RFP-syntaxin I and myc-VAMP II in the cell body and in cell processes suggests that 
the two proteins were mostly sorted into identical vesicular organelles. It is possible that these 
syntaxin I- or SNAP-25-containing vesicles are used as a reserve pool of these t-SNAREs. 
However, it cannot be excluded that these t-SNARE proteins may also be involved in other 
functions, in addition to their participation in the formation of SNARE fusion complex.  
Cellubrevin:  Cellubrevin, a ubiquitously expressed small (14 kDa) integral membrane 
protein, is 97% identical to VAMP II (McMahon et al., 1993). It has a wide tissue distribution 
in non-neural cells and is selectively cleaved by tetanus toxin (Yamasaki et al., 1994; 
McMahon et al., 1993).  This toxin cleavage has been indicated to impair exocytosis of 
transferrin receptor-containing recycling vesicles in CHO cells (Galli et al., 1994).  In the 
nervous system cellubrevin is expressed at significant levels primarily in glial cells (Chilcote 
et al., 1995). In cultured astrocytes, cellubrevin was localized throughout the cytoplasm and 
accumulated primarily in the area occupied by the Golgi complex (Parpura et al., 1995a). 
Furthermore, cellubrevin has been revealed to interact with the t-SNAREs syntaxin I and 
SNAP-23 (Hepp et al., 1999) and also be a substrate for the proteolytic action of tetanus toxin 
and botulinum toxins in astrocytes (Verderio et al., 1999; Parpura et al., 1995a). In U373 
cells, the recombinant flag-cellubrevin was found throughout the cytoplasm and to be 
concentrated in the perinuclear area, consistent with the results from cultured astrocytes. 
Correspondingly, the gold particles for flag-cellubrevin were observed by electron 
microscopy at small vesicles dispersed in the cytoplasm and particularly at the TGN vesicles 
of the Golgi complex. Cellubrevin has been targeted to synaptic vesicle-like microvesicles 
when expressed in PC12 cells (Chilcote et al., 1995; Grote et al., 1995) and thought to have 
similar function as its homologue VAMP II because of their similar subcellular localization 
and biochemical properties (Chilcote et al., 1995). In U373 cells, though the overall 
distribution pattern of these two proteins was similar, double labeling of flag-cellubrevin with 
myc-VAMP II revealed only a partial colocalization in the cytoplasm as revealed by 
fluorescence microscopy. The yellow staining was confined to the differentially sized puncta 
dispersed in the cytoplasm. Under the electron microscopy, differentially sized gold particles 
for both proteins were visualized only over electron-lucent vesicles. The partial colocalization 
of these two proteins implies a similar function as v-SNARE.  Discussion  112
Rab5: The low molecular weight GTP-binding protein Rab5 has been known to regulate 
membrane traffic in the early endocytic pathway. It is responsible for the delivery of material 
from the plasma membrane to early endosomes (Bucci et al., 1992; Trischler et al., 1999) and 
functions as an important regulator of endosome fusion (Barbieri et al., 1998; Gorvel et al., 
1991; Stenmark et al., 1994). In addition, it has also been proposed that Rab5 is involved in 
membrane transport, motility and intracellular distribution of early endosomes by regulating 
the endosome interaction with microtubules (Nielsen et al., 1999). Rab5 has  been localized to 
endosomes (Sonnichsen et al., 2000; Novick and Zerial, 1997) and also to synaptic vesicles in 
rat brain (Fischer et al., 1994b). The Rab5-dependent trafficking pathway has been 
demonstrated to play an important role in synaptic neurotransmitter release. Rab5 
overexpression increases the release efficacy (Wucherpfennig et al., 2003). In primary 
astrocyte cultures Rab5 is found in the cytoplasm and over the membrane of the endosomes 
(Megias et al., 2000). In U373 cells, GFP-Rab5 was observed at clustered vesicular organelles 
and endosomes. This suggests that Rab5 is involved in the vesicle cycle and in endosome 
fusion of U373 cells. Double labeling for GFP-Rab5 and myc-VAMP II by fluorescent 
microscopy showed a partial colocalization in the cytoplasm. GFP-Rab5 was obviously more 
intensely expressed in the perinuclear area. A colocalization of these two proteins at the 
ultrastructural level was only found on some clustered vesicles. Partial colocalization of Rab5 
with VAMP II in U373 cells suggested that the endosomal protein Rab5 is associated with 
VAMP II-containing organelles during some stages of their life cycle. The potential 
functional relations between these two proteins require further study. 
4.3.3. Formation of small vesicles in U373 cells  
Numerous small vesicles (40-60 nm in diameter) occur in clusters or are dispersed 
individually in the cytoplasm of U373 cells. They represent potential organelles for the 
secretion of low molecule weight messengers in the cells. It has been known that early 
endosomes can act not only as an acceptor for membrane-derived endocytic vesicles but also 
as a sorting station for vesicle proteins in the vesicle recycling pathway (Grote and Kelly, 
1996). In PC12 cells, the recombinant protein VAMP II has been found to recycle through the 
vacuolar part of early endosomes to the associated tubules (emanating from vacuole). 
Moreover, endosome tubules have been demonstrated to bud off to yield a population of 
transport vesicles (de Wit et al., 1999; Geuze et al., 1987). On the other hand, a second 
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plasma membrane is the direct precursor of synaptic vesicles (Schmidt et al., 1997; Shi et al., 
1998; Takei et al., 1996). The proteins of small vesicles are sorted directly from plasma 
membrane, without passing through an endosomal intermediate. Schmidt et al. (1997) 
described a novel compartment, from which small vesicles originate. This compartment was 
connected to the plasma membrane via narrow membrane continuity, forming the so-called 
sub-plasmalemmal tubulo-cisternal membrane system.  
In the present experiment, tubular structures were observed to be connected directly with 
the plasma membrane. Furthermore, some small round vesicles appeared to be budding from 
thick and deep tubulovesicular invaginations of the plasma membrane. Many vesicle clusters 
were found to be generated from plasma membrane-deriving tubulovesicular structures or 
vacuoles in the periphery of the cells. Moreover, the wide tubulovesicular structures beneath 
the plasma membrane which were similar to the donor compartments of synaptic-like 
microvesicles in PC12 cells (Schmidt et al., 1997) were labeled by VAMP II. These 
observations provide direct morphological evidence for the existence of a plasma membrane-
derived pathway of vesicle formation in U373 cells. In addition, a high level of the vesicle 
protein VAMP II was localized to both the endosomal vacuoles and the associated 
tubulovesicular  structures. Interestingly, also tubules that were fragmenting into small 
vesicular profiles were observed in the cytoplasm. These tubules are likely candidates for the 
intracellular  donor compartment of small vesicles in U373 cells. VAMP II has been 
demonstrated to be sorted into small vesicles from both endosomes and the plasma membrane 
in PC12 cells (Shi et al., 1998). The results from U373 cells support the notion that two 
pathways of small vesicle formation coexist in the same cell.  
4.3.4. Similarities between U373 cells and cultured astrocytes in 
exocytosis 
The subcellular fractionation experiments in our laboratory revealed that U373 cells 
contain two pools of vesicular organelles with clearly different density. The organelles of 
lower density carry the majority of myc-VAMP II and the granule pool of high density 
contains mainly secretogranin II and a small amount of myc-VAMP II. Thus, U373 MG cells 
may also use two types of vesicular organelles to release messenger substances by the 
regulated pathway (Volknandt et al., 2002).  In line with these findings the present study 
indicates that U373 MG cells can express many essential proteins that are involved in 
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the association of all these expressed proteins with electron-lucent vesicular organelles, 
indicating the potential of U373 MG cells to release low molecular weight messengers by 
vesicular secreting pathway similar or identical to that in neurons or cultured astrocytes. In 
addition, the labeling of myc-VAMP II on the granules exhibits that VAMP II may participate 
in the release of the granules in U373 cells. The release of secretogranin II from granules by 
means of bradykinin and ATP as well as the calcium ionophore calcimycin has been shown in 
U373 cells, suggesting that U373 cells can secrete proteins or peptides via a regulated release 
pathway similar to astrocytes (Volknandt et al., 2002).  
Similar to cultured astrocytes, U373 cells do not form axons and lack synapses. While 
clustered small vesicles or tubulovesicular structures were extensively observed in the 
cytoplasm or even close to plasma membrane, neither a distinct release region, such as “the 
active zone” nor docked small vesicles  in specialized areas of the cells were found. In 
addition, the expression pattern of the investigated proteins in U373 cells shares similarities 
with that in long term cultured astrocytes. VAMP II, cellubrevin, syntaxin I, SNAP-25 and 
SNAP-23 were demonstrated to be the essential members of SNARE proteins in U373 cells 
(Volknandt et al., 2002). Moreover, unlike in neurons, syntaxin I and SNAP-25 in U373 cells 
were found to be associated only with intracellular vesicular organelles showing a similar 
organellar association as in cultured astrocytes. Obviously, the GFAP-expressed astrocytoma 
cell line U373 MG is equipped with many representative astrocytic release characteristics. 
The cells release their messenger substances probably via a similar secretory mechanism as 
astrocytes.  
4.4. Perspectives 
The present study reveals that the cryo-immunogold technique has strong advantages in 
preserving both structural integrity and peptide antigenicity. The negative contrast is excellent 
to delineate membrane structure. This technique is expected to be applied in the further 
studies for the localization of the synaptic proteins and/or the other membrane proteins.   
As expected, in the present study, an evidently increased immunolabeling for VAMP II, 
SNAP-25, Rab3A, SV2 and N-type Ca
2+ channels is revealed at active zones of fast synapses. 
However, the widespread distribution of the t-SNAREs along the axonal plasma membranes 
reveals that the specific SNARE interactions cannot be the sole targeting determinants. The 
presumptive role of SNARE proteins in docking and exocytosis of the synaptic vesicles must Discussion  115
be complemented by other factors. The presynaptic dense projections of the active zone have 
been thought to serve as structures for guiding vesicle to release sites (Zimmermann, 1993). 
However, these could not be recognized in the present experiment because they are only 
revealed by staining with phosphotungstic acid. The improvement of the staining method for 
displaying this structure together with the docked vesicles and the immunolabeling of the 
synaptic proteins on the cryosections should be helpful for a further functional analysis of 
these synaptic proteins at the action zone and in the study of the mechanism of exocytosis.  
Although the immunolabeling was specifically allocated to defined organelles, not all of 
them could be labeled. At the active zone, only part of the proteins involved in the docking 
complex bound the gold particles. A possible explanation is that the immunolabeling is 
mostly limited to the available epitopes exposed at the surface of the cryosections. The small 
1.4 nm Nanogold proved to be able to penetrate farther into the low-density matrix of the 
cryosections. In the present experiments, 1.4 nm immunogold particles together with silver 
enhancement gave rise to a higher labeling density than colloidal gold. However, there are 
still some problems with the irregular size of the enhanced particles and the merging of 
growing silver/gold particles. An improvement of the present procedure with more suitable 
experimental conditions would provide a more effective approach for the further studies.   
Dense gold particles for α/β-SNAP, as well as for Rab3A and P/Q-type Ca
2+ channels were 
found selectively on the granules in some specific terminals. However, the presence of the 
labeling of these proteins in the interior of the granules is very elusive. Whether the selective 
labeling of the interior of the granules implies a specific association with the core material of 
the granules or an artifactual association requires further study. The investigation of the 
function of these proteins in the granules might provide important data for the study of the 
granule secretory mechanism.  
Microvesicles have a similar morphology and membrane composition as synaptic vesicles 
and also store neurotransmitters. Their secretion competence is demonstrated again in the 
present study. The study of messenger substance release from neurohypophysial nerve 
endings should include not only exocytosis from secretory granules but also from 
microvesicles. Further investigatios on the release mechanism and the physiological function 
of microvesicles will be very important for understanding thoroughly the properties of 
neurosecretion in the neurohypophysis.  Discussion  116
Like neurons and astrocytes, U373 MG cells may also use two types of vesicular 
organelles to release messenger substance via regulated pathway (Volknandt et al., 2002). The 
present results demonstrated that U373 MG cells are capable of expressing all three members 
of the synaptic SNARE complex (v-SNARE VAMP II, t-SNAREs syntaxin I and SNAP25) 
and the ubiquitous v-SNARE cellubrevin.  However, similar to cultured  astrocytes, the 
immunolabeling of both presumptive t-SNAREs syntaxin I and SNAP-25 was confined to the 
intracellular vesicular organelles. No significant labeling was identified by electron 
microscopy at the plasma membrane of U373 MG cells. The high level of fluorescent 
colocalization of syntaxin I and VAMP II in the cell body and in processes suggests that 
syntaxin I is mostly sorted into identical vesicular organelles as VAMP II. The exact function 
of these presumptive t-SNARE proteins in this astrocytic cell line requires further study. On 
the other hand, if syntaxin I and SNAP-25 are not present at the plasma membrane, which 
proteins would then take over the t-SNARE function for exocytosis in U373 cells? Isoforms 
of these t-SNARE proteins seem to be potential candidates. The identification of the possible 
t-SNARE proteins by means of the biochemical and/or immunochemical methods will be very 
significant for the clarification of the release mechanism in astrocytic cells.  Summary  117
5. Summary / Zusammenfassung 
SUMMARY: In the present study the cryo-immunogold technique was used and 
optimized for investigating the ultrastructure and immunolabeling of synaptic proteins. It is 
evidently a suitable method for the localization of membrane proteins since the antigens are 
not treated with any chemical denaturation before immunolabeling except for the fixation and 
since the antigens are directly exposed to the surface of the cryo-ultrasections.  
The v-SNARE VAMP II and the vesicle-associated proteins SV2 and Rab3A were 
detected extensively at small vesicles in the mossy fiber terminals. The t-SNARE SNAP-25, 
and N-type and P/Q type Ca
2+ channels were allocated to the plasma membrane both at the 
active zone and outside the active zone. SNAP-25 and N-type Ca
2+ channels appeared also at 
synaptic vesicles. A significantly increased immunolabeling of VAMP II, SV2, Rab3A, 
SNAP-25 and N-type Ca
2+ channels was found at the active zones of fast synapses, indicating 
a concentration of these proteins at sites of exocytosis.  
The widespread distribution of the t-SNARE SNAP-25 at the axonal plasma membrane 
reveals that membrane-targeting specificity cannot be determined solely by v/t-SNARE 
interactions. Additional control components are required to assure the docking and exocytosis 
of the synaptic vesicles at active zones. 
The novel protein Bassoon was only found at active zones of central synapses and showed 
the highest specific labeling among all proteins investigated. Its labeling pattern implies an 
association of Bassoon with the presynaptic dense projections, the structural guide for vesicle 
exocytosis. The involvement of Bassoon in the organization of the neurotransmitter release 
site suggests that Bassoon may play an important role in determining the specificity of vesicle 
docking and fusion. 
In the neurosecretory endings of neurohypophysis the synaptic proteins VAMP II, SNAP-
25, SV2, Rab3A, and the N-type Ca
2+ channels showed a preferential labeling over 
microvesicles. Moreover, the immunolabeling intensity of these proteins over microvesicles 
corresponded closely to that over synaptic vesicles. This suggests that these synaptic proteins 
share an identical association with synaptic vesicle and microvesicles. A significant labeling 
of SNAP-25, the N-type Ca
2+ channels and VAMP II was also detected at the plasma Summary  118
membrane near the clustered microvesicles, indicating the competence of microvesicles for 
docking and exocytosis along the plasma membrane in the absence of active zones.  
No significant labeling of VAMP II, SNAP-25, SV2 and N-type Ca
2+ channel was 
observed at the membrane of neurosecretory granules. This is in agreement with the notion 
that synaptic vesicles and microvesicles possess regulatory mechanisms for exocytosis 
different from those of granules. In contrast, α/β-SNAP and NSF were found on the granules, 
and Rab3A and the P/Q-type Ca
2+ channels on granules in a subset of terminals. Rab3A is 
associated specifically with the oxytocin-containing granule population.  
Interestingly, some plasma membrane proteins, such as SNAP-25 and even N-type Ca
2+ 
channels and P/Q-type Ca
2+ channels, were observed not only at the plasma membrane but 
also at the vesicular organelles. This suggests that these vesicular organelles may be involved 
in transporting newly synthesized proteins from the soma to the plasma membrane of the 
terminal. Furthermore, the vesicular pool of the Ca
2+ channels may serve in the stimulation-
induced translocation into the plasma membrane when required.  
Using the conventional preembedding method with Epon and the post-embedding method 
with LR Gold, VAMP II was localized at vesicular organelles of varying size and on 
horseradish peroxidase filled endocytic organelles in cultured astrocytes, with and without 
stimulation in the presence of the horseradish peroxidase. This indicates that VAMP II is 
involved in the cycle of vesicular exocytosis and endocytosis in astrocytes.  
U373 cells are capable of expressing all three members of the synaptic SNARE complex 
(v-SNARE VAMP II, t-SNARE syntaxin I and SNAP25). This indicates the competence of 
U373 to carry out regulated exocytosis by means of the classical SNARE mechanism. In 
addition, the ubiquitous v-SNARE cellubrevin and the endosome-associated small GTP-
binding protein Rab5 could be expressed in U373 cells.  
All recombinant synaptic proteins investigated in U373 cells revealed a punctuate cellular 
distribution under the fluorescence microscope, suggesting that they are mainly associated 
with intracellular compartments. The cryo-electron microscopy provided direct evidence for 
the association of all expressed proteins with electron-lucent vesicular organelles. It further 
supports the potential of U373 MG cells to release low molecular weight messengers by a 
regulated exocytosis mechanism. In addition, myc-VAMP II was found on dispersed granules. 
Probably, VAMP II also participates in the exocytosis event of granules in U373 cells.  Summary  119
Gold labeling for the two presumptive t-SNAREs syntaxin I and SNAP-25 in U373 cells 
was confined to the vesicular organelles. At the ultrastructural level no significant labeling 
was identified at the plasma membrane.  
The high level of colocalization of the two SNARE proteins VAMP II and syntaxin I in the 
cell body and in cell processes suggests that the two proteins are mostly sorted into identical 
vesicular organelles. A partial colocalization of VAMP II and cellubrevin as well as of 
VAMP II and Rab5 was observed under the fluorescence microscope. At the ultrastructural 
level, a colocalization of VAMP II and cellubrevin as well as of VAMP II and Rab5 was 
found on some clustered vesicles. The partial colocalization of VAMP II and cellubrevin 
implies that they similarly function as v-SNAREs. The partial colocalization of Rab5 with 
VAMP II in U373 cells suggests that the endosomal protein Rab5 is associated with VAMP 
II-containing organelles during some stages of their life cycle.  Zusammenfassung  120
ZUSAMMENFASSUNG: Die Freisetzung von Neurotransmittern aus kleinen synaptischen 
Vesikeln schneller Synapsen hängt von dem koordinierten Zusammenwirken spezifischer 
Vesikelproteine ab. Genetische, physiologische und biochemische Untersuchungen legen 
nahe, dass sich viele synaptische Proteine - einschließlich der Mitglieder der SNARE-Familie 
- an den Exozytose-Prozessen der synaptischen Vesikel beteiligen. Die genauen molekularen 
Mechanismen der Vesikel-Exozytose sind jedoch weitgehend unbekannt. Es fehlen außerdem 
eindeutige morphologische Nachweise der bevorzugten Lokalisation dieser Proteine an den 
aktiven Zonen des Synapsen, die ihre Assoziation mit der schnellen Neurotransmitter-
Freisetzung in situ zeigen könnten. Die fundamentalen Mechanismen des „membrane traffic“ 
gelten bei allen eukaryotischen Zellen als phylogenetisch konserviert. Dies bedeutet, dass 
ähnliche Proteine für die Kontrolle der Membranfusion sowohl bei Neuronen als auch bei 
anderen nicht-neuralen Zellen benutzt werden können. Wie zahlreiche jüngere 
Untersuchungen zeigen, können Astrozyten ihre Botenstoffe mittels eines Neuronen-
ähnlichen sekretorischen Prozesses freisetzen. Dabei wird vermutlich eine regulierte Vesikel-
Exozytose und besonders der klassische SNARE-Mechanismus in den Sekretionsprozess 
miteinbezogen. Allerdings gibt es für den Vesikelzyklus bei Astrozyten kaum 
morphologische Nachweise für die Funktion der Exozytose-relevanten Proteine.  
In der vorliegenden Arbeit wurden daher die Lokalisation von SNARE-Proteinen sowie 
anderen Vesikel-relevanten Proteinen an zwei unterschiedlichen Nerventerminalen sowie bei 
astrozytären Zellen mittels Immunfluoreszenz und Elektronenmikroskopie untersucht. Ziel 
dieser Arbeit ist es, ein besseres Verständnis der Funktion dieser Proteine bei der Freisetzung 
der Botenstoffe zu erhalten. 
1. Lokalisation der synaptischen Proteine an zwei unterschiedlichen Typen von 
Nervenendigungen 
Zum morphologischen Nachweis der verschiedenen synaptischen Proteine wurde die 
Methode der Immungoldmarkierung an ultradünnen Kryoschnitten angewendet. Untersucht 
und analysiert wurden die Lokalisation und die Verteilung dieser synaptischen Proteine an (1) 
den großen Moosfaserendigungen mit vielen aktiven Zonen in der hippocampalen CA3 
Region, und an (2) den neurosekretorischen Terminalen ohne spezielle Freisetzungsstellen in 
Neurohypophyse. Hier war besonders von Interesse, ob SNARE-Proteine vorzugsweise mit 
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dieser Proteine in solchen Endigungen, die keine definierten Freisetzungsstellen besitzen, von 
denjenigen in den synaptischen Terminalen verschieden sind.  
In den hippokampalen Moosfaserendigungen wurden das v-SNARE VAMP II und die 
weiteren Vesikel-gebundenen Proteine SV2 und Rab3A umfassend an den synaptischen 
Vesikeln lokalisiert. Das t-SNARE SNAP-25, und N- und P/Q-Typ Ca
2+-Kanäle ließen sich 
an der Plasmamembran in und außerhalb der aktiven Zone nachweisen. SNAP-25 und N-Typ 
Ca
2+-Kanäle wurden auch an synaptischen Vesikeln gefunden. Die quantitative Analyse 
zeigte eine deutlich erhöhte Immunmarkierung von VAMP II, SV2, Rab3A, SNAP-25, und 
N-Typ Ca
2+-Kanäle an den aktiven Zonen. Dies deutet auf eine direkte Teilnahme solcher 
Proteine an der Exozytose von synaptischen Vesikeln in den schnellen zentralen Synapsen. 
Besonders die Markierung von VAMP II und SNAP-25 dicht an den angedockten 
synaptischen Vesikeln und an der Plasmamembran in aktiven Zonen weist auf eine 
Assoziation von diesen Proteinen mit dem präsynaptischen Docking-Komplex hin. Der 
Nachweis von N-Typ und P/Q-Typ Ca
2+-Kanäle an den aktiven Zonen liefert einen 
morphologischen Beleg für ihre Beteiligung an der Regulierung der schnellen 
Neurotransmission. Er unterstützt auch die Hypothese, dass diese beiden Ca
2+-Kanäle mit 
dem SNARE-Komplex interagieren können.  
Die breite Verteilung von SNAP-25 an der axonalen Plasmamembran weist darauf hin, dass 
seine Funktion nicht wesentlich für die Positionierung der Freisetzungsstelle von synaptischen 
Vesikeln sein dürfte. Die Docking-Spezifität der Vesikel wird nicht nur durch die v/t-
SNARE-Interaktion definiert. Zusätzliche kontrollierende Faktoren sind folglich erforderlich, 
um „docking“ und Exozytose der synaptische Vesikel an der aktiven Zone zu gewährleisten.  
Das hochmolekulare Protein Bassoon war hauptsächlich an den aktiven Zonen der zentralen 
Synapsen zu finden. Direkt auf der Plasmamembran waren jedoch keine Markierungen 
nachzuweisen. Das Verteilungsmuster deutet auf eine Assoziation von Bassoon mit den 
„presynaptic dense projections“ hin. Die Einbeziehung von Bassoon in die Organisation des 
Freisetzungsortes von Neurotransmittern verdeutlicht, dass dieses Protein eine wichtige Rolle 
bei der Definition der Spezifität für „docking“ und Fusion der synaptischen Vesikeln spielt. 
In den neurosekretorischen Endigungen der Neurohypophyse zeigten die synaptischen 
Proteine VAMP II, SV2, Rab3A, SNAP-25, und die N-Typ Ca
2+-Kanäle eine bevorzugte 
Markierung auf Mikrovesikeln. Die Intensität der Immunmarkierung dieser Proteine auf den 
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dass diese synaptischen Proteine eine identische funktionelle Bedeutung auf synaptischen 
Vesikeln und Mikrovesikeln besitzen. Die vorliegende Untersuchung stützt damit die 
Hypothese, dass die Mikrovesikel nicht nur bezüglich ihrer Größe und ihrer Morphologie 
denen typischer synaptischer Vesikel ähnlich sind, sondern auch ähnliche Eigenschaften wie 
diese haben. Eine starke Markierung von SNAP-25, N-Typ Ca
2+-Kanäle sowie von VAMP II 
ließ sich auch an der Plasmamembran nahe der Mikrovesikel-Cluster nachweisen. Dies läßt 
vermuten, dass Mikrovesikel die Kompetenz zum „docking“ und zur Exozytose entlang der 
Plasmamembran besitzen, auch wenn eine aktive Zone fehlt. Die aus den Mikrovesikeln 
freigesetzten Botenstoffe könnten als lokale regulierende Faktoren verwendet werden, um die 
Sekretion an neurohypophysären Endigungen zu koordinieren.  
An den neurosekretorischen Granula konnten Markierungen von VAMP II, SV2, SNAP-25, 
und N-Typ Ca
2+-Kanäle nicht nachgewiesen werden. Dies entspricht der Vorstellung, dass 
Granula, verglichen mit Mikrovesikeln und synaptischen Vesikeln, unterschiedliche 
Mechanismen für die Exozytose besitzen. Allerdings wurden α/β-SNAP und NSF auf den 
Granula nachgewiesen, und ebenso Rab3A und P/Q-Typ Ca
2+-Kanäle auf den Granula einer 
Subpopulation von neurohypophysären Terminalen. Rab3A war mit Oxytocin-Granula 
spezifisch assoziiert, wie durch die Doppelmarkierung gezeigt werden konnte. Die 
Markierungen von α/β-SNAP an der Plasmamembran und am Verbindungsstiel des 
Granulums mit der Plasmamembran lassen vermuten, dass α/β-SNAP an die Regulierung der 
Exozytose der neurohypophysärer Granula mitbeteiligt ist. Die Markierungen für α/β-SNAP 
und NSF auf den Granula unterstützen die Hypothese, dass vesikuläre Organellen beide 
Proteine zum Exozytoseort transportieren können. Möglicherweise können diese Proteine ihre 
Funktion bereits vor dem Vesikeldocking ausüben. Außerdem zeigte keine der untersuchten 
Proteine eine konzentrierte Markierung an spezifischen Domänen der Plasmamembran der 
neurohypophysären Endigungen. Auch diese Ergebnisse machen deutlich, dass in den 
neurohypophysären Endigungen ein definierter Freisetzungsort fehlt. Offensichtlich 
entsprechen die Unterschiede bezüglich der Verteilung der untersuchten Proteine in den 
beiden Nerventerminalen auch den spezifischen Funktionseigenschaften dieser Proteine, was 
wiederum in hohem Maße mit den spezifischen Funktionseigenschaften der beiden 
Nerventerminalen selbst korrespondiert.  
Interessanterweise konnten einige Plasmamembranproteine, wie SNAP-25, sogar N- und P/Q-
Typ Ca
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lokalisiert werden. Vermutlich sind diese vesikulären Organellen am Transport von neu 
synthetisierten Proteinen vom Soma bis zur Plasmamembran in den Nervenendigungen 
beteiligt. Weiterhin wurde vorgeschlagen, dass SNAP-25 zusammen mit den synaptischen 
Vesikeln in den Terminalen rezirkuliert wird, um sie dann zu reaktivieren. Der vesikuläre 
Vorrat an Ca
2+-Kanälen könnte wiederum der stimulationsabhängigen Translokation in die 
Plasmamembran dienen.  
2. Lokalisation der Vesikel-relevanten Proteine in astrozytären Zellen 
Um die Funktion von synaptischen Proteinen in astrocytären Zellen zu verstehen, wurde die 
subzelluläre Lokalisation von den Proteinen auf vesikulären Organellen sowie auf den durch 
Stimulation induzierten endozytotischen Kompartimenten an kultivierten kortikalen 
Astrozyten von neonatalen Ratten nachgewiesen. Zusätzlich wurden die Expression und die 
Lokalisation vieler Proteine, die für eine regulierte Exozytose und die interzelluläre 
Membranfusion verantwortlich sind, an Zellen aus einer permanenten Astrozytoma-Zellinie 
(U373 MG) untersucht. Verschiedene Konstrukte, die für die Proteine und die relevanten 
zusätzlichen Tags kodieren, wurden transient in diese Zellen transfiziert. Die Lokalisation der 
exprimierten rekombinanten Proteine wurde anschließend mittels Immunfluoreszenz und 
Kryo-Immunelektronmikroskopie nachgewiesen. Das Ziel war es, die sekretorischen 
Charakteristika der U373 MG Zellen aufzuklären sowie zu prüfen, ob diese Zell-Linie als 
effektives experimentelles Modell zur weiteren Studie des astrozytären Exozytose-
Mechanismus genutzt werden kann. 
In kultivierten Astrozyten konnte VAMP II an elektronenlichten vesikulären Organellen 
variierender Größe sowie an mit Meerrettich-Peroxidase (HRP) gefüllten endozytotischen 
Organellen - mit oder ohne Stimulation in Anwesenheit von HRP - sowohl mittels der 
Präembedding-Methode als auch mittels der LR Gold Postembedding-Methode nachgewiesen 
werden. Daraus folgt, dass in Astrozyten VAMP II am Zyklus der vesikulären Exo- und 
Endozytose beteiligt wird.  
U373 MG Zellen konnten alle drei Mitglieder des synaptischen SNARE-Komplexes (v-
SNARE VAMP II, t-SNARE Syntaxin I, und SNAP-25) exprimieren. U373 MG Zellen sind 
folglich fähig, eine regulierte Exozytose mittels des klassischen vesikulären SNARE-
Mechanismus durchzuführen. Zusätzlich konnten auch das ubiquitär vorhandene v-SNARE 
Cellubrevin und das Endosomen-assoziierte kleine GTP-bindende Protein Rab5 in den U373 
MG Zellen exprimiert werden. Zusammenfassung  124
Alle exprimierten rekombinanten Proteine zeigten in den U373 MG Zellen fluoreszenz-
mikroskopisch eine punktuelle zelluläre Verteilung. Vermutlich sind diese Proteine vor allem 
mit intrazellulären Kompartimenten assoziiert. Elektronenmikroskopisch zeigten sich in U373 
MG Zellen zahlreiche vesikuläre Organellen. Den direkten Nachweis für eine Assoziation 
dieser Proteine mit den hellen Vesikeln lieferte der immunzytochemische Nachweis aller 
exprimierten Proteine an ultradünnen Kryoschnitten. Diese Daten weisen vor allem auf das 
Potential der U373 MG Zellen hin, niedermolekulare Botenstoffe mittels einer regulierten 
Exozytose freizusetzen.  
Die Kryoelektronen-Mikroskopie zeigte außerdem, dass myc-VAMP II in größerer Menge als 
die anderen untersuchten Proteine in U373 MG Zellen exprimiert wurden. Verschiedene 
Typen vesikulärer Organellen wurden intensiv mit myc-VAMP II markiert. Besonders 
auffallend sind dichte Markierungen auf zahlreichen kleinen Vesikeln, tubulovesikulären 
Organellen sowie der Plasmamembran. Vermutlich ist myc-VAMP II am Recycling von 
hellen vesikulären Organellen mitbeteiligt. Auch Granula sind mit myc-VAMP II markiert. 
Dies bedeutet, dass sich dieses Protein in den U373 MG Zellen auch an der Exozytose der 
Granula beteiligen kann. Die massive Expression von myc-VAMP II an multivesikulären 
Körpern und Lysosomen läßt sich wahrscheinlich auf überexprimiertes rekombinantes Protein 
zurückführen, das schließlich degradiert wird. Diese vielfältige VAMP II Markierung in U373 
MG Zellen weist darauf hin, dass dieses Protein an den verschiedenen Stadien des 
Vesikelrecyclings beteiligt ist. Die hohe Kolokalisation der zwei SNARE-Proteine VAMP II 
und Syntaxin I im Zellkörper und in den Zellfortsätzen weist darauf hin, dass beide Proteine 
in der Regel in identische vesikuläre Organellen sortiert werden. Die teilweise Kolokalisation 
von VAMP II mit Cellubrevin an den hellen Vesikeln deutet auf eine ähnliche Funktion der 
beiden v-SNAREs hin.  
GFP-Rab5 ließ sich an hellen Vesikeln und Endosomen nachweisen. Vermutlich ist Rab5 
sowohl in das Vesikelrecycling als auch in die Endosomenfusion der U373 MG Zellen 
involviert. Die teilweise Kolokalisation von Rab5 mit VAMP II an den hellen Vesikeln weist 
darauf hin, dass das endosomale Protein Rab5 während einiger Stadien seines Lebenszyklus 
mit den VAMP II-enthaltenen Organellen verbunden ist. 
Ähnlich wie bei den kultivierten Astrozyten konnten bei U373 MG Zellen keine eindeutigen 
Freisetzungsorte, wie eine neuronale aktive Zone, nachgewiesen werden. Auch kleine 
gedockte Vesikel sind in definierten Zellbereichen nicht zu finden. Überdies ähnelt das Zusammenfassung  125
Expressionsmuster der untersuchten Proteine dem über lange Zeit kultivierter primärer 
Astrozyten. Die Markierung für die beiden mutmaßlichen t-SNARE Syntaxin I und SNAP-25 
fand sich auf vesikulären Organellen. Die Plasmamembran der U373 MG Zellen zeigte keine 
signifikante Markierung. Diese Befunde legen nahe, dass U373 MG Zellen ihre Botenstoffe 
über einen ähnlichen Sekretionsmechanismus wie Astrozyten freisetzen. Sie können daher als 
geeignetes Model für weitere Untersuchungen des astrozytären Exozytosemechanismus 
eingesetzt werden. References  126
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